Sommaire

• • ·Author Index

    Page :317-329

    
• • ·Notes Page

    Page :330

    

• Podium Sessions

  • ·PD-01.01 : Even in low PSA ranges (0-2.5 ng/ml/cc) the PSA density of the transition zone is a very significant adjunct to serum PSA in differentiating prostate cancer from benign disease

    Page :1

    V. Scattoni, T. Ben Addi, P. Hoffman, C.C. Schulman, P. Rigatti, F. Montorsi, A.R. Zlotta

    Plan Plan
  • ·PD-01.02 : The PSA era is not over for detecting prostate cancer: correlations between PSA levels and transition zone volume in 1952 men with PSA levels < 10 ng / ml who underwent 10-14 biopsies

    Page :1

    V. Scattoni, T. Ben Addi, C.C. Schulman, P. Rigatti, F. Montorsi, A.R. Zlotta

    Plan Plan
  • ·PD-01.03 : Is adjuvant androgen deprivation therapy a treatment of curative intent?

    Page :1-2

    N. Fleshner, T.E. Keane, C.A. Lawton, P.F. Mulders, H. Payne, S. Taneja, T. Morris

    Plan Plan
  • ·PD-01.04 : Phase II dose finding study of ozarelix, an LHRH antagonist, in patients with inoperable prostate cancer

    Page :2

    F.M.J. Debruyne, K. Neykov, V.D. Taskova, S. Stratev, A. Bantchev, S.S. Karanikolov, S. Chawla, G. Lenaz, M. Peukert, J. Engel

    Plan Plan
  • ·PD-01.05 : Analysis of body temperature changes during hot flushes in men after bilateral orchidectomy (BO) for prostate cancer

    Page :2

    N.A. Aziz, C.F. Heyns

    Plan Plan
  • ·PD-01.06 : PSA / PAP ratio is a significant prognostic factor in patients with stage IV prostate cancer

    Page :2-3

    T. Saito, N. Hara, Y. Kitamura, S. Komatsubara

    Plan Plan
  • ·PD-01.07 : ATP combination therapy enhances the cytotoxic effect of mitoxantrone in hormone refractory prostate cancer

    Page :3

    M. Shabbir, C.S. Thompson, R.J. Morgan, G. Burnstock

    Plan Plan
  • ·PD-01.08 : Pragmatic recommendations and directions for future work based on a meta-analysis of 1653 patients treated with intermittent hormone therapy (IHT) for adenocarcinoma of the prostate

    Page :3

    G. Shaw, J. Cuzick, L. Goldenberg, N. Spry, D. Prapotnich, S. Malone, J. Forman, M. Scholz, W. Albrecht, T. Oliver

    Plan Plan
  • ·PD-01.09 : The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management

    Page :3-4

    A. Ochiai, P. Troncoso, M. Chen, R.J. Babaian

    Plan Plan
  • ·PD-01.10 : Erectile dysfunction in men treated with visually directed HIFU for clinically localized prostate cancer

    Page :4

    R.O. Illing, S. Dawkins, C.W. Ogden, M. Emberton

    Plan Plan
  • ·PD-02.01 : The effects of one-year treatment with an isoflavone extract from red clover on prostate, liver, sexual function and quality of life in men

    Page :4

    P. Engelhardt, C. Riedl

    Plan Plan
  • ·PD-02.02 : The effects of alpha-blockers, finasteride and plant extracts on the need for surgical treatment among Slovakian men with benign prostatic hyperplasia: a cross-sectional study of ten years’ follow-up

    Page :4-5

    J. Svihra, A. Szalayova, D. Bushnell, L. Macko, L. Poliak, J. Luptak, J. Kliment

    Plan Plan
  • ·PD-02.03 : A low vitamin D level is an independent risk factor for the development of benign prostatic hyperplasia

    Page :5

    J. Hammarsten, J.-E. Damber, O. Johnell, T. Knutson, Ö. Ljunggren, C. Ohlsson, R. Peeker, U. Smith, W. Waern, D. Mellström

    Plan Plan
  • ·PD-02.04 : Myocardial injury during transurethral prostatectomy: identification, incidence, and risk factors

    Page :5-6

    H. Ibrahim, D. Brathwaite, Z. Hussain, R.D. Inman, M.J. Hallworth, P.W. Jones, S.W.V. Coppinger

    Plan Plan
  • ·PD-02.05 : Effect of dutasteride on improvement of each IPSS item in patients with symptomatic benign prostatic hyperplasia

    Page :6

    F. Desgrandchamps, S. Droupy, J. Irani, C. Saussine, A. Comenducci

    Plan Plan  
  • ·PD-02.06 : Impact of baseline variables on the risk of BPH/LUTS progression: results of a 2-year placebo-controlled study with alfuzosin 10mg once daily

    Page :6-7

    C. Roehrborn, ALTESS study group

    Plan Plan
  • ·PD-02.07 : Serum prostate-specific antigen is a predictor of the transition zone volume rather than total prostate volume in men with benign prostatic hyperplasia

    Page :7

    A.R. Zlotta, T. Ben Addi, C.C. Schulman, P. Rigatti, V. Scattoni, F. Montorsi

    Plan Plan
  • ·PD-02.08 : The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH)

    Page :7-8

    C.G. Roehrborn, K.T. McVary, J.D. Kaminestsky, S.M. Auerbach, B. Wachs, J.M. Young, A. Sesler, G.D. Sides, B.S. Denes

    Plan Plan
  • ·PD-02.09 : Finasteride alone maintains stable urinary symptoms (ipss) in men with benign prostatic hyperplasia after 9 months of combination therapy using an alpha-blocker and finasteride

    Page :8

    M. Elhilali, C. Dupont, C. Koch, PROACT study centers

    Plan Plan
  • ·PD-02.10 : Day surgery transurethral resection of prostate: our initial experience

    Page :8

    W.J. Chua, M.J.B. Tibung, D. Consigliere

    Plan Plan
  • ·PD-02.11 : Cetrorelix pamoate, an LHRH antagonist, in the treatment of BPH: randomized, placebo-controlled multicenter study

    Page :8-9

    F.M.J. Debruyne, M. Tzvetkov, Z. Medverec, S. Altarac, M. Peukert, J. Engel

    Plan Plan
  • ·PD-03.01 : Peri-urethral Zuidex^™ injection: a walk-in, walkout treatment for stress urinary incontinence

    Page :9

    H.P. Marsh, N. Dunne, S.J. Foley

    Plan Plan
  • ·PD-03.02 : Tension-free vaginal tape and autologous rectus fascia pubovaginal sling for the treatment of stress urinary incontinence: a medium-term follow-up

    Page :9

    F. Sharifi-Aghdas, N. Mortazavi

    Plan Plan
  • ·PD-03.03 : Comparison of lower urinary tract symptoms (LUTS) reported in voiding diary and its agreement to urologist and nurse assessment

    Page :9-10

    J. Gajewski, J. Puthenparumpil, S. Weerasinghe

    Plan Plan
  • ·PD-03.04 : Value of the I-PSS in women with bladder outlet obstruction following anti-incontinence surgery

    Page :10

    T. Fourie

    Plan Plan
  • ·PD-03.05 : Social demographic and clinical characteristics of females having lower urinary tract symptoms (FLUTS) in northern Malaysia: preliminary results from the FLUTS cohort study

    Page :10-11

    B.Y. Low, M.L. Liong, K.H. Yuen, C. Chee, W.L. Chong, W.S. Leong, N. Karim, P.Y. Cheah

    Plan Plan
  • ·PD-03.06 : The effects of duloxetine on urethral function and sphincter structure

    Page :11

    S. Athanasiou, C. Chaliha, A. Digesu, M. Sotiropoulou, A. Rodolakis, S. Jeffery, A. Antsaklis

    Plan Plan
  • ·PD-03.07 : Kiricuta’s omentoplasty in the treatment of vesico-vaginal fistulae

    Page :11

    D.-S. Popescu, A.D. Gavris, C.C. Turcu

    Plan Plan
  • ·PD-03.08 : An implant for the surgical treatment of stress urinary incontinence: Remeex System (TRT)

    Page :11-12

    J. Cabrera Pérez, I. Bravo Fernández, G. Pérez, C. González Enguita

    Plan Plan
  • ·PD-03.09 : Long term outcome of laparoscopic promontofixation for vaginal prolapse

    Page :12

    R. Sabbagh, P.E. Bryckaert, E. Mandron, J. Piussan

    Plan Plan
  • ·PD-04.01 : Clinical evaluation of the Stonebreaker^™, a new pneumatic intracorporeal lithotripter

    Page :12-13

    A. Rané, P. Rao, S.V. Kandaswamy, R. Kumar, N. Gupta

    Plan Plan
  • ·PD-04.02 : Novel deflecting stone basket improves calyceal access

    Page :13

    M. Monga, D. Weiland, B.K. Canales, J. Landman

    Plan Plan
  • ·PD-04.03 : Chronic dietary potassium depletion increases urinary oxalate excretion in rats

    Page :13

    R.Z. Hossain, C. Yachantha, Y. Ogawa, K. Yamakawa, M. Morozumi, K. Sugaya, P. Tosukhowong

    Plan Plan
  • ·PD-04.04 : Vitamin B6 deficiency causes hypocitraturia within one week in rats

    Page :13

    Y. Ogawa, R.Z. Hossain, K. Yamakawa, M. Morozumi, S. Hokama, Y. Oshiro, A. Uchida, K. Sugaya

    Plan Plan
  • ·PD-04.05 : Radial dilation of nephrostomy balloons: a comparative in vitro analysis

    Page :13-14

    M. Monga, K. Hendlin

    Plan Plan
  • ·PD-04.06 : Beneficial effect of lime powder intake on urinary oxidative status: a promising defence towards tubular injury

    Page :14

    C. Yachantha, T. Sasivongsbhakdi, S. Chaisawasdi, R.Z. Hossain, Y. Ogawa, K. Tangsanga, P. Tosukhowong

    Plan Plan
  • ·PD-04.07 : Novel inhibitors of calcium oxalate crystallisation

    Page :14

    S.E. Allen, C.H. Fry, S. Choong, W.G. Robertson

    Plan Plan
  • ·PD-04.08 : Laparoscopic management of upper urinary tract stones: a report of 134 cases

    Page :15

    N. Simforoosh, A. Bassiri, A. Danesh, A.M. Ziaee, F. Sharifi Aghdas, A. Tabibi, H. Abdi

    Plan Plan
  • ·PD-03.09 : Physical characteristics of next-generation ureteral access sheaths: buckling and kinking

    Page :15

    K. Hendlin, W.K. Durfee, M. Monga

    Plan Plan
  • ·PD-04.10 : Virtual reality percutaneous nephrostomy simulator: stab in the dark or valuable tool?

    Page :15

    J.R. Henderson, K. Thomas, P. Dasgupta, J.M. Glass

    Plan Plan
  • ·PD-04.11 : In vitro testing of a novel ureteroscopic plug to control projectile stone fragments

    Page :15-16

    D.M. Albala, G. Kolb

    Plan Plan
  • ·PD-05.01 : Protective effect of ADI on reperfusion injury following testicular torsion

    Page :16

    C. Yoon, D. Yoon, M. Oh, Y. Shim, B. Min, D. Yoon

    Plan Plan
  • ·PD-05.02 : Endoscopic management of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer (Deflux) with 196 ureters in 125 patients

    Page :16

    A.N. Bissada, A.S. Safwat, N.K. Bissada

    Plan Plan
  • ·PD-05.03 : Urodynamic risk factors against spontaneous resolution of primary vesico-ureteral reflux in male infants

    Page :16

    Y. Igawa, M. Ichino, S. Seki, Y. Iijima, O. Ishizuka, O. Nishizawa

    Plan Plan
  • ·PD-05.04 : Child, family and socio-economic- dependent risk factors on nocturnal enuresis

    Page :17

    H. Basar, M. Basar, M. Saygun, E. Yilmaz, A. Cakmak, D. Tuglu, E. Batislam

    Plan Plan
  • ·PD-05.05 : When should cryptorchid boys have surgery? A prospective randomized controlled study

    Page :17

    C. Kollin, U. Hesser, M. Ritzén, B. Karpe

    Plan Plan
  • ·PD-05.06 : Evaluation of relationship between adenotonsilar hypertrophy and enuresis in children

    Page :17

    M. Mohamadzadeh Rezaei, M. Aslzare

    Plan Plan
  • ·PD-05.07 : Outcome analysis of one-stage repair for severe hypospadias

    Page :18

    L.H.P. Braga, J.L. Pippi Salle, A.J. Lorenzo, D. Bagli, A.E. Khoury

    Plan Plan
  • ·PD-05.08 : Surgical anatomy of epispadias and its impact on surgical treatment

    Page :18

    M. Djordjevic, S. Perovic, V. Vukadinovic

    Plan Plan
  • ·PD-05.09 : Tubularized incised urethral plate versus tubularized intact urethral plate for hypospadias repair: a comparative study

    Page :18

    A. Elbakry

    Plan Plan
  • ·PD-05.10 : Descent of the testes and insertion of the gubernaculum: optimal time for correction of cryptorchid testes

    Page :19

    K. Kim, H. Jung

    Plan Plan
  • ·PD-06.01 : Retroperitoneoscopy in urology: the Binh Dan experience in 276 initial cases

    Page :19

    P.C.H. Nguyen, V.A. Nguyen, V.L. Chuyen, T.K. Nguyen, T.P. Tran

    Plan Plan
  • ·PD-06.02 : Initial experience with the Endoassist^® camera holding robot in laparoscopic urological surgery

    Page :19-20

    A. Rané, P. Rimington, C. Anderson

    Plan Plan
  • ·PD-06.03 : Laparoscopic pyeloplasty in secondary ureteropelvic junction obstruction due to failed open surgery: a comparative clinical trial

    Page :20

    A. Basiri, S. Behjati, S. Hosseini Moghaddam, F.M.A. Beigi

    Plan Plan
  • ·PD-06.04 : General surgeons have a role to play in urological laparoscopic training

    Page :20

    A. Engledow, P. Tozer, M. Hussain, S. Warren, G. Webster

    Plan Plan
  • ·PD-06.05 : Outcomes of hand-assisted laparoscopic nephrectomy in technically challenging cases

    Page :20-21

    J. Tornero, A. Prieto, P. Lopez-Cubillana, F. Escudero, G. Gómez, M. Perez-Albacete

    Plan Plan
  • ·PD-06.06 : The en bloc control of the renal pedicule with gastrointestinal anastomosis stapler in laparoscopic nephrectomy

    Page :21

    M. Arslan, T. Degirmenci, B. Gunlusoy, S. Minareci, K. Ýlhan, N. Nergiz, A. Ayder

    Plan Plan
  • ·PD-06.07 : Our laparoscopic nephrectomy experiences: transperitoneal versus retroperitoneal approach

    Page :21

    M. Arslan, T. Degirmenci, B. Gunlusoy, I. Hergul, S. Minareci, A.R. Ayder

    Plan Plan
  • ·PD-06.08 : Laparoscopy assisted retroperitoneal pyeloplasty and via pelvis stone removal

    Page :21-22

    S.J. Yoon, J.B. Lee, H. Jung, M.S. Lee, J.C. Yun, J.Y. Park, E.S. Lee, H. Choi

    Plan Plan
  • ·PD-06.09 : Comparison laparoscopic radical and laparoscopic simple nephrectomy

    Page :22

    V. Hanchanale, A. Al-Sarira, D. Gerald, J.E. McCabe, P. Javle

    Plan Plan
  • ·PD-06.10 : LOTUS® vs. Harmonic Scalpel: A Controlled Pilot Study of Efficacy Ergonomics and Pathological Outcome in the Porcine Model

    Page :22

    A. Henderson, E. Whitehead, M. Nora, A. Rané

    Plan Plan
  • ·PD-06.11 : 44 laparoscopic retroperitoneal and transperitoneal adrenalectomies: results and complications

    Page :22-23

    Z. Jablonowski, E. Miekoś, C. Zydek, L. Kutwin, M. Sosnowski, W. Różański

    Plan Plan
  • ·PD-06.12 : Experience of retroperitoneal laparoscopic surgery with 1560 cases at a single institution

    Page :23

    M. Li, L. Zhou, N. Li, Y. Na

    Plan Plan
  • ·PD-07.01 : Incidence of bladder outlet obstruction after primary treatment for prostate cancer: data from CaPSURE

    Page :23-24

    S. Elliott, M. Meng, E. Elkin, J. McAninch, J. DuChane, P. Carroll

    Plan Plan
  • ·PD-07.02 : Prostatic unsaturated fatty acid levels in patients with clinically localized prostate cancer and risk of biochemical recurrence following prostatectomy

    Page :24

    R.C. Flanigan, V.L. Freeman, M. Meydani

    Plan Plan
  • ·PD-07.03 : Comparison of site specific labeling of prostate biopsy specimens as compared to grouped labeling by side only

    Page :24

    E.R. Richter, J.T. Moncur, I.A. Sesterhenn, D.G. McLeod

    Plan Plan
  • ·PD-07.04 : Transurethral resection for prostate cancer (TURPC), a radical procedure: Experience with 1084 cases

    Page :24-25

    M.A. Reuter, W. Epple, G. Ungemach, A.B. Verger-Kuhnke

    Plan Plan
  • ·PD-07.05 : Comparing radical retropubic prostatectomy and laparoscopic radical prostatectomy at the beginning of the learning curve for both procedures. Experience from average prostate cancer volume centre in South Africa

    Page :25

    R. Mierzwinski, F. Nel, M. Conradie

    Plan Plan
  • ·PD-07.06 : Impact of hospital provider volume on short-term outcomes for radical urological cancer surgery in England

    Page :25-26

    V. Hanchanale, A. Al-Sarira, D. Gerald, J. McCabe, P. Javle

    Plan Plan
  • ·PD-07.07 : Prospective health-related quality of life assessment in an initial cohort of robotic radical prostatectomy patients

    Page :26

    D.M. Albala, T.Y. Tseng, H. Kuebler, Q.V. Cancel, P. Dahm

    Plan Plan
  • ·PD-07.08 : Low correlation between insignificant cancer (ICA) on prostate biopsy and radical prostatectomy (RP) specimens

    Page :26

    M. Brausi, M. Gavioli, M. Viola, G.L. Simonini, G. DeLuca, G. Verrini, G. Peracchia, B. Djavan

    Plan Plan
  • ·PD-07.09 : Is the low prostate specific antigen cutoff point applicable to Chinese men?

    Page :26-27

    M. Li, Y. Na

    Plan Plan
  • ·PD-07.10 : High intensity focused ultrasound (HIFU) for prostate cancer: Outcome 5 years, 450 patients, and sex life, AZ Middelheim, Antwerp, Belgium

    Page :27

    C. D’Hont, P. Van Erps, J. Cortvriend, M. Sorber, W. Gelders

    Plan Plan
  • ·PD-07.11 : Prostate specific antigen is no longer accurate for prostate cancer (PCa) diagnosis

    Page :27

    T. Ben Addi, A. Zlotta, C. Schulman

    Plan Plan
  • ·PD-07.12 : Vascular targeted phototherapy with Tookad for the treatment of prostate cancer after radiation therapy

    Page :27-28

    J. Trachtenberg, M. Elhilali, J. Chin

    Plan Plan
  • ·PD-08.01 : Partial nephrectomy is safe and efficacious for pathologic stage T2-T3b renal cell carcinoma

    Page :28

    K.M. Jacobsohn, R. Sanchez-Ortiz, S.F. Matin, P. Tamboli, L.L. Pisters, D.A. Swanson, C.G. Wood

    Plan Plan
  • ·PD-08.02 : High intensity focused ultrasound for the treatment of small renal tumours. Phase II trial results from Oxford

    Page :28

    T.A. Leslie, R.O. Illing, J.E. Kennedy, F. Wu, G.R. ter Haar, R.R. Phillips, A. Protheroe, D.W. Cranston

    Plan Plan
  • ·PD-08.03 : Ureteroscopic holmium laser ablation of upper urinary tract carcinoma

    Page :28-29

    K. Matsuoka, K. Tomiyasu, S. Suekane, M. Noguchi

    Plan Plan
  • ·PD-08.04 : Percutaneous radio frequency ablation in renal tumors: the Gothenburg experience

    Page :29

    D. Lyrdal, M. Andersson, J. Sternal, S. Lundstam

    Plan Plan
  • ·PD-08.05 : Protective effect of arginine deiminase against interleukin induced morbidity is related with plasma NO level

    Page :29

    C.Y. Yoon, D.H. Yoon, Y.J. Shim, E.H. Kim, B.H. Min, D.K. Yoon

    Plan Plan
  • ·PD-08.06 : Biological significance of fascin expression in clear cell renal cell carcinoma

    Page :29-30

    R. Zigeuner, N. Droschl, V. Tauber, P. Rehak, C. Langner

    Plan Plan
  • ·PD-08.07 : Ureteroscopic management of transitional cell carcinoma

    Page :30

    K. Thomas, J. Henderson, O. Wiseman, P. DasGupta, J. Glass, R. Tiptaft

    Plan Plan
  • ·PD-08.08 : VEGF, VEGF-R1 and VEGF-R2 mRNA expression profiles different between clear and papillary renal cell carcinoma. Importance for angiogenic therapies

    Page :30

    B. Ljungberg, J. Jacobsen, K. Grankvist, T. Rasmuson, G. Lindh, S. Häggström Rudolfsson

    Plan Plan
  • ·PD-08.09 : Tumor VEGF and microvessel density in renal cell carcinoma

    Page :30-31

    S.K. Singh, N. Bhuvanesh, R. Prasad, K. Joshi

    Plan Plan
  • ·PD-08.10 : Percutaneous radiofrequency ablation (PRFA) of small renal tumors under ultrasound (US) in high-risk patients: 2-year follow-up

    Page :31

    M. Brausi, M. Gavioli, G. Verrini, G. De Luca, G. Peracchia, G. Simonini, M. Viola, F. Ferrari

    Plan Plan
  • ·PD-09.01 : Subcostal kidney extraction: a novel approach to laparoscopic donor nephrectomy

    Page :31

    B. Radolinski, E.K. Diner, J.D. Murdock, S.R. Ghasemian

    Plan Plan
  • ·PD-09.02 : Right laparoscopic donor nephrectomy: the Washington Hospital Center experience

    Page :31

    B. Radolinski, E.K. Diner, J.D. Murdock, S. Ghasemian

    Plan Plan
  • ·PD-09.03 : Evolution of renal transplants: arterial multiplicity influence

    Page :32

    P. Nunes, B. Parada, A. Figueiredo, A. Roseiro, V. Dias, C. Bastos, F. Rolo, A. Mota

    Plan Plan
  • ·PD-09.04 : Laparoscopic versus open donor nephrectomy for pediatric kidney recipients: a randomized controlled trial

    Page :32

    A. Basiri, N. Simforoosh, M. Heidari, S.M.M. Hosseini Moghaddam

    Plan Plan
  • ·PD-09.05 : Detouring the obstructed transplant ureter

    Page :32

    J. Olsburgh, P. Tait, G. Williams

    Plan Plan
  • ·PD-09.06 : Third kidney transplants: surgical aspects

    Page :32-33

    A. Rodriguez Antolin, M. Blanco, F. De la Rosa, F. Villacampa, M. Pamplona, A. Andres, J.M. Morales, J.F. Aguirre, R. Diaz, M. Praga, O. Leiva

    Plan Plan
  • ·PD-09.07 : Single or double kidney transplant?

    Page :33

    F. De La Rosa, A. Rodriguez, M. Pamplona, F. Villacampa, J. Passas, A. Andres, M. Praga, J.F. Aguirre, R. Diaz, O. Leiva

    Plan Plan
  • ·PD-09.08 : Graft loss during the first year after renal transplantation

    Page :33

    B. Parada, A. Figueiredo, P. Nunes, P. Moreira, F. Rolo, A. Mota

    Plan Plan
  • ·PD-09.09 : Old-to-old renal transplantation program: Single center results

    Page :33-34

    A. Schlichter, T. Steiner, W. Werner, S. Jörg

    Plan Plan
  • ·PD-09.10 : Experience with 350 cases of laparoscopic live donor nephrectomy; development of cost-effective techniques

    Page :34

    A. Kumar, N. Gupta, A. Srivastava, D. Dubey

    Plan Plan
  • ·PD-09.11 : Radiocephalic fistula at elbow-A simple solution to prevent vascular steal syndrome associated with brachiocephalic fistula: review of over 300 cases

    Page :34

    A. Kumar, N. Gupta, A. Srivastava, D. Dubey, P. Raina, V.K. Vijjan, M. Jha

    Plan Plan
  • ·PD-10.01 : Long-term survival of inflatable penile prostheses

    Page :34-35

    S.K. Wilson, J. Delk, A. Neeb, M. Cleves

    Plan Plan
  • ·PD-10.02 : Seminal plasma magnesium and premature ejaculation: a case-control study

    Page :35

    M.R. Nikoobakht, G. Pourmand, M. Aloosh, M. Hasani, A. Emamzadeh, A. Mehrsai

    Plan Plan
  • ·PD-10.03 : A prospective assessment of chronic post-vasectomy scrotal pain

    Page :35

    T.A. Leslie, R.O. Illing, J. Guillebaud, D.W. Cranston

    Plan Plan
  • ·PD-10.04 : Erectile dysfunction: the expression of phosphodiesterase-5 and soluble guanylate cyclase in circulating mononuclear cells is related with erectile dysfunction aetiology

    Page :35

    R. Vela Navarrete, J. Garcia Cardoso, A. Lopez Farre, P. Mateos Caceres, L. Lapuente, S. Zamorano Leon

    Plan Plan
  • ·PD-10.05 : The influence of partial androgen deficiency among aging men (PADAM) on the development of metabolic syndrome

    Page :35-36

    A.V. Pechersky, V.F. Semiglazov, V.I. Mazurov, A.I. Karpischenko, V.I. Pechersky, N.N. Zibina, N.I. Davydova, V.Y. Kravtsov, S.N. Proshin, M.G. Skorobogatikh, O.B. Loran

    Plan Plan
  • ·PD-10.06 : Localization of increased insulin-like growth factor binding protein-3 in the diabetic rat penis; implication for erectile dysfunction

    Page :36

    J. Soh, M. Katsuyama, S. Ushijima, Y. Naya, A. Ochiai, Y. Naitoh, K. Yoneda, A. Kawauchi, C. Yabe-Nishimura, T. MIki

    Plan Plan
  • ·PD-10.07 : Measurement of external genitalia dimensions and their correlation to other somatometric parameters in young Iranian men

    Page :36-37

    D. Mehraban, G.H. Naderi, S.A. Tahvildar, M. Salehi, M. Amirchagmaghi

    Plan Plan
  • ·PD-10.08 : Effects of statin treatment on autonomic and erectile function

    Page :37

    M. Tolga Doğru, M.M. Basar, A. Simse, E. Yuvanç, M. Güneri, H. Ebinç, E. Batislam

    Plan Plan
  • ·PD-10.09 : Effect of serum gonadotropins and sex steroids levels on autonomic function

    Page :37

    M. Tolga Dogru, M.M. Basar, E. Yilmaz, E. Yuvanç, E. Batsilam

    Plan Plan
  • ·PD-10.10 : Results and complications of bilateral vasectomy performed under local anaesthesia by urology registrars at a secondary level hospital

    Page :37-38

    G. Trollip, A. Alexander, M. Fisher, A. Naidoo, P.D. Theron, C.F. Heyns

    Plan Plan
  • ·PD-11.01 : Diagnosis and surveillance of bladder cancer using a point-of care proteomic assay

    Page :38

    H. Grossman, M. Soloway, NMP22 Clinical Investigation Group 3

    Plan Plan
  • ·PD-11.02 : Cycle-dependent response to maintenance BCG in high-risk superficial bladder cancer

    Page :38

    L. Lacombe, M. Decobert, F. Harel, H. Larue, G. Steinhoff, J. Kinahan, Y. Fradet

    Plan Plan
  • ·PD-11.03 : uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1,991 analyses

    Page :38-39

    C. Mian, K. Maier, E. Comploj, M. Lodde, L. Berner, L. Lusuardi, S. Palermo, F. Vittadello, A. Pycha

    Plan Plan
  • ·PD-11.04 : Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies

    Page :39

    A. Sherif, L. Holmberg, E. Rintala, O. Mestad, J. Nilsson, S. Nilsson, P.U. Malmström

    Plan Plan
  • ·PD-11.05 : In vivo observation of living bladder cancer cells using catheter-type contact ultra-magnifying endoscope

    Page :39

    T. Ohigashi, N. Kozakai, R. Mizuno, K. Nishimoto, A. Miyajima, K. Nakagawa, M. Murai

    Plan Plan
  • ·PD-11.06 : Correlation of overall survival with pre-operative delays prior to cystectomy for bladder cancer: population-based study in Quebec

    Page :39-40

    N. Fahmy, S. Jeyaganth, S. Mahmud, S. Tanguay, A. Aprikian

    Plan Plan
  • ·PD-11.07 : “Second–look” TURB in the diagnostic work up of high risk superficial bladder cancer

    Page :40

    R. Sanseverino, A. Campitelli, A. Barela, G. Napodano, O. Intilla, G. Miracolo, A. Perna

    Plan Plan
  • ·PD-11.08 : Bladder cancer outcome prediction using gene expression signatures–a large scale international validation study

    Page :40

    L. Dyrskjøt, P.-U. Malmström, K. Zieger, F. Real, N. Malats, M. Knowles, A. Caillault, F. Radvanyi, K. Wester, T. Ørntoft

    Plan Plan
  • ·PD-11.09 : Potential cost savings through the use of fluorescence cystoscopy in superficial bladder cancer: development of an economic model

    Page :40-41

    P.-U. Malmström, H. Hedelin

    Plan Plan
  • ·PD-11.10 : The use of local anesthesia with N-DO injector (Physion) for TUR of small bladder tumors (BT) and bladder mapping: preliminary results and cost-effectiveness analysis

    Page :41

    M. Brausi, M. Gavioli, G. Peracchia, G. De Luca, M. Viola, G. Simonini, G. Verrini

    Plan Plan
  • ·PD-11.11 : Phase II marker lesion study with intravesical instillation of Eoquin^™ in superficial bladder cancer: toxicity, marker response and follow up

    Page :41

    A.G. van der Heijden, K. Hendricksen, E.B. Cornel, H. Vergunst, T.M. de Reijke, E. van Boven, E.J. Barten, S. Chawla, G. Lenaz, J.A. Witjes

    Plan Plan
  • ·PD-11.12 : Prophylactic ofloxacin to improve tolerance of BCG instillations: two-year results of a prospective double blind placebo-controlled study in patients with bladder cancer

    Page :42

    R. Buckley, P. Rischmann, M. Colombel, F. Saint, B. Malavaud, D.K. Chopin, L. Nicholas

    Plan Plan
  • ·PD-12.01 : A retrospective analysis of the use of intravesical Botox injection for the treatment of overactive bladder in a non-specialised unit

    Page :42

    C. Blick, J.K. Kennedy, S.J. Foley

    Plan Plan
  • ·PD-12.02 : Treatment of overactive bladder syndrome (OAB) with botulinum toxin-A: when anticholinergic therapy fails

    Page :42

    S. Carl, H.J. Forth, S. Laschke

    Plan Plan
  • ·PD-12.03 : Long-term follow-up for neurogenic bladder disorders in spina bifida children treated with Dysport botulinum toxin

    Page :43

    S. Laschke, H. Gerner, S. Carl

    Plan Plan
  • ·PD-12.05 : Long term evaluation of chemodenervation of detrusor and External Urethral sphincter (EUS) in patients with detrusor overactivity (DO) and external urethral sphincter dyssynergia (DESD) of both neurogenic and non-neurogenic etiologies using botulinum-A toxin (BTX-A): A multi-center study

    Page :43

    I.O. Abdel Hafeez, H.M. El-Shawaf, H.S. Shaker, K. Mokhtar

    Plan Plan
  • ·PD-12.06 : Repeat Botox A injections are safe and efficacious in neurogenic overactive patients: results of a single center prospective trial

    Page :43-44

    P. Barboglio, R. Rivera, H. Tunuguntla, L. Cason, A.E. Gousse

    Plan Plan  
  • ·PD-12.07 : Validated instrument to assess pain tolerance during flexible endoscopy for intradetrusor botulinum toxin-A injection

    Page :44

    B. Cohen, R. Rivera, P.G. Barboglio, A.E. Gousse

    Plan Plan
  • ·PD-12.08 : Real time measurement of bladder sensation during cystometry

    Page :44-45

    J. O’Donoghue, W. Tsang, J. Moore, J. Reynard, J. Noble, A. Brading

    Plan Plan
  • ·PD-12.09 : Botulinum toxin A in severe neurogenic detrusor overactivity and incontinence: long-term success of repeat detrusor injections without loss of efficacy

    Page :45

    J.O. Grosse, G. Kramer, M. Stöhrer, G. Jakse

    Plan Plan
  • ·PD-12.10 : Botox^™ injections in idiopathic overactive bladder: long-term outcome data after repeated injections

    Page :45-46

    A. Gousse, P. Barboglio, D. Rodriguez, R. Rivera

    Plan Plan  
  • ·PD-12.11 : Is the success of first and repeat multifocal Botulinum Toxin A detrusor injections predictable by urodynamics in neurogenic detrusor overactivity?

    Page :46

    J.O. Grosse, G. Kramer, G. Jakse

    Plan Plan
  • ·PD-12.12 : Efficacy and complications of the intradetrusor injection of Dysport (Botulinum Toxin A) in patients with refractory OAB

    Page :46-47

    S. Jeffery, K. Wang, F. Lee, R. Morley, M. Fynes

    Plan Plan

• Moderated Poster Sessions

  • ·Comparison of prazosin with combination of prazosin and finasteride in successful spontaneous voiding for 48 hours after removal of urethral catheter in men with acute urinary retention (AUR) due to benign prostatic hyperplasia (BPH)

    Page :48

    M. Salehi, F. Poor Reza, H. Ghasemi, M. Fouladi Mehr

    Plan Plan
  • ·MP-01.02 : Bilateral seminal vesicles puncture unremitting instillation: an effective way to treat intractable hemospermia

    Page :48

    X.R. Zhang, Y.M. Xu, R. Chen

    Plan Plan
  • ·MP-01.03 : Additive effects of extracorporeal magnetic innervation and terazosin therapy for non-inflammatory chronic pelvic pain syndrome: a pilot study

    Page :48-49

    J. Paick, S. Song, J. Ku, S. Oh, S. Kim

    Plan Plan
  • ·MP-01.04 : Prognostic factors in Fournier gangrene

    Page :49

    H. Jeong, S. Park, S. Oh, I. Seo, J. Rim, D. Kwon, S. Kim, S. Baek

    Plan Plan
  • ·MP-01.05 : Genitourinary filariasis: the West African experience

    Page :49

    S. Mante, A. Seim

    Plan Plan
  • ·MP-01.06 : Treatment of interstitial cystitis with botulinum toxin type A

    Page :49

    S. Carl, J. Grosse, S. Laschke

    Plan Plan
  • ·MP-01.07 : A study of the bacterial flora of the perineum in adult male urological patients

    Page :50

    E. Kehinde, Y. Ali, F. Khodakhast, W. Jamal, V. Rotimi

    Plan Plan
  • ·MP-01.08 : Evaluation of a rapid test for detection of chlamydia trachomatis infection in female commercial sex workers

    Page :50

    G. Lee, Y. Byun, Y. Ryu, H. Kim

    Plan Plan
  • ·MP-01.09 : Antibiotics resistance pattern in urinary isolated bacteria

    Page :50

    M. Mansour Ghanai, S.A. Asgari

    Plan Plan
  • ·MP-01.10 : Factors influencing urinary tract infection after flexible cystoscopy: does wearing a sterile surgical gown prevent UTI after flexible cystoscopy?

    Page :50-51

    P. Chandrasekar, J. Raynard, J.S. Virdi, B.S. Potluri

    Plan Plan
  • ·MP-01.11 : The epidemiology and clinical characteristics of acute pediatric epididymitis in Korea

    Page :51

    C.H. Lee, D.S. Kim, Y.S. Jeon, N.K. Lee

    Plan Plan  
  • ·MP-01.12 : A pilot study of tamsulosin in patients with chronic pelvic pain syndrome: prospective trial

    Page :51

    C.H. Lee, D.S. Kim, Y.S. Jeon, N.K. Lee

    Plan Plan
  • ·MP-01.13 : Treatment of infected urachal cyst: single stage vs two stage

    Page :51-52

    K. Yoo, S. Joen, S. Lee, S. Chang, J. Kim

    Plan Plan
  • ·MP-01.14 : The analysis of autoinducer synthesis gene expression involved in quorum sensing mechanism with catheter associated urinary tract infection (CAUTI)

    Page :52

    J.S. Koh, H.S. Kim, K. Peck, M. Lee, H. Lee, S. Lee, J.Y. Lee

    Plan Plan
  • ·MP-01.15 : Epididymectomy in the management of chronic scrotal pain

    Page :52

    C. Sweeney, G. Oades

    Plan Plan
  • ·MP-01.16 : Diagnostic and treatment of prostatic abscess: value of transrectal ultrasonography. Our experience

    Page :52-53

    A. Sanchı́s Bonet, F. Cabrera Meirás, O. Blanco Carballo, A. Martı́n Parada, G. Duque Ruiz, A. Tejido Sánchez, A. Rodriguez Antolı́n, J. Passas Martı́nez, O. Leiva Galvis

    Plan Plan
  • ·MP-01.17 : Intravesical electromotive drug administration as a treatment option for females with interstitial cystitis

    Page :53

    K. Tevlin, D. Pushkar, I. Korsunskaya

    Plan Plan
  • ·MP-01.18 : The influence of endovesical electromotive drug therapy on sexual function of female patients suffering from interstitial cystitis

    Page :53

    K. Tevlin, D. Pushkar, I. Korsunskaya

    Plan Plan
  • ·MP-01.19 : Fluoxetine in the management of men with chronic prostatitis/chronic pelvic pain syndrome

    Page :53-54

    P. Xanthopoulos, P.M. Pavlopoulos, G. Xanthopoulou, P. Kakouri, S. Bouzoukas

    Plan Plan
  • ·MP-01.20 : Augmented floor strip dorsal onlay urethroplasty for anterior urethral strictures

    Page :54

    A. Kumar, R. Kapoor, A. Srivastava, A. Mandhani, D. Dubey

    Plan Plan
  • ·MP-01.21 : Dorsal onlay buccal mucosa versus penile skin flap urethroplasty for anterior urethral strictures: results from a randomized prospective trial

    Page :54

    D. Dubey, K. Rakesh, K. Anant, S. Anees

    Plan Plan
  • ·MP-01.22 : A single centre experience of male urethral diverticula

    Page :54

    V. Mishra, D. Allen, M. Sharma, A. Hussain, S. Shah, H. Motiwala

    Plan Plan
  • ·MP-01.23 : Circumcision: a ‘vaccine’ against AIDS? Changing concepts in Swaziland

    Page :54-55

    A.E. Groeneveld, D. Halperin

    Plan Plan
  • ·MP-01.24 : Prostatic fistula to perineum and rectum: a vexing problem

    Page :55

    V. Mishra, A. Rao, V. Hanchanale, R. Plail, O. Karim, H. Motiwala

    Plan Plan
  • ·MP-01.25 : The effect of terazosin on symptom recurrence in men with chronic prostatitis/chronic pelvic pain syndrome

    Page :55

    I. Cho, J. Kim, K. Lee, K. Lee, Y. Chang

    Plan Plan
  • ·MP-02.01 : Azoospermia and diagnostic methods

    Page :56

    S. Falahatkar, A. Hamidi, S. Tavasoli, Z. Atrkar, M. Zareian, E. Sazgari, S. Nicpoor

    Plan Plan
  • ·MP-02.02 : Comparison of results of bilateral testicular biopsy with conventional markers of testicular size and serum FSH in presence of testicular spermatozoa in azoospermic infertile men

    Page :56

    S. Falahatkar, A. Hamidi, Z. Atrkar Roshan, M. Zareian, E. Sazgari, G. Fadakar Soogheh

    Plan Plan
  • ·MP-02.03 : Effect of varicocelectomy on spermogram, fertility, premature ejaculation and abortion

    Page :56

    A. Shamsa, M. Nademi, M. Aqaee, A. Nouraee Fard

    Plan Plan
  • ·MP-02.04 : Comparison of the perinatal outcome in ICSI cycles with testicular or seminal spermatozoa

    Page :56-57

    M. Badalotti, C. Telöken, A. Arent, P. Telöken, F. Badalotti, D. Farinatti, R. Azambuja, J. Michelon, A. Petracco

    Plan Plan
  • ·MP-02.05 : Double-blind, case-control, multicenter study for therapeutic effects of panax ginseng C.A. Meyer extract in male infertility with low sperm quality

    Page :57

    H. Lee, S. Woo, H. Kim, H. Park, T. Kim, N. Youn, J. Kim, S. Chang

    Plan Plan
  • ·MP-02.06 : Invagination of tubular loop: A new modified technique of microsurgical vasoepididymostomy

    Page :57

    R.K. Shimpi

    Plan Plan
  • ·MP-02.07 : Laparoscopic varicocelectomy using bipolar cautery vs. open varicocelectomy: first randomized clinical trial

    Page :57-58

    N. Simforoosh, S. Behjati, A. Bassiri, S.A.M. Ziai, A. Danesh, A. Tabibi, F. Sharifi Aghdas, F.M.A. Beygi

    Plan Plan
  • ·MP-02.08 : Seminal plasma epidermal growth factor and transforming growth factor-beta levels in varicocele patients: the role of testicular autocrine function in varicocele physiopathology

    Page :58

    U. Kisa, M.M. Basar, M. Ferhat, O. Caglayan, E. Yilmaz, E. Batislam

    Plan Plan
  • ·MP-02.09 : Serum and seminal plasma inhibin B levels in adult and adolescent patients with varicocele and comparison of semen parameters

    Page :58

    M. Basar, U. Kisa, D. Tuglu, M. Kacmaz, H. Basar, E. Batislam

    Plan Plan
  • ·MP-02.10 : ICSI outcome using frozen oocytes and three different sperm sources

    Page :58-59

    C. Telöken, A. Arent, M. Badalotti, R. Azambuja, L. Okada, A. Petracco

    Plan Plan
  • ·MP-02.11 : Comparison of the reproductive performance of testicular sperm with ejaculated sperm from severe oligospermia

    Page :59

    C. Telöken, M. Badalotti, A. Arent, R. Azambuja, P. Telöken, L. Okada, F. Badalotti, A. Petracco

    Plan Plan
  • ·MP-02.12 : The comparison of infusion of sterile water with normal saline into distal vas deferens on post-vasectomy azoospermia

    Page :59

    A. Roshani, A. Kiani, M.A. Golbaghi

    Plan Plan
  • ·MP-02.13 : Serum inhibin-B as a prognostic factor to predict sperm retrieval in testis biopsy of patients with azoospermia

    Page :59-60

    M. Nowroozi, K. Radkhah

    Plan Plan
  • ·MP-02.14 : Prevalence of disease in brothers of patients with varicocele: a comparison with healthy controls

    Page :60

    F. Mohammad Ali Beigi, S. Mehrabi

    Plan Plan
  • ·MP-02.15 : Seminal plasma interleukin-10 levels and effect on seminal parameters

    Page :60

    S.H. Unal, M.M. Basar, O. Caǧlayan, E. Yılmaz, E. Batislam

    Plan Plan
  • ·MP-02.16 : Evaluation of the reactive oxygen species in peripheral and testicular vein in patients with varicocele

    Page :60-61

    M. Karalar, M. Şamlý, E. Tüzel, T. Köken, M. Demirbaş, C. Güler

    Plan Plan
  • ·MP-02.17 : Smoking and semen parameters in infertile men

    Page :61

    M. Hosseini, S. Zahraee, S. Hashemi, B. Kasraee

    Plan Plan
  • ·MP-02.18 : Comparison of systematic fine needle aspiration mapping and multiple microbiopsies of testis in evaluation of azoospermia

    Page :61

    D. Hota, S. Sasturkar

    Plan Plan
  • ·MP-03.01 : The correlation between spinning and erectile dysfunction

    Page :61

    G. Meyer, M. Gross, M. Mullerad, A. Kravtsov, B. Moskovitz, O. Nativ

    Plan Plan
  • ·MP-03.02 : Sildenafil efficacy: does food matter? Sixteen-week randomized, double blind, placebo-controlled, double-crossover study assessing effects of food and dose timing

    Page :61-62

    N. Zinner

    Plan Plan
  • ·MP-03.03 : Role of histamine type 2 receptor antagonist in erectile dysfunction

    Page :62

    J. Park, W.S. Cui, S.Z. Kim, Y.K. Park, K.W. Cho, J.H. Lim

    Plan Plan
  • ·MP-03.04 : Metabolic syndrome as an indicator of erectile dysfunction

    Page :62

    N. Park, H. Park, B. Park

    Plan Plan
  • ·MP-03.05 : Effects of long-term administration of tadalafil on lower urinary tract symptoms and erectile dysfunction

    Page :62-63

    J.S. Hyun, S.C. Gam, S.M. Choi, K.H. Moon

    Plan Plan
  • ·MP-03.06 : Mini-incision high open varicocelectomy

    Page :63

    A. Hinev, S. Paunov

    Plan Plan
  • ·MP-03.07 : Change in the serum testosterone level and quality of life after transdermal testosterone (Testogel) supplement therapy in late onset hypogonadism patients

    Page :63

    J.J. Kim, J.H. Bae, D.G. Moon, S.H. Kang, J. Cheon, N.S. Kim

    Plan Plan
  • ·MP-03.08 : Abstract Withdrawn

    Page :63

    
  • ·MP-03.09 : The COUPLE-project: pooled analysis of satisfaction with vardenafil treatment in men with erectile dysfunction and their partners

    Page :64

    W.A. Fisher, R.C. Rosen, M. Beneke, M. Homering, T. Evers, I. Eardley

    Plan Plan
  • ·MP-03.10 : The effect of transdermal electromotive administration (EMDA) of verapamil on the serum levels of transforming growth factor-beta (TGF-beta), metalloproteinase 1 (MMP1) and their inhibitors (TIMPs) in Peyronie’s disease

    Page :64

    A. Lekas, G. Doumanis, C. Tsalikis, S. Tsalavoutas, V. Politis, C. Mitsios, S. Koritsiadis

    Plan Plan
  • ·MP-03.11 : The effect of vardenafil on cell proliferation in the paraventricular nucleus and dentate gyrus of conscious rats

    Page :64-65

    K. Kim, C. Kwon, H. Park, J. Park, H. Kim, Y. Kim, H. Lee, K. Min, Y. Song, G. Sim

    Plan Plan
  • ·MP-03.12 : Mini-incision high open varicocelectomy versus laparoscopic varicocelectomy: a prospective comparative study with two microsurgical lymphatic sparing techniques

    Page :65

    A. Hinev, S. Paunov, V. Bojkov, M. Andonov

    Plan Plan
  • ·MP-03.13 : Efficacy and safety of tadalafil in men with erectile dysfunction: results of the first Middle East clinical study

    Page :65

    I. Khalaf, M. Elgallad

    Plan Plan
  • ·MP-03.14 : The real-life safety and efficacy of vardenafil (REALISE) study: results from South Africa

    Page :65-66

    M. Haffejee, R. Coetzee, H. Landen

    Plan Plan
  • ·MP-03.15 : Premature ejaculation: combined intervention

    Page :66

    A. Fernández Lozano, F. Cabello Santamarı́a, I. Sotolongo Vergo, E. Ruiz Castañe

    Plan Plan
  • ·MP-03.16 : How strong is the relationship between the metabolic syndrome and erectile dysfunction?

    Page :66

    V. Bucuras, F. Stiuca-Seracu, R. Bardan

    Plan Plan
  • ·MP-03.17 : Impact of patient-physician communication on continuation of PDE5 inhibitor treatment: subset analysis of men with ED from the multinational Men’s Attitudes to Life Events and Sexuality (MALES) Phase II

    Page :66-67

    I. Eardley, R.C. Rosen, W.A. Fisher, M. Sand

    Plan Plan
  • ·MP-03.18 : Vardenafil improves treatment satisfaction and sexual pleasure in men with erectile dysfunction and their partners

    Page :67

    W. Fisher, R. Rosen, I. Eardley, G. Brock, G. Karlin, P. Pommerville, X.Y. Huang, K. Bangerter, M.S. Sand, Z. Herman-Gnjidic, L. Derogatis, Vardenafil Study Group 9

    Plan Plan
  • ·MP-03.19 : Sources of influence on continuation of PDE5 inhibitor therapy: analysis of men with erectile dysfunction from the Multinational Men’s Attitudes to Life Events and Sexuality (MALES) Phase II Study

    Page :67

    I. Eardley, R.C. Rosen, W. Fisher, S. Meryn, M. Sand

    Plan Plan
  • ·MP-03.20 : Female partners’ attitudes are associated with treatment seeking for erectile dysfunction (ED) in men with ED

    Page :67-68

    I. Eardley, R.C. Rosen, W. Fisher, M. Sand

    Plan Plan
  • ·MP-03.21 : Development and validation of a simple tool estimating the risk of erectile dysfunction

    Page :68

    M. Braun, T. Evers, S. Merchant, M. Hellmich, I. Eardley

    Plan Plan
  • ·MP-04.01 : Intermediate-term outcome of bone anchored male sling in stress urinary incontinence

    Page :68-69

    A. Singla, N. Aggarwal

    Plan Plan
  • ·MP-04.02 : Artificial urinary sphincter vs bone anchored male sling for post radical prostatectomy urinary incontinence

    Page :69

    A. Singla, N. Aggarwal, M. Samli

    Plan Plan
  • ·MP-04.03 : Feasibility of artificial urinary sphincter male slings failure

    Page :69

    A. Singla, N. Aggarwal

    Plan Plan
  • ·MP-04.04 : Urinary continence after nerve-sparing radical prostatectomy and its interference on sexual activity

    Page :69-70

    V. Li Marzi, G. Del Popolo, M. Filocamo, D. Villari, M. Marzocco, A. Delle Rose, G. Nicita

    Plan Plan
  • ·MP-04.05 : UK experience of 2-stage sacral neuromodulation for women with urinary retention

    Page :70

    S. Datta, R. Kavia, G. Gonzales, R. DasGupta, C. Fowler, S. Elneil

    Plan Plan
  • ·MP-04.06 : Impact of solifenacin on health utility, work productivity, and medical care utilization

    Page :70-71

    N. Zinner, L. Black, R. Seifeldin, L. Rasouliyan

    Plan Plan
  • ·MP-04.07 : Role of prostaglandin E2 and EP-1 receptor on detrusor overactivity in spinal cord injury

    Page :71

    K. Masunaga, M. Yoshida, A. Inadome, K. Matsumoto, M. Yono, Y. Sugiyama, Y. Maeda, Y. Satoji, W. Takahashi, S. Ueda

    Plan Plan
  • ·MP-04.08 : Evaluation of lower urinary tract symptoms with or without urinary incontinence: A study in apparently healthy Japanese persons of both sexes

    Page :71

    T. Shimabukuro, K. Naito

    Plan Plan
  • ·MP-04.09 : Cardiovascular safety of solifenacin in routine clinical use

    Page :71-72

    M. Michel, U. Wetterauer, M. Vogel, J. de la Rosette

    Plan Plan
  • ·MP-04.10 : The phantom bladder following cystectomy

    Page :72

    M. Sharma, R. Vaidyanathan, L. Kumar, A. Rao, O. Karim, H. Motiwala

    Plan Plan
  • ·MP-04.11 : Solifenacin significantly improves urgency in overactive bladder (OAB) patients compared to placebo

    Page :72

    S. Serels, M. Andoh, N. Smith

    Plan Plan
  • ·MP-04.12 : Solifenacin reduces overactive bladder symptoms and improves health-related quality of life in patients previously receiving tolterodine

    Page :72-73

    N. Zinner, K. Kobashi, M. Andoh, N. Smith

    Plan Plan
  • ·MP-04.14 : Pad testing and perineometry do not correlate with quality of life scores in women with stress incontinence

    Page :73

    P.J. Gilling, L.C. Wilson, D. Bell, K. Kennett, T. Wrigley, M.R. Fraundorfer

    Plan Plan
  • ·MP-04.15 : Solifenacin treatment in patients with OAB reduces symptom bother and improves health-related quality of life

    Page :73

    S. Serels, M. Andoh, N. Smith

    Plan Plan
  • ·MP-04.16 : Use of bilumen catheter for pressure flow study in the diagnosis of bladder outflow obstruction in men

    Page :73-74

    S. Yande

    Plan Plan
  • ·MP-04.17 : A comparison of two techniques for the implantation of the adjustable continence therapy (ProACT™) for the treatment of post-prostatectomy stress urinary incontinence

    Page :74

    P. Gilling, L. Wilson, A. Westenberg, M. Fraundorfer, D. Bell

    Plan Plan
  • ·MP-04.18 : Results of double blind placebo controlled crossover study of sildenafil citrate (Viagra) in women suffering from obstructed voiding or retention associated with the primary disorder of sphincter relaxation

    Page :74

    S.N. Datta, R.B.C. Kavia, G.E. Gonzales, C.J. Fowler

    Plan Plan
  • ·MP-04.19 : A prospective comparative study comparing transvaginal tapes (Sparc^™ sling system) and transobturator suburethral tapes (Monarc^™ sling system) for the surgical treatment of female stress urinary incontinence: 2 year short-term follow-up

    Page :74-75

    S. So, J. Shin, G. Gil, J. Lim, H. Kim, Y. Na, C. Sul, D. Kim

    Plan Plan
  • ·MP-04.20 : Surgical treatment for post prostatectomy urinary incontinence

    Page :75-76

    T. Beaven, A. Foliaki

    Plan Plan
  • ·MP-04.21 : Laparoscopic sacrocolpopexy with anterior and posterior mesh extension for treatment of severe pelvic organ prolapse: preliminary report of 42 procedures

    Page :76

    R. Mierzwinski, F. Nel, M. Conradie

    Plan Plan
  • ·MP-04.22 : Laparoscopic bladder autoaugmentation combined with intravesical Botox injection for treatment of poorly compliant bladder and urge type of urinary incontinence: initial report

    Page :76

    F. Nel, R. Mierzwinski, M. Conradie

    Plan Plan
  • ·MP-04.23 : A short-term comparison of 3 different transobturator vaginal tape procedures, TVT-O, MONARC, IRIS-TOT, for the treatment of female stress and mixed urinary incontinence in Korea

    Page :76-77

    T.G. Kwon, H.T. Kim, K.H. Kim, E.S. Yoo, S. Chung, B. Kim, Y. Park

    Plan Plan
  • ·MP-04.24 : The change of cognitive function after administration of tolterodine in brain disease patients with OAB

    Page :77

    W.Y. Cho, T.H. Kim, G.S. Kong, J.H. Yoon, M.J. Park

    Plan Plan
  • ·MP-04.25 : Altered expressions of calcium-activated potassium channel and connexin in bladder mucosa of stress urinary incontinence patients with overactive bladder

    Page :77

    D.Y. Kim, E.K. Yang, J.W. Kim, H.J. Kim, T. Yoo, T.G. Kwon, T.H. Oh

    Plan Plan
  • ·MP-04.26 : Clinical results of male transobturator sling suspension in the treatment of male urinary incontinence

    Page :77-78

    P. Rehder, G. Bartsch, C. Gozzi

    Plan Plan
  • ·MP-04.27 : Xenobiotics in genito-urology: pyrethroid-induced functional disturbances in vesical detrusor and vas deferens

    Page :78

    E. Neu, U. Haerlin, A. Hofstetter, S. Magour, M. Michailov, W. Seidenbusch

    Plan Plan
  • ·MP-04.28 : On physiological fundamentals of vesical dysfunction

    Page :78-79

    M. Michailov, E. Neu, D. Martin, E. Gornik, V. Foltin, G. Ernst, G. Staehler

    Plan Plan
  • ·MP-05.01 : Evaluation of the effect of bromhexine administration on urinary stone formation in rats

    Page :79

    H. Ahmadnia, A. Yarmohamadi, M.K. Daloei, K. Sardari

    Plan Plan
  • ·MP-05.02 : Management of lower third ureteral stones

    Page :79

    G. Bochorishvili, K. Tevzadze, L. Varshanidze, G. Managadze

    Plan Plan
  • ·MP-05.03 : Management of large (more than 1.5cm) upper third ureteric calculi with rigid URS and ESWL on daycare

    Page :79-80

    J.G. Lalmalani, R. Lalmalani

    Plan Plan
  • ·MP-05.04 : In vitro evaluation of ureteral perforation forces

    Page :80

    M. Monga, K. Hendlin, D. Weiland, A. Ramani, T. Kohler, K. Anderson

    Plan Plan
  • ·MP-05.05 : Intrarenal manipulation of flexible ureteroscopes: A comparative study

    Page :80

    M. Monga, D. Weiland, A.C. Lynch, H. Rashid, B. Canales, M. Jones, T.S. Kohler, N. Nakib, A. Ramani, J. Anderson

    Plan Plan
  • ·MP-05.06 : The effect of impaction on the outcome of treatment of pelvic kidney stones: Comparing shock wave lithotripsy and percutaneous nephrolithotomy

    Page :80-81

    A. Basiri, S. Ziaee, S. Hosseini Moghaddam, S.M. Hosseini, A. Danesh, F. Sharifi Aghdas

    Plan Plan
  • ·MP-05.07 : Blind access in comparison with fluoroscopic guidance in percutaneous nephrolithotripsy: A randomized controlled trial

    Page :81

    A. Basiri, S. Mehrabi, M. Kamran-Manesh

    Plan Plan
  • ·MP-05.08 : Role of tamsulosin in the management of patients with pre-vesical ureteral calculi

    Page :81

    R. Puthenveetil, P. Deka, S. Barua, S. Baruah

    Plan Plan
  • ·MP-05.09 : Diagnostic accuracy of ultrasonography for stone and obstruction in patients with renal failure

    Page :81

    M.H. Ather, A.H. Jafri, M.N. Sulaiman

    Plan Plan
  • ·MP-05.10 : Role of the inflammatory marker CRP as an aid to emergency management of the acutely obstructed kidney

    Page :81-82

    R. Vaidyanathan, M. Sharma, A. Hussain, V. Mishra, O. Karim, H. Motiwala

    Plan Plan
  • ·MP-05.11 : Correlation between urinary stone composition and 24-hour urinary metabolic stone screening results

    Page :82

    H. Ibrahim, N.N.K. Lynn, N. Hon, S.W.V. Coppinger

    Plan Plan
  • ·MP-05.12 : ESWL treatment of ureteric stones with an electromagnetic shockwave system – 12 year experience of a single center

    Page :82

    T. Bergsdorf, C. Chaussy, S. Thueroff

    Plan Plan
  • ·MP-05.13 : Urolithiasis in children and the value of ESWL

    Page :82-83

    C. Chaussy, T. Bergsdorf, S. Thueroff

    Plan Plan
  • ·MP-05.14 : ESWL with wide focal spot: first clinical experience with Siemens LITHOSKOP^®

    Page :83

    T. Bergsdorf, C. Chaussy, S. Thueroff

    Plan Plan
  • ·MP-05.15 : Risk factors for urinary stone formation in the morbidly obese

    Page :83

    B. Duffey, D. Weiland, J. Melquist, C. Kriedberg, S. Ikramuddin, T. Kellogg, B. Slusarek, K. Hendlin, M. Stessman, M. Monga

    Plan Plan
  • ·MP-05.16 : Adopting aggressive approach to staghorn calculi with experience- optimizing the outcome

    Page :83

    R. Kapoor, N. Gupta, D. Dubey, A. Mandhani, A. Srivastava, A. Kumar

    Plan Plan
  • ·MP-05.17 : ESWL versus PCNL for treatment of lower pole stones: Preliminary results of a prospective randomized study

    Page :84

    R.F. Youssef, A.R. El-Nahas, A.M. El-Assmy, A. Shoma, K.Z. Sheir, M. El-Kenawy

    Plan Plan
  • ·MP-05.18 : The role of serum testosterone and urinary citrate on urolithiasis

    Page :84

    H. Jamshidian, M. Ayati, M.R. Nowroozi, P. Jabalameli

    Plan Plan
  • ·MP-06.01 : Laparoscopic pyeloplasty - our experiences with resection method and flap technique

    Page :84

    J. Vseticka, M. Vrany, J. Luptak

    Plan Plan
  • ·MP-06.02 : Laparoscopic nephropexy improves quality of life in patients with symptomatic nephroptosis

    Page :84-85

    M. Slojewski, A. Kaliszczak, B. Gliniewicz, A. Sikorski

    Plan Plan
  • ·MP-06.03 : Laparoscopic bladder diverticulectomy

    Page :85

    M. Slojewski, A. Golab, A. Sikorski

    Plan Plan
  • ·MP-06.04 : Learning curve of laparoscopic radical prostatectomy: A junior surgeon’s experience in a laparoscopic center with 50 initial cases

    Page :85

    P. Bryckaert, E. Mandron, F. Blackburn, R. Sabbagh

    Plan Plan
  • ·MP-06.05 : Bilateral same session ureteroscopy

    Page :85-86

    M. Darabi Mahboob, M. Keshvari, H. Ahmadnia

    Plan Plan
  • ·MP-06.06 : Retroperitoneoscopic nephrectomy for renal autotransplantation and ex vivo surgery

    Page :86

    T. Seki, M. Nakamura, K. Hotta, A. Taniguchi, M. Miura, M. Togashi, H. Harada, T. Hirano

    Plan Plan
  • ·MP-06.07 : Retroperitoneal laparoscopic nephrectomy for giant hydronephrosis

    Page :86

    R. Rabii, S. Elmhef, B. Querfani, H. Essaki, A. Joual, F. Meziane

    Plan Plan
  • ·MP-06.08 : Laparoscopic treatment for renal hydatid cyst

    Page :86

    R. Rabii, B. Querfani, H. Essaki, S. Elmhef, A. Joual, M. Fathi

    Plan Plan
  • ·MP-06.09 : One hundred experiences and the oncological outcome of hand-assisted retroperitoneoscopic nephroureterectomy

    Page :86-87

    A. Kawauchi, K. Yoneda, J. Soh, Y. Naitoh, Y. Mizutani, T. Miki

    Plan Plan
  • ·MP-06.10 : Effect of obesity on the result of laparoscopic nephrectomy

    Page :87

    T. Oh, D. Ryu, J. Kwon, Y. Kim

    Plan Plan
  • ·MP-06.11 : The spectrum of use of the high-powered holmium laser in a laser training center

    Page :87

    P. Gilling, L. Wilson, P. Meiklejohn, A. Westenberg, M. Fraundorfer

    Plan Plan
  • ·MP-06.12 : The effects of carbon dioxide pneumoretroperitoneum on bacterial translocation in an experimental retroperitoneoscopy model

    Page :87

    E. Tüzel, C. Güler, O. Aktepe, K. Sarýtaþ, M. Þamlý, M. Demirbaþ

    Plan Plan
  • ·MP-06.13 : Laparoscopic training in urology: are we geared up for the future? Results of a UK-based questionnaire survey

    Page :87-88

    S. Ravichandran, G. Reddy, D. O’Sullivan, E. Williamson, D. Machin

    Plan Plan
  • ·MP-06.14 : Laparoscopic and endourological management of urological diseases: clinical experience at Binh Dan Hospital

    Page :88

    V. Chuyen

    Plan Plan
  • ·MP-06.15 : Point of technique: a novel use of the harmonic scalpel in partial nephrectomy

    Page :88

    S. Shahzad, O. Karim, H. Motiwala, G. Turner

    Plan Plan
  • ·MP-06.16 : Laparoscopic adrenalectomy early results: transperitoneal and retroperitoneal approaches

    Page :88-89

    M. Arslan, T. Degirmenci, B. Gunlusoy, T. Demir, S. Minareci, A. Ayder

    Plan Plan
  • ·MP-06.17 : Transperitoneal laparoscopic adrenalectomy: results of 134 consecutive procedures

    Page :89

    J. Luptak, J. Vseticka, M. Vrany, J. Svihra, B. Elias, R. Tomaskin, J. Kliment

    Plan Plan
  • ·MP-06.18 : Surgical complications in 707 laparoscopic procedures in general practice of urology in South Africa

    Page :89

    R. Mierzwinski, F. Nel, M. Conradie

    Plan Plan
  • ·MP-06.19 : Modified cost effective hand assisted laparoscopic nephrectomy

    Page :89-90

    N. Ujmajuridze, A. Ujmajuridze, S. Mshvildadze, L. Managadze

    Plan Plan
  • ·MP-06.20 : Retroperitoneal laparoscopic approach of symptomatic peripelvic renal cysts

    Page :90

    R. Rabii, H. Essaki, S. Elmhef, B. Querfani

    Plan Plan
  • ·MP-07.01 : Continent cutaneous urinary diversion: issues on quality of life. A decade later

    Page :90

    A. Bissada, A. Safwat, N. Bissada

    Plan Plan
  • ·MP-07.02 : Gastrointestinal functions and metabolic control after construction of orthotopic neobladder in bladder cancer

    Page :90

    A. Thorstenson, H. Jacobsson, E. Onelov, J. Holst, P. Hellstrom, A. Kinn

    Plan Plan
  • ·MP-07.03 : Randomized clinical trial of bowel preparation versus no preparation before ileal urinary diversion

    Page :90-91

    A. Tabibi, N. Simforoosh, A. Basiri, H. Abdi, F. Farrokhi

    Plan Plan
  • ·MP-07.04 : Uretero-ureterocutaneostomy (wrapped by omentum)

    Page :91

    L. Lusuardi, M. Lodde, A. Pycha, S. Palermo, E. Comploj, E. Valimberti, D. Signorello, R. Hohenfellner

    Plan Plan
  • ·MP-07.05 : Long-term multi institutional evaluation of classic Charleston pouch continent urinary diversion

    Page :91

    N. Bissada, M. Abdallah, H. Hammouda, I. Aaronson, M. Badreldin, O. Abdelgawad

    Plan Plan
  • ·MP-07.06 : Long-term outcome of reconstruction of the ileocecal valve in patients with impaired bowel function after continent urinary diversion

    Page :91-92

    R. Stein, A. Schroeder, A. Schenk, J. Thueroff

    Plan Plan
  • ·MP-07.07 : Changes of bowel movements after urinary diversion: matched pairs of ileal conduit and ileocecal pouch

    Page :92

    R. Stein, A. Schroeder, A. Schenk, C. Wiesner, A. Faldum, J. Thueroff

    Plan Plan
  • ·MP-07.08 : Functional results of the implementation of the serous-lined extramural tunnel technique of ureterointestinal reimplantation

    Page :92

    A. Hinev, S. Paunov, M. Kojuharova, R. Madjov

    Plan Plan
  • ·MP-07.09 : Long term outcome of tunnelled uretrocolonic implantation in orthotopic sigmoid bladder after radical cystectomy

    Page :92-93

    I. Khalaf, S. Hathout, M. Mahmoud

    Plan Plan
  • ·MP-07.10 : Quality of life in orthotopic neobladders performed in a district general hospital

    Page :93

    J. Beatty, E. Havranek, K. Yajnik, M. Mariappan, G. Reilly, M. Pancharatnam

    Plan Plan
  • ·MP-07.11 : Reduction of postoperative side effects associated with orthotopic neobladder by using a more proximal segment of ileum. A quality of life based analysis

    Page :93

    E. Havranek, J. Beatty, K. Yajnik, M. Mariappan, R. MacGregor, M. Pancharatnam

    Plan Plan
  • ·MP-07.12 : Integrative approach of urologic and orthopedic surgeons in extensive surgery needed for bladder exstrophy and oestrogenic or urogenic tumours

    Page :93-94

    G. Riedasch, M. Akbar, J. Hodzic, L. Bernd, K. Möhring

    Plan Plan
  • ·MP-07.13 : Bladder exstrophy and ureterosigmoidostomy: Late complications and secondary malignancies

    Page :94

    A. Schroeder, R. Stein, J. Thuroff

    Plan Plan
  • ·MP-07.14 : Ureterosigmoidostomy: a gold standard in orthotopic bladder era

    Page :94

    T. El-Leithy

    Plan Plan
  • ·MP-07.15 : The rate of occurrence of pouch stones in patients who underwent enterocystoplasty using absorbable sutures instead of staplers

    Page :94

    A. Danesh Dezfuli, M. Samimi

    Plan Plan
  • ·MP-07.16 : Memokath stent implantation in urogenital system

    Page :95

    R. Berdou

    Plan Plan
  • ·MP-07.17 : 10-year experience and evaluation of a personal modification of the ileal S-pouch

    Page :95

    C. Constantinides, S. Tyritzis, T. Manousakas, N. Panagis, E. Liatsikos, A. Zervas

    Plan Plan
  • ·MP-07.18 : Comparison between two continent techniques after cystectomy in females with 10-year follow-up

    Page :95-96

    M. Wishahi, T. Amin

    Plan Plan
  • ·MP-08.01 : Expression of hypoxia-inducible factor 1 (HIF-1) in benign prostate hyperplasia and prostate adenocarcinoma: Correlation with clinicopathological parameters

    Page :96

    A. Bantis, P. Athanassiadou, C. Tsolos, P. Sountoulidis, M. Gonidi, E. Agelonidou, A. Athanassiadou, P. Athanassiades, E. Patsouris

    Plan Plan
  • ·MP-08.02 : The value of DEAF-1 expression in smears of prostate cancer: correlation with prognostic factors and disease outcome

    Page :96

    A. Bantis, P. Athanassiadou, C. Tsolos, P. Sountoulidis, M. Gonidi, E. Agelonidou, A. Athanassiadou, P. Athanassiades, E. Patsouris

    Plan Plan
  • ·MP-08.03 : Plexin B1 and prostate cancer

    Page :96-97

    T. Nitkunan, J. Constantinou, M. Williamson, J. Masters

    Plan Plan
  • ·MP-08.04 : Does PTEN gene play a role in prostate cancer progression?

    Page :97

    G. Pourmand, A.R. Abedi, A.R. Mehrsai, H.A. Alavi, A. Ahmadi, A.A. Ziaee, A. Emamzadeh

    Plan Plan
  • ·MP-08.05 : HCG beta as a prognostic marker in adenocarcinoma of the prostate in men of multi-ethnic origins

    Page :97

    A. Thwaini, L. Ghali, S. Baithun, F. Chinegwundoh, R. Ahmed, I. Elterifi, D. Morgan, L. Richard, R. Iles

    Plan Plan
  • ·MP-08.06 : A table to predict final histopathology after radical prostatectomy for clinical unilateral T3a prostate cancer

    Page :97

    C. Hsu, S. Joniau, A. Van Baelen, T. Roskams, R. Oyen, H. Van Poppel

    Plan Plan
  • ·MP-08.07 : Immunohistochemical study of the robustness of prostate cancer

    Page :97-98

    M. Noguchi, S. Homma, Y. Komohara, M. Harada, K. Itoh, K. Matsuoka

    Plan Plan
  • ·MP-08.08 : Targeting suicide gene therapy using anti-prostate-specific membrane antigen monoclonal antibodies

    Page :98

    Y. Horiguchi, T. Gondo, S. Saito, A. Takayanagi, N. Shimizu, M. Murai, M. Tachibana

    Plan Plan
  • ·MP-08.09 : The influence of patient race and social vulnerability on urologist treatment: recommendations in localized prostate carcinoma

    Page :98-99

    R. Flanigan, T. Denberg, T. Melhado, F. Kim, D. Fairclough, B. Beaty, J. Steiner, R. Hoffman

    Plan Plan
  • ·MP-08.10 : LnCaP cell line subtypes, generated to show different degrees of androgen independent growth, is a model by which to identify potential therapeutic targets in androgen independent prostate cancer

    Page :99

    G. Shaw, T. Oliver, T. Purkiss, D. Prowse

    Plan Plan
  • ·MP-08.11 : Vitamin E succinate inactivates androgen receptor and enhances the cytotoxic effects of paclitaxel in prostate cancer cells

    Page :99

    T. Ohigashi, Y. Uchida, E. Kikuchi, A. Miyajima, J. Nakashima, M. Murai

    Plan Plan
  • ·MP-08.12 : Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with Bicalutamide 150 mg monotherapy in patients with prostate cancer

    Page :99-100

    Y. Fradet, M. Andersen, T. Tammela, M. Nachabe, J. Armstrong, T. Morris, S. Navani

    Plan Plan
  • ·MP-08.13 : Gonadotropin-releasing hormone-II antagonist triptorelix-1 induces hormone-refractory prostate cancer cell death

    Page :100

    S. Kang, H. Park, J. Kim, J. Seong, J. Cheon

    Plan Plan
  • ·MP-08.14 : Ambulatory management of prostate cancer at Midtown Urology Surgical Center

    Page :100

    J. Bennett, P. Alphonse, N. Smith, S. Hill

    Plan Plan
  • ·MP-08.15 : Prolonged culture of LNCaP prostate cancer cells leads to androgen independence and resistance to doxazosin induced apoptosis with clusterin up-regulation

    Page :100-101

    T.K. Yoo, Y. Youm, H.J. Park, J.Y. Kang, J.Y. Park, T.W. Kim

    Plan Plan
  • ·MP-08.16 : Disruption of lipid raft cholesterol could cause apoptotic cell death and induce the alteration of Akt-1/Bad and ERK signal transductions

    Page :101

    H. Oh, E. Lee, K. Cho, B. Chung, S. Yoon, S. Hong

    Plan Plan
  • ·MP-08.17 : Mutations of epidermal growth factor receptor in hormone sensitive and refractory prostate cancers

    Page :101-102

    Y.D. Choi, N.H. Cho, K. Park, K.S. Cho, S.Y. Cho, W.K. Han, M.S. Lee, J.S. Lee

    Plan Plan
  • ·MP-08.18 : Determining the optimal initiation and maintenance dose of degarelix for hormone therapy of prostate cancer patients

    Page :102

    P. Iversen, H. Van Poppel, T. Tammela, J. de la Rosette, J.E. Johansson, B.E. Persson, J.K. Jensen, T.K. Olesen

    Plan Plan
  • ·MP-08.19 : Expression of Ki67, p21, p53 in prostate biopsy tissue

    Page :102

    C. Slavov, A. Vlahova, S. Christova, E. Popov

    Plan Plan
  • ·MP-08.20 : Observational multicenter study on prostate cancer (PCA) prevalence and risk factors in men with low urinary tract symptoms (LUTS) in Italy: preliminary report

    Page :102-103

    M. Brausi, D. Prezioso, G. Bianchi, M. Carini

    Plan Plan
  • ·MP-08.21 : Downregulation of peroxisome proliferator-activated receptor (PPAR)alpha, PPARgamma, and phosphoglycerate mutase 2 in prostate cancer

    Page :103

    D. Kim, T. Yoo, T.G. Kwon, T.H. Oh, H.J. Kim, J.W. Kim, E.K. Yang

    Plan Plan
  • ·MP-08.22 : The expression of microvessel density (MVD), vascular endothelial growth factor (VEGF) and hypoxia inducible factor (HIF-1a) in hyperplastic and malignant prostate tissue

    Page :103

    A. Lekas, A. Lazaris, L. Nakopoulou, M. Chrisofos, D. Lappas, T. Papathomas, I. Fokitis, S. Koritsiadis, C. Deliveliotis

    Plan Plan
  • ·MP-08.23 : The effects of NCX4040 on apoptosis in cultured prostate cells

    Page :103-104

    D. Brown, F. Habib

    Plan Plan
  • ·MP-08.24 : Expression of the urokinase-plasminogen-activator receptor (UPA-R) in disseminated tumor cells in bone marrow and peripheral blood specimens of patients with prostate cancer

    Page :104

    C. Thomas, S. Melchior, J. Pfitzenmaier, R. Gillitzer, J. Thuroff

    Plan Plan
  • ·MP-08.25 : Gleason score migration between prostate biopsy and prostatectomy specimens in a contemporary series of patients undergoing radical prostatectomy

    Page :104

    C. Thomas, R. Gillitzer, J. Thuroff, S. Melchior

    Plan Plan
  • ·MP-08.26 : Genetic polymorphisms of genes involved in androgen metabolism and synthesis pathway and prostate cancer risk among Chinese population

    Page :104-105

    M. Li, T. Guan, Y. Na

    Plan Plan
  • ·MP-09.01 : Correlation of prostate symptom score (IPSS) with quality of life, peak urine flow rate, post void residual urine volume and total TRUS prostate volume in Ghanaian men with LUTS due to prostatic enlargement

    Page :105

    M. Kyei, E. Yeboah, Y. Tettey, R. Kumoji

    Plan Plan
  • ·MP-09.02 : Development of a low cost urine flow rate meter for primary health care

    Page :105

    A. Van Der Merwe, H. Esterhuyse, A. Pontin

    Plan Plan
  • ·MP-09.03 : Non invasive transabdominal ultrasound classification of benign prostatic enlargement (BPE) to predict bladder outlet obstruction (BOO) in real life practice

    Page :105-106

    K. Foo, H. Ho, K. Lim, S. Fook

    Plan Plan
  • ·MP-09.04 : Prostate Awareness Week in Singapore

    Page :106

    C. Chin, W. Lau, S. Ho, J. Tan, S. Chia

    Plan Plan
  • ·MP-09.05 : The efficacy of every other day alpha-blocker therapy in men with benign prostatic hyperplasia

    Page :106-107

    D. Lee, D. Seong, I. Cho, S. Hong

    Plan Plan
  • ·MP-09.06 : Preliminary assessment of the Olympus Surgmaster^™ bipolar system: physiological changes, early complications, and short-term outcome

    Page :107

    H. Ibrahim, N. Lynn, N. Hon, H. Brace, S. Ghiblawi, S. Coppinger

    Plan Plan
  • ·MP-09.07 : Alfuzosin 10mg once daily prevents overall clinical progression of BPH but not acute urinary retention occurrence: results of a 2-year placebo-controlled study

    Page :107

    C. Roehrborn

    Plan Plan
  • ·MP-09.08 : CombAT and MTOPS: a comparison of the study designs and study populations

    Page :107-108

    C. Roehrborn, J. Barkin, D. Quast, A. Duggan, K. Major-Walker, B. Morrill

    Plan Plan
  • ·MP-09.09 : The effects of BMI, alcohol and smoking on measures of sexual dysfunction: baseline data from dutasteride studies involving a total of 18,966 subjects

    Page :108-109

    C. Roehrborn, M. Marberger, E. Wolford, T. Wilson

    Plan Plan
  • ·MP-09.10 : Role of nocturia for the quality of life of patients with benign prostatic hyperplasia

    Page :109

    M.M. van Dijk, H. Wijkstra, J.J.M.C.H. de la Rosette, M.C. Michel

    Plan Plan
  • ·MP-09.11 : The impact of nocturia on signs and symptoms associated with benign prostatic hyperplasia

    Page :109-110

    M. Michel, H. Schumacher, L. Mehlburger, J.J.M.C.H. de la Rosette

    Plan Plan
  • ·MP-09.12 : Factors associated with improvements of the nocturia quality of life score upon treatment of benign prostatic hyperplasia with tamsulosin oral-controlled absorption system

    Page :110

    M. Michel, H. Schumacher, M. Busse, J.J.M.C.H. de la Rosette

    Plan Plan
  • ·MP-09.13 : The frequency of pathologic findings in routine urethrocystoscopy before open prostatectomy

    Page :110

    D. Mehraban, G. Naderi, S. Tahvildar, A. Razi, M. Sedighi, S. Kazemeyni

    Plan Plan
  • ·MP-09.14 : Does sildenafil affect the uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia?

    Page :110-111

    E. Tüzel, C. Güler, E. Doðantekin, G. Kýzýltepe

    Plan Plan
  • ·MP-09.15 : Early results of transurethral ethanol ablation of the prostate for the treatment of benign prostatic hyperplasia in a resource-poor setting

    Page :111

    M. Labib

    Plan Plan
  • ·MP-09.16 : Differences between PCPs and urologists in the clinical evaluation of men with LUTS/BPH

    Page :111

    C. Roehrborn, J. Nuckolls, M. Miner, C. Metzger, J. Wei

    Plan Plan
  • ·MP-09.17 : Differences between PCPs and urologists in the medical treatment of men with LUTS/BPH

    Page :111-112

    C. Roehrborn, J. Nuckolls, M. Miner, C. Metzger, J. Wei

    Plan Plan
  • ·MP-09.18 : Use of alternative therapies by men enrolled in the USA BPH Registry & Patient Survey

    Page :112

    C. Roehrborn, W. Steers, M. Perelman, J. Wei

    Plan Plan
  • ·MP-09.19 : Why men on watchful waiting for LUTS/BPH start medical therapy: findings from the USA BPH Registry & Patient Survey

    Page :112-113

    C. Roehrborn, D. Penson, A. Te, J. Wei, J. Nuckolls

    Plan Plan
  • ·MP-09.20 : Management of patients with moderate to severe benign prostatic hyperplasia: treatment strategies in real-life practice of French urologists (the DUO study)

    Page :113

    R. Fourcade, M. Picot, A. Gaudin, N. Texier, A. Slama

    Plan Plan
  • ·MP-09.21 : Are Muscarinic Receptors of the Prostate Having Significant Role in the Pathophysiology of Bladder Outlet Obstruction? Phase I (In vitro-) Study

    Page :113

    M. Abdel-Khalek, M. El-Baz, A. Nabieh, I. El-Houssieny

    Plan Plan
  • ·MP-09.22 : Multicenter prospective study on the changes of sexual function following treatment with alfuzosin in patients with benign prostate hypertrophy

    Page :114

    S.W. Lee, T.Y. Ahn, J.K. Park, S.W. Kim, N.C. Park, K.S. Park, J.J. Kim, J.S. Paick, D.Y. Yang, H.Y. Park

    Plan Plan
  • ·MP-10.01 : Methylated glutathione-S-transferase P1 in prostate biopsy needle washing solution of the first biopsy setting as a potential diagnostic tool to avoid rebiopsies

    Page :114

    M. Auprich, H. Augustin, K. Pummer, S. Mannweiler, G. Tilz, P. Rehak, P. Petritsch

    Plan Plan
  • ·MP-10.02 : Sensitivity of digital rectal examination and various PSA levels in prostate cancer detection using transrectal ultrasound guided biopsy of the prostate in 464 Ghanaians presenting at an urology clinic

    Page :114-115

    E. Yeboah, M. Kyei, Y. Tettey, R. Kumoji

    Plan Plan
  • ·MP-10.03 : Comparison of four different anesthesia methods during transrectal ultrasound guided prostate biopsy

    Page :115

    G. Inal, O. Adsan, O. Ugurlu, O. Kaygisiz, M. Kosan, M. Cetinkaya

    Plan Plan
  • ·MP-10.04 : Effects of subclinical prostatitis in prostate needle biopsies on the serum prostate specific antigen: the role of pathology of inflammation

    Page :115

    J. Shin, D. Kim, S. Cho, J. Lee

    Plan Plan
  • ·MP-10.05 : Complexed PSA improves prostate cancer detection: results from a multicenter Japanese clinical trial

    Page :115

    K. Okihara, O. Ukimura, T. Nakamura, S. Ushijima, Y. Mizutani, A. Kawauchi, Y. Naya, M. Kojima, T. Miki

    Plan Plan
  • ·MP-10.06 : The rate of prostate cancer on needle biopsy is higher in HIV patients

    Page :116

    M. Issa, W. Hsiao, K. Anastasia, J. Hall, C. Ritenour

    Plan Plan
  • ·MP-10.07 : Repeat trans-rectal ultrasound (TRUS) guided prostate biopsies: our experience

    Page :116

    M. Quinlan, R. Casey, R. Flynn, R. Grainger, T. McDermott, J. Thornhill

    Plan Plan
  • ·MP-10.08 : Use of prostate-specific antigen and PSA-based parameters in the diagnosis of bone metastases in Chinese prostate cancer patients

    Page :116-117

    F. Jie, S. Xia, K. Cai, Y. Ruan, Y. He, Y. Zhu, J. Lu, X. Tang

    Plan Plan
  • ·MP-10.09 : How do we select patients for prostate biopsy and choose the treatment modality when PSA value is 4ng/ml or less?

    Page :117

    K. Nagao, Y. Baba, Y. Yamamoto, K. Matsuda, K. Fujikawa, T. Hiragino, H. Matsuyama, K. Naito

    Plan Plan
  • ·MP-10.10 : Identification of enhancer of zeste homolog 2 in peripheral circulating epithelial cells in metastatic prostate cancer patients

    Page :117

    S. Hong, K. Cho, H. Oh, E. Lee

    Plan Plan
  • ·MP-10.11 : In vivo stability of cPSA in comparison with tPSA and fPSA: a contribution to early detection diagnostics of prostate carcinoma

    Page :117-118

    W. Berg, C. Haas, U. Becker, T. Keller, A. Bürner, T. Deufel, J. Schubert

    Plan Plan
  • ·MP-10.12 : The significance of hypoechoic lesion on transrectal ultrasound for prostate cancer detection

    Page :118

    K. Yoo, S. Jeon, H. Lee, S. Chang, J. Lim

    Plan Plan
  • ·MP-10.13 : The spectrum of prostate cancer presentation among different racial groups in the Western Cape Province, South Africa, during the period 1995 to 2005

    Page :118

    M. Fisher, M. Pretorius, C. Heyns

    Plan Plan
  • ·MP-10.14 : Utility of total, free, and complexed PSA for detection of prostate cancer and high-grade disease in the contemporary extended biopsy era

    Page :118-119

    B. Mian, G. Bratslavsky, H. Fisher, R. Kaufman, D. Voskoboynik, T. Nazeer

    Plan Plan
  • ·MP-10.15 : Characteristics of serum prostate-specific antigen level according to age in healthy Korean men: a multicenter study

    Page :119

    K.S. Cho, S.J. Hong, J.S. Cho, S.J. Kim, C. Kim, B.H. Chung, Y.D. Choi, D.H. Seong, S.H. Cheon, Y.S. Kim, I.R. Cho, S. Kim, W.J. Yang, H. Lee D, J.S. Lee

    Plan Plan
  • ·MP-10.16 : Free/total PSA: a useful tool to select patients for biopsy in borderline cases

    Page :119

    S. Ravichandran, M. Lucky, A. Arulanandarajah, R. Stephenson

    Plan Plan
  • ·MP-10.17 : Are the volume of high-grade prostatic intraepithelial neoplasia (HG PIN) and the number of biopsies with HG PIN predictive for prostate cancer?

    Page :119-120

    D. Pushkar, A. Govorov, J. Kosko, M. Kovylina

    Plan Plan
  • ·MP-10.18 : Morbidity is not increased with extended 12 prostate biopsy protocol

    Page :120

    B. Trajcevska-Boskovska, V. Georgiev, Z. Popov, B. Bogoeva, S. Banev

    Plan Plan
  • ·MP-10.19 : Frequency of lymphatic invasion in prostatectomies for prostate cancer

    Page :120

    I.A. Sesterhenn, D. Cordaro, C.J. Davis, B. Furusato

    Plan Plan
  • ·MP-10.20 : Follow-up on patients with small prostate cancer following radical prostatectomy at Walter Reed Army Medical Center

    Page :120-121

    B. Furusato, D. Osborn, I. Rosner, J. Cullen, Y. Chen, C. Davis, J. Moul, D. McLeod, I. Sesterhenn

    Plan Plan
  • ·MP-10.21 : Prostate cancer screening decreases the absolute risk to be diagnosed with advanced prostate cancer – Results from a prospective, population-based randomized controlled trial

    Page :121

    G. Aus, S. Bergdahl, P. Lodding, H. Lilja, J. Hugosson

    Plan Plan
  • ·MP-10.22 : Current practice of PSA testing amongst hospital doctors in the United Kingdom

    Page :121

    A.A. Khan, A. Thwaini, S. Gupta, I.S. Shergill, M. Arya, H.R.H. Patel

    Plan Plan
  • ·MP-11.01 : One stage repair of iatrogenic trapped penis

    Page :121-122

    M. Djordjevic, S. Perovic

    Plan Plan
  • ·MP-11.02 : Choice of treatment of long segment anterior urethral stricture: pedicled skin flap urethroplasty or dorsal free graft urethroplasty

    Page :122

    S. Hossain, A. Hossain, S. Khan, M. Islam

    Plan Plan
  • ·MP-11.03 : Histologic type and staging distribution of germ cell tumors in Korean adults

    Page :122

    D. Park, M. Chung, J. Chung, H. Ahn, E. Lee, H. Choi, S. Hong, J. Cheon, D. Yoon, Y. Lee, S. Yoon, W. Kim, H. Kim, S. Ryu, S. Lee

    Plan Plan
  • ·MP-11.04 : Unusual genitourinary cancers: results of irradiation treatment for penile cancer

    Page :122-123

    R. Mayer, J. Poschauko, F. Quehenberger, T. Eder, K. Pummer

    Plan Plan
  • ·MP-11.05 : Importance of human papillomavirus in penile carcinoma

    Page :123

    A. Gil, A. Pompeo, P. Goldstein, L. Saldanha, J. Mesquita, A. Sarkis, M. Srougi

    Plan Plan
  • ·MP-11.06 : Buccal mucosal graft usage where treating tissue defects upon partial or total penectomy in the case of penile cancer

    Page :123

    G. Venkov

    Plan Plan
  • ·MP-11.07 : Increasing incidence with better survival of testicular cancer in Chile

    Page :123

    J. Dominguez, R. Pinochet, J. Cabello, P. Gonzalez

    Plan Plan
  • ·MP-11.08 : Penectomy with simultaneous compared to deferred bilateral inguinal lymph node dissection (ILND) for squamous carcinoma of the penis. Evaluation of surgical complications

    Page :124

    C. Heyns, P. Theron

    Plan Plan
  • ·MP-11.09 : Replication licensing factor Mcm2 predicts disease progression in penile cancer patients

    Page :124

    O. Kayes, D. Ralph, S. Minhas, A. Freeman, G. Williams

    Plan Plan
  • ·MP-11.10 : Early outcome data in advanced penile cancer

    Page :124

    O. Kayes, D. Ralph, S. Minhas

    Plan Plan
  • ·MP-11.11 : Frenular grafting: an alternative to circumcision

    Page :124-125

    O. Kayes, S. Minhas, D. Ralph

    Plan Plan
  • ·MP-11.12 : Penile preserving surgery for anterior urethral cancers

    Page :125

    Y. Smith, P. Hadway, S. Ahmed, M. Perry, C. Corbishley, N. Watkin

    Plan Plan
  • ·MP-11.13 : Dynamic sentinel lymph node biopsy for penile cancer: Initial experience from a UK centre

    Page :125

    P. Hadway, Y. Smith, C. Corbishley, S. Heenan, M. Perry, N. Watkin

    Plan Plan
  • ·MP-11.14 : The outcome of glansectomy for invasive penile cancer

    Page :125-126

    Y. Smith, P. Hadway, M. Perry, C. Corbishley, N. Watkin

    Plan Plan
  • ·MP-11.15 : M2A antigen (podoplanin) distribution in prepubertal and adult testes and testicular tumors

    Page :126

    I. Sesterhenn, C. Davis, B. Furusato

    Plan Plan
  • ·MP-11.16 : Malignant mesotheliomas of tunica vaginalis

    Page :126

    I. Sesterhenn, C. Davis

    Plan Plan
  • ·MP-11.17 : Management of tumors in undescended testis: Experience of Tata Memorial Hospital, India

    Page :126

    Y. Thyavihally, H. Tongaonkar, K. Prabhash, A. Kakade

    Plan Plan
  • ·MP-11.18 : Clinical stage-A (CS-A) germ cell testicular tumors (GCTT) with normal values of serum tumor markers (STM) post orchiectomy

    Page :126-127

    D. Argirovic, L. Jelic

    Plan Plan
  • ·MP-11.19 : Bilateral germ cell testicular tumors: a report of 44 patients with long term follow-up

    Page :127

    D. Argirovic

    Plan Plan
  • ·MP-11.20 : A prospective 10 year audit of a single Irish centre’s experience of retroperitoneal lymph node dissection for metastatic testis cancer

    Page :127-128

    R. Casey, M. Aktar, P. Hegarty, M. Butler, J. Thornhill

    Plan Plan
  • ·MP-11.21 : Public awareness of testis cancer and the prevalence of testis self-examination – is there a further role for physician directed screening?

    Page :128

    R. Casey, F. O’Brien, P. Hegarty, R. Grainger, M. Butler, T. McDermott, J. Thornhill

    Plan Plan
  • ·MP-12.01 : Immunohistochemical demonstration of the gamma-2 chain of laminin-5 in urinary bladder urothelial carcinoma- impact for diagnosis and prognosis

    Page :128

    H. Wunderlich, A. Berndt, D. Katenkamp, J. Schubert, H. Kosmehl

    Plan Plan
  • ·MP-12.02 : Prognostic value of the differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder

    Page :128-129

    H. Wunderlich, A. Berndt, K. Anger, L. Borsi, S. Brack, M. Silacci, M. Gajda, L. Zardi, D. Neri, H. Kosmehl

    Plan Plan
  • ·MP-12.03 : Expression of the novel isoform VEGF165b in transitional cell carcinoma of bladder

    Page :129

    W. Lau, K. Das, Y. Zhao, M. Sugiono, P.H. Tan, C. Cheng

    Plan Plan
  • ·MP-12.04 : Low frequency of chromosomal alterations in CGH analysis in low-risk papillary bladder tumors with FGFR3 mutations

    Page :129

    K. Junker, J. van Oers, E. Zwarthoff, I. Kania, J. Schubert, A. Hartmann

    Plan Plan
  • ·MP-12.05 : DNA damage repair in urinary bladder carcinogenesis induced by chronic low-dose ionizing radiation after the Chernobyl accident in Ukraine

    Page :129-130

    A. Romanenko, A. Vozianov, S. Fukushima

    Plan Plan
  • ·MP-12.06 : Abstract Withdrawn

    Page :130

    
  • ·MP-12.07 : Comparative study of bladder biopsies performed by using flexible and rigid cystoscopes

    Page :130

    P. Chandrasekar, G. Krishnamoorthy, M. Gopal, F. Kapasi, B. Potluri

    Plan Plan
  • ·MP-12.08 : Nuclear morphometry for predicting outcome in patients with invasive bladder cancer following radical cystectomy

    Page :130-131

    A. Kravtsov, E. Sabo, M. Mullerad, G. Meyer, M. Gross, E. Issaq, B. Moskovitz, O. Nativ

    Plan Plan
  • ·MP-12.09 : Urinary expression and activity of metalloproteinases (MMPs) in bladder cancer: Detection using specific fluorogenic substrates

    Page :131

    R. Cursio, N. Belhacene, C. Choquenet, F. Dupre, C. Mainguene, V. Dive, P. Auberger, B. Mari

    Plan Plan
  • ·MP-12.10 : Therapeutic impact of NF-kB Inhibitor against human bladder cancer in murine xenograft model

    Page :131

    Y. Horiguchi, M. Kosugi, E. Kikuchi, A. Miyajima, J. Nakashima, M. Murai, K. Umezawa, M. Tachibana

    Plan Plan
  • ·MP-12.11 : An experimental model of bladder cancer using nonviral vector expressing uroplakin II promoter and SV40 T antigen

    Page :131-132

    J. Koh, D. Sohn, D. Kim, H. Kim, S. Paik, J. Lee

    Plan Plan
  • ·MP-12.12 : Significance of target cell infection and NK cells in the antitumor effects of bacillus Calmette-Guérin (BCG) in murine bladder cancer

    Page :132

    T. Sonoda, K. Sugimura, K. Matsumura, S. Ikemoto, T. Nakatani

    Plan Plan
  • ·MP-12.13 : The role of sequential evaluation of BTA TRAK and UBC IRMA in urine during follow-up in patients with Ta T1 bladder transitional cell carcinoma (TCC)

    Page :132

    M. Babjuk, V. Soukup, M. Pesl, M. Kostirova, J. Tejckova, J. Dvoracek, I. Pavlik

    Plan Plan
  • ·MP-12.14 : Fluorescence-in-situ hybridisation (FISH) for the non-invasive bladder cancer detection

    Page :132-133

    M. Babjuk, L. Houskova, M. Pesl, V. Soukup, Z. Zemanova, K. Michalova, J. Dvoracek, I. Pavlik

    Plan Plan
  • ·MP-12.15 : The role of transforming growth factor-Beta1 in human bladder cancer cell lines

    Page :133

    C. Lee, S. Lee, D. Kim, Y. Jeon, N. Lee

    Plan Plan
  • ·MP-12.16 : Analysis of human V-erbA related Ear-3 gene in the development of bladder transitional cell carcinoma

    Page :133

    Y. Choi, W. Ham, S. Cho, M. Lee, K. Cho, S. Hong, W. Han

    Plan Plan
  • ·MP-12.17 : Human papillomavirus DNA and p53 mutation analysis in relation to clinical outcome of bladder cancer

    Page :133

    P. Moonen, J. Bakkers, W. Melchers, J. Witjes

    Plan Plan
  • ·MP-12.18 : The regulation of apoptosis related molecules in bladder cancer T24 cell following Taxol treatment

    Page :133-134

    C. Yang, Y.-C. Ou, S.-Y. Yuan

    Plan Plan
  • ·MP-12.19 : Differentiation of normal and tumor tissue of the urinary bladder by high-resolution optical coherence tomography

    Page :134

    J. Grosse, B. Hermes, J. Bornemann, F. Spöler, M. Först, G. Jakse

    Plan Plan
  • ·MP-12.20 : Downregulation of X-linked inhibitor of apoptosis protein sensitizes bladder cancer cell to chemotherapeutics

    Page :134

    M. Li, Z. Yin, Y. Na

    Plan Plan
  • ·MP-12.21 : Anti-tumor effect of ADI on bladder tumor is correlated with ASS expression

    Page :134-135

    C.Y. Yoon, D.H. Yoon, Y.J. Shim, E.H. Kim, B.H. Min, D.K. Yoon

    Plan Plan
  • ·MP-13.01 : Minimally invasive radical cystectomy (RC) with prostate and seminal sparing: A good option for selected young patients with transitional cell carcinoma (TCC) of the bladder

    Page :135

    M. Brausi, M. Gavioli, G.L. Simonini, G. Peracchia, M. Viola, G. Verrini, G. De Luca, M. Viola

    Plan Plan
  • ·MP-13.02 : Multiprobe-FISH: Prognostic perspectives in superficial bladder cancer

    Page :135

    C. Mian, M. Lodde, E. Comploj, S. Palermo, E. Trenti, L. Lusuardi, M. Mian, K. Maier, A. Pycha

    Plan Plan
  • ·MP-13.03 : Hypercontinence in women undergoing orthotopic diversion

    Page :135-136

    M. Ismail, S. Ghobashi, M. Helal, M. Wishahi

    Plan Plan
  • ·MP-13.04 : Hand assisted laparoscopic radical cystectomy and formation of ileal conduit

    Page :136

    P.J. Meffan

    Plan Plan
  • ·MP-13.05 : Quality of life after radical cystectomy and orthotopic bladder substitution in Sweden and in Egypt: a prospective, comparative study

    Page :136

    Å. Månsson, M. al Amin, P. Malmström, H. Wijkström, H. Abol Enein, W. Månsson

    Plan Plan
  • ·MP-13.06 : Expression of S100A2 and A4 in radical cystectomy predicts bladder cancer disease progression and survival

    Page :136-137

    K. Matsumoto, A. Irie, T. Satoh, J. Ishii, T. Fujita, E. Satoh, K. Iwabuchi, M. Iwamura, S. Baba

    Plan Plan
  • ·MP-13.07 : Downstaging and pathoanatomical outcome following neoadjuvant cisplatinum based combination chemotherapy for muscle invasive bladder carcinoma: An analysis of selected patients from two combined randomised prospective Nordic trials

    Page :137

    A. Sherif, E. Rintala, O. Mestad, J. Nilsson, L. Holmberg, S. Nilsson, P. Malmström, H. Wijkstrom

    Plan Plan
  • ·MP-13.08 : Detection of immune responses against urinary bladder cancer in sentinel lymph nodes

    Page :137

    P. Marits, M. Karlsson, A. Sherif, U. Garske, M. Thorn, O. Winqvist

    Plan Plan
  • ·MP-13.09 : Surgical volume and post-operative mortality after radical cystectomy in the province of Quebec

    Page :137-138

    N. Fahmy, S. Jeyaganth, S. Mahmud, S. Tanguay, A. Aprikian

    Plan Plan
  • ·MP-13.10 : Bladder cancer after radical prostatectomy and external beam radiotherapy: is it any difference?

    Page :138

    J. Palou, N. De Graeve, G. Sancho, O. Rodrı́guez, H. Manavella, J. Huguet, A. Rosales, H. Villavicencio

    Plan Plan
  • ·MP-13.11 : Urethral tumor following cystectomy: patients with orthotopic diversion do not have less urethral recurrences

    Page :138

    J. Huguet, V. Monllau, S. Sabate, J. Palou, H. Villavicencio

    Plan Plan
  • ·MP-13.12 : Feasibility of real time TRUS during laparoscopic radical cystectomy

    Page :138-139

    J. Clavijo Eisele, P. Rimington, R. Paul, P. Dasgupta

    Plan Plan
  • ·MP-13.13 : Icodextrin solution for adhesions prevention after laparoscopic radical cystectomy

    Page :139

    J. Clavijo Eisele, P. Rimington, R. Paul, T. Kamani, P. Dasgupta

    Plan Plan
  • ·MP-13.14 : Cisplatin with concurrent radiation therapy for patients with muscle-invasive bladder cancer

    Page :139

    S. Eguchi, Y. Kawai, J. Akao, T. Hara, K. Nagao, C. Ohmi, S. Sakano, H. Matsuyama, K. Naito

    Plan Plan
  • ·MP-13.15 : Intra-arterial chemotherapy for extravesical and intrapelvic recurrence of bladder transitional cell carcinoma

    Page :139

    F. Zhou, S. Yu, Z. Liu

    Plan Plan
  • ·MP-14.01 : Brachytherapy for prostate cancer: is pre-treatment prostate volume important?

    Page :139-140

    J. Meyer, R. Bell, R. Kunkler, P. Golding, S. Duggleby, C. Elwell

    Plan Plan
  • ·MP-14.02 : Stage migration in clinically localised prostate cancer treated with radical prostatectomy between 1993 and 2004

    Page :140

    H. Augustin, M. Auprich, P. Stummvoll, K. Lipsky, K. Pummer, P. Petritsch

    Plan Plan
  • ·MP-14.03 : Prostate brachytherapy: risk factors, sexual function and results after 5-year experience

    Page :140

    A. Rempelakos, A. Palantzas, I. Katsilieris, T. Arvanitakis, G. Ioannidou, A. Thanos

    Plan Plan
  • ·MP-14.04 : Factors predicting PSA recurrence after cryoablation of the prostate

    Page :141

    A. Perlmutter, S. Prettyman, H. Farivar-Mohseni

    Plan Plan
  • ·MP-14.05 : Impact of the variations in shapes of prostatic apex on early recovery of urinary continence after radical retropubic prostatectomy

    Page :141

    S. Lee, S. Hong, Y. Kim, I. Chang, J. Han, B. Han, J. Yu, S. Byun

    Plan Plan
  • ·MP-14.06 : Oncological and functional results after laparoscopic extraperitoneal radical prostatectomy: Experience with 200 cases

    Page :141-142

    P. Bryckaert, E. Mandron, F. Blackburn, R. Sabbagh

    Plan Plan
  • ·MP-14.07 : Laparoscopic nerve sparing and bladder neck sparing radical prostatectomy: preliminary evaluation after 15 interventions

    Page :142

    F. Nel, R. Mierzwinski, M. Conradie

    Plan Plan
  • ·MP-14.08 : Precision external beam radiation therapy for prostate cancer using real-time image-guidance

    Page :142

    K. Godette, T. Fox, J. Bennett

    Plan Plan
  • ·MP-14.09 : The prognostic significance of angiogenesis and matrix metalloproteinase expression in prostate cancer: a multivariate analysis study

    Page :142-143

    M. Abdel-Khalek, M. Abdel-Hamid, E. Ibrahiem

    Plan Plan
  • ·MP-14.10 : Radical nerve sparing perineal prostatectomy: point of technique leading to improved potency rates in 565 patients operated on over 10 years

    Page :143

    L. Coetzee, R. Campbell

    Plan Plan
  • ·MP-14.11 : Histopathological findings after radiofrequency in treatment for prostate cancer

    Page :143

    C. Patriarca, F. Bergamaschi, G. Gazzano, P. Corrada, G. Ordesi, L. Zanitzer, M. DiPasquale, P. Giunta, R. Macchi, B. Campo

    Plan Plan
  • ·MP-14.12 : Radical perineal prostatectomy: a combined UK and South African series of 752 patients

    Page :143-144

    G. Boustead, L. Coetzee

    Plan Plan
  • ·MP-14.13 : Site of positive surgical margins in laparoscopic prostatectomy: the impact of apical dissection

    Page :144

    T. Satoh, M. Iwamura, S. Egawa, A. Irie, H. Tsumura, K. Matsumoto, M. Kimura, H. Okusa, S. Baba

    Plan Plan
  • ·MP-14.14 : Laparoscopic radical prostatectomy: perioperative complications in 100 cases in Catholic University of Korea

    Page :144

    T. Hwang, S. Hong, S. Seo, J. Kim

    Plan Plan
  • ·MP-14.15 : Transperineal injection of the tetradecilsolfatum sodium 3% in the treatment of pelvic lymphocele after lymphodenectomia for prostatic cancer

    Page :144-145

    M. Madonia, M. Deriu, G. Barabino, S. Canessa, F. Pirozzi Farina, G. Morgia

    Plan Plan
  • ·MP-14.16 : Minimizing risk of rectourethral fistula during cryosurgical ablation of prostate cancer using ultrasound probe placement

    Page :145

    J. Jones

    Plan Plan
  • ·MP-14.17 : Is there any difference in Gleason score between prostate biopsy and prostatectomy specimen?

    Page :145

    V. Študent, R. Fiala, A. VidláŠ, M. Hrabec, M. M. Grepl

    Plan Plan
  • ·MP-14.18 : Peri-operative complications with radical perineal prostatectomy: joint South African and UK experience of 1000 consecutive cases

    Page :145-146

    G. Boustead, L. Coetzee

    Plan Plan
  • ·MP-14.19 : Training for robotic radical prostatectomy: A strategy for residents

    Page :146

    D. Albala, G. Haleblian, R. Sur, G. Preminger

    Plan Plan
  • ·MP-14.20 : Intermediate-term outcome and morbidity of high-dose-rate brachytherapy (HDR-BT) combined with external beam radiotherapy (EBRT) for clinically localized prostate cancer

    Page :146

    T. Inagaki, T. Mori

    Plan Plan
  • ·MP-14.21 : Early quality of life assessment in men treated with visually directed HIFU for clinically localized prostate cancer

    Page :146

    R.O. Illing, S. Dawkins, C.W. Ogden, M. Emberton

    Plan Plan
  • ·MP-14.22 : The effect of neo-adjuvant androgen suppression on prostate cancer related outcomes following HIFU therapy

    Page :146-147

    T. Uchida, R.O. Illing, P.J. Cathcart, M. Emberton

    Plan Plan
  • ·MP-14.23 : Retropubic radical prostatectomy (rRPE) following bilateral laparoscopic hernia repair with mesh: urologist nightmare or awful reality?

    Page :147

    U. Hanschmann, U. Humke

    Plan Plan
  • ·MP-15.01 : Cystodiathermy under flexible cystoscopy and its proposed benefits

    Page :147-148

    N. Vasdev, A. Thwaini, N. Sezhian, S. Kothandaraman, G. Suresh

    Plan Plan
  • ·MP-15.02 : Efficacy of managing small recurrent bladder tumours by diathermy using the CYF-4 Olympus flexible cystoscope in the day surgery unit

    Page :148

    P. Chandrasekar, G. Krishnamoorthy, G. Walkay, J. Calleary, R. Samman, J. Virdi, B. Potluri

    Plan Plan
  • ·MP-15.03 : Initial experience with intravesical gemcitabine treatment of urinary bladder superficial transitional cell carcinoma

    Page :148

    M. Mullerad, A. Kravtzov, G. Meyer, A. Kastin, M. Gross, K. Biton, I. Elias, M. Boaz, N. Ofer

    Plan Plan
  • ·MP-15.04 : Hybrid SPECT-CT, an additional technique for sentinel node detection of patients with invasive bladder cancer

    Page :148-149

    A. Sherif, U. Garske, M. de La Torre, M. Thorn

    Plan Plan
  • ·MP-15.05 : Intermediate-risk urothelial carcinoma: an unresolved problem?

    Page :149

    L. Lusuardi, A. Pycha, M. Lodde, E. Comploj, G. Negri, E. Edgarter-Vigl, S. Palermo, C. Mian

    Plan Plan
  • ·MP-15.06 : Pattern of recurrence and progression according to substaging and with or without BCG treatment in T1G3 urothelial bladder carcinoma

    Page :149

    J. Palou, J. Huguet, O. Rodriguez, J. Vayreda, J. Gómez, F. Algaba, H. Villavicencio

    Plan Plan
  • ·MP-15.07 : Retinoblastoma protein expression is a predictor of response to BCG and interferon alpha treatment for superficial bladder cancer

    Page :149-150

    E. Chiong, T. Thamboo, M. Teh, Y. Chan, K. Esuvaranathan

    Plan Plan
  • ·MP-15.08 : Clinical evaluation of bacillus Calmette-Guerin for eradication of superficial bladder cancers: focus on dose and pretreatment episodes

    Page :150

    T. Okamura, K. Mizuno, M. Kato, K. Yamada, Y. Iwase, K. Kohri

    Plan Plan
  • ·MP-15.09 : The significance of simultaneous transurethral resection of bladder tumor and prostate in the bladder tumor patients with infravesical obstruction

    Page :150

    Y. Choi, S. Cho, D. Lee, H. Jeon, K. Cho, M. Lee, Y.D. Choi

    Plan Plan
  • ·MP-15.10 : The influence of thermo-chemotherapy on bladder tumours. An immunohistochemical analysis

    Page :150-151

    A. van der Heijden, C. Hulsbergen-van de Kaa, J. Witjes

    Plan Plan
  • ·MP-15.11 : Prognostic value of P53 in high-risk superficial bladder cancer with long-term follow-up

    Page :151

    P. Moonen, B. van Balken-Ory, L. Kiemeny, J. Witjes

    Plan Plan
  • ·MP-15.12 : UroVysion® compared to cytology and quantitative cytology in the surveillance of superficial bladder cancer

    Page :151

    P. Moonen, G. Merckx, P. Peelen, D. Smeets, J. Witjes

    Plan Plan
  • ·MP-15.13 : Post TURBT intensive and long-term maintenance intravesical mitomycin C for managing superficial TCC in Bangladeshi patients: interim results of an ongoing prospective study

    Page :151-152

    M. Islam, Z. Bhuiyan, S. Khan, K. Tawhid

    Plan Plan
  • ·MP-15.14 : Immediate intraoperative instillation of mitomycin-C following TURBT: An analysis of 195 instillations in 170 patients with non-invasive bladder cancer, including effect on recurrence rate

    Page :152

    H. Mostafid, D. Moon, S. Biers

    Plan Plan
  • ·MP-15.15 : Outpatient endoscopic management of non-invasive bladder cancer using intravesical electromotive drug administration (EMDA) of local anaesthetic

    Page :152

    H. Mostafid, R. Rajkumar, S. Biers

    Plan Plan
  • ·MP-15.16 : Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder TCC

    Page :152-153

    J. Hassan, M.R. Nowroozi, M. Ayati, M. Hashemi

    Plan Plan
  • ·MP-15.17 : Comparison of efficacy of post-TURBT adjuvant intravesical mitomycin C therapy in preventing the recurrence of intermediate risk superficial TCC: peri-operative single dose versus delayed multi-dose regimen, short- versus long-term result

    Page :153

    Z. Bhuiyan, M. Islam, S. Khan, K. Tawhid

    Plan Plan
  • ·MP-15.18 : Pseudosarcomatous fibromyxoid tumor of the urinary bladder: an extremely rare tumor

    Page :153

    A. Lekas, I. Fokitis, G. Doumanis, A. Parasi, V. Politis, M. Karagianni, S. Koritsiadis

    Plan Plan
  • ·MP-15.19 : Impact of age on outcome of patients with superficial bladder cancer

    Page :153-154

    Y. Kohjimoto, A. Iba, T. Kuramoto, Y. Shintani, T. Inagaki, Y. Uekado, T. Shinka

    Plan Plan
  • ·MP-15.20 : Evaluating the novel photosensitizer Hexvix® in photodynamic diagnosis of superficial bladder cancer

    Page :154

    E. Ray, K. Thomas, L. Ajayi, K. Chatterton, S. Khan, T. O’Brien

    Plan Plan
  • ·MP-15.21 : New staging system for squamous cell carcinoma of the urinary bladder

    Page :154

    M. Wishahi

    Plan Plan
  • ·MP-16.01 : The clinical impact of urolithiasis in childhood: 254 clinical cases

    Page :154-155

    H. Wunderlich, C. Klitsch, O. Reichelt, J. Baumgart, P. Höntzsch, J. Schubert

    Plan Plan
  • ·MP-16.02 : Tubularization of incised urethral plate in the repair of severe proximal hypospadias

    Page :155

    W. Abu Arafeh, M. Zilberman, R. Salah Eddin

    Plan Plan
  • ·MP-16.03 : A study of spontaneous cure of hydrocele in children

    Page :155

    M. Tsugaya, T. Ito, S. Endo, S. Okada, Y. Ito

    Plan Plan
  • ·MP-16.04 : Childhood urolithiasis: safety of holmium laser ureterolithotripsy

    Page :155

    A. Safwat, A. Bissada, M. Taha, A. Gafaar, A. El-Taher, M. Abdalla, N. Bissada

    Plan Plan
  • ·MP-16.05 : Characteristics of pheochromocytoma in children

    Page :155-156

    M. Bissada, A. Safwat, R. Jackson, N. Sakati, A. El-Zawahry, N. Bissada

    Plan Plan
  • ·MP-16.06 : Comparison of Snodgrass and Mathieu surgical techniques in anterior distal shaft hypospadias repair

    Page :156

    M. Moradi, A. Moradi

    Plan Plan
  • ·MP-16.07 : Pathophysiology of high pressure voiding in male infants: longitudinal analysis of repeated video urodynamic studies

    Page :156

    M. Ichino, Y. Igawa, S. Seki, O. Ishizuka, O. Nishizawa

    Plan Plan
  • ·MP-16.08 : Reconstruction of urothelium on the scaffold using vascular acellular matrix graft in rat

    Page :156-157

    Y. Tokuda, C. Fujiyama, A. Kaneko, Y. Sato, J. Uozumi

    Plan Plan
  • ·MP-16.09 : Acute urinary retention in children

    Page :157

    M. Mansour Ghanai, S. Asgari

    Plan Plan
  • ·MP-16.10 : Children with a primary non-refluxing megaureter: a shift in presentation and treatment

    Page :157

    R. Stein, R. Beetz, A. Schroeder, S. Woelfle, J. Thüroff

    Plan Plan
  • ·MP-16.11 : Incidence of vesicoureteral reflux in Korean children according to the clinical indications, gender and age

    Page :157-158

    J. Park, K. Lee, H. Jung, G. Moon

    Plan Plan
  • ·MP-16.12 : Snodgrass technique of urethroplasty modified with the adjunct of techniques of substitution urethroplasty: experience in 125 cases in a prospective study

    Page :158

    Z.H. Bhuiyan, M.F. Islam, S.A. Khan, K.M.H. Tawhid

    Plan Plan
  • ·MP-16.13 : Long-term patient-reported outcome of urinary symptoms after hypospadias surgery: norm-related study in adolescents

    Page :158

    K. Moriya, H. Kakizaki, H. Tanaka, T. Mitsui, T. Furuno, T. Kitta, H. Sano, H. Higashiyama, K. Nonomura

    Plan Plan
  • ·MP-16.14 : Lich-Gregoir ureteral reimplantation of the ureter with fixation during detrusorraphy as a reliable and effective procedure

    Page :158-159

    S. Onol, F. Onol, H. Inal, S. Onur, H. Hayýt, A. Akbas

    Plan Plan
  • ·MP-16.15 : Long-term outcome of ventral penile lengthening for correction of severe curvature in boys with proximal hypospadias

    Page :159

    L. Braga, J. Pippi Salle, A. Lorenzo, D. Bagli, A. Khoury

    Plan Plan
  • ·MP-16.16 : The search for predictive factors in patients with posterior urethral valves: analysis of a single institution experience over 20 years

    Page :159

    A. Lorenzo, N. Macedo, A. Cook, M. Del Valle, D. Bagli, A. Khoury, J. Pippi Salle

    Plan Plan
  • ·MP-16.17 : The impact of prenatal diagnosis in complete duplex system

    Page :159-160

    M. Baek, S. Paick, S. Jeong, H. Choi

    Plan Plan
  • ·MP-16.18 : Histological alterations in the ipsilateral and contralateral testes and epididymides of the rat following unilateral torsion and detorsion of testis

    Page :160

    M. Baek, S. Oh, H. Choi

    Plan Plan
  • ·MP-16.19 : West Virginia University Deflux experience and the utility of an intra-operative cystogram with a simulated voiding phase

    Page :160

    A. Perlmutter, W. Tarry, H. Farivar-Mohseni

    Plan Plan
  • ·MP-16.20 : Acute epididymitis in children: the role of radiological studies

    Page :160-161

    K. Al-Taheini, J. Pike, M. Leonard

    Plan Plan
  • ·MP-16.21 : Management of renal abscess in children

    Page :161

    K. Al-Taheini, M. Leonard, J. Pike

    Plan Plan
  • ·MP-16.22 : Prevalence and risk factors of nocturnal enuresis in Egyptian school children

    Page :161

    A. Elbakry, A. Taman

    Plan Plan
  • ·MP-17.01 : Fistula and fetal outcomes in patients achieving pregnancy after vesicovaginal fistula repair in Nigeria

    Page :161-162

    K. Chrouser, D. Lightner, C. Kirschner

    Plan Plan
  • ·MP-17.02 : The burden of male urethral stricture disease in the USA

    Page :162

    R. Santucci

    Plan Plan
  • ·MP-17.03 : Buccal mucosal onlay urethroplasty or anastomotic urethroplasty for short and medium length urethral strictures: Which is better?

    Page :162

    R. Santucci, H. Al-Qudah

    Plan Plan
  • ·MP-17.04 : Treatment of urinary bladder sphincter insufficiency grade III with autologous unipotent skeletal muscle cells

    Page :162

    T. Otto, K. Schwartmann, D. Betz, K. Bornemeyer, J. Bagner

    Plan Plan
  • ·MP-17.05 : Outcomes with bone anchored male Bulbourethral Sling

    Page :162-163

    B. Gallagher, N. Dwyer, D. Gaynor-Krupnick, J. Latini, K. Kreder

    Plan Plan
  • ·MP-17.06 : Approach to complications of traditional circumcision in Transkei, South Africa

    Page :163

    N. Bustamante Sigarroa, L. Mazwai, N. Bustamante Salazar, Y. Ordaz Fuentes

    Plan Plan
  • ·MP-17.07 : Management of severe urethral complications of prostate cancer therapy

    Page :163

    S. Elliott, J. McAninch, T. Chi, S. Doyle, V. Master

    Plan Plan
  • ·MP-17.08 : Single-stage fasciocutaneous flap urethral reconstruction of strictures involving the fossa navicularis

    Page :164

    M. Garcia, S. Elliott, J. McAninch

    Plan Plan
  • ·MP-17.09 : Prospective study on male sexual function after urethroplasty

    Page :164

    J. Ponce-De-León, J. Sarquella, L. Gausa, M. Montlleó, J. Caparrós

    Plan Plan
  • ·MP-17.10 : Augmentation by buccal mucosa in ureteric strictures

    Page :164

    C. Mallikarjuna, A. Suri Babu

    Plan Plan
  • ·MP-17.11 : Closure and continence in obstetric VVF involving the continence mechanism

    Page :165

    I. Vaz, J. Naude

    Plan Plan
  • ·MP-17.12 : Staging of rectourinary fistulas to guide surgical treatment

    Page :165

    R. Rivera, P. Barboglio, M. Hellinger, A. Gousse

    Plan Plan
  • ·MP-17.13 : Single-stage perineal repair of panurethral stricture disease with buccal mucosal grafting

    Page :165

    F.E. Martins, T.M. Lopes

    Plan Plan
  • ·MP-17.14 : Direct vision internal urethrotomy: predictors of success

    Page :165-166

    R. Gomez, C. Ramos, P. Marchetti

    Plan Plan
  • ·MP-17.15 : Twenty years of urethroplasty: fate of each option

    Page :166

    R. Gomez, C. Ramos, P. Marchetti, P. Gonzalez

    Plan Plan
  • ·MP-17.16 : Clinical features of urologic complications following obstetric and gynecological surgery

    Page :166

    J.S. Lee, K.T. Kim, J.T. Seo, D.H. Lee, W.J. Ko

    Plan Plan
  • ·MP-17.17 : Comparison of outcomes in immediate cystostomy with delayed repair and immediate cystostomy with primary urethral realignment in severe urethral injuries

    Page :166-167

    K. Kim, J.S. Nas, S.T. Cho

    Plan Plan
  • ·MP-17.18 : Beta-2 microglobulin in urinary sample: a reliable marker of renal injury

    Page :167

    A. Lekas, I. Fokitis, V. Politis, K. Mitsios, V. Charalampidis, S. Tsalavoutas, K. Sotirios

    Plan Plan
  • ·MP-17.19 : Renal trauma: our experience in the diagnosis and treatment of renal injuries in the past decade

    Page :167

    A. Lekas, I. Fokitis, G. Lefakis, V. Charalampidis, S. Tsalavoutas, K. Filis, S. Koritsiadis

    Plan Plan
  • ·MP-17.20 : Augmentation cystoplasty in patients with multiple sclerosis: long term follow-up

    Page :168

    R. Zachoval, V. Vik, M. Urban, M. Zalesky, J. Heracek, M. Lukes, K. Mayerova, E. Medova, J. Pitha

    Plan Plan
  • ·MP-17.21 : New insights of male transobturator sling suspension: mechanism of action

    Page :168

    P. Rehder, G. Bartsch, C. Gozzi

    Plan Plan
  • ·MP-17.22 : Musculocutaneous latissmus dorsi free transfer flap for total phalloplasty

    Page :168

    M. Djordjevic, S. Perovic, R. Djinovic

    Plan Plan
  • ·MP-17.23 : The surgical management of obstructive Urolume® stents used for urethral strictures

    Page :168-169

    A. Elkassaby, A. Al-Kandari

    Plan Plan
  • ·MP-17.24 : Surgical management of constrictive penile tie with urethrocutaneous and corporeal mutilation

    Page :169

    A.-W. Elkassaby, A.M. Al-Kandari, S. Elazzazy, T. Elzayat

    Plan Plan
  • ·MP-17.25 : The benefits of early reconstructive repair in genitourinary fistulas as compared to classical approach

    Page :169

    S. Onol, F. Onol, H. Inal, H. Hayýt, S. Onur, H. Cam

    Plan Plan
  • ·MP-18.01 : Management of complete duplication of bladder, urethra, vagina and uterus in a woman

    Page :170

    J. Zhao, F. Zhang, W. Lv, L. Du

    Plan Plan
  • ·MP-18.02 : Fascial slings for stress incontinence: outcome of 44 procedures over 10 years

    Page :170

    R. Rajasundaram, R. Montague, E. Lupton

    Plan Plan
  • ·MP-18.03 : Primary vesico ureteral reflux in adult females: late diagnosis and result of surgical treatment

    Page :170

    F. Sharifi-Aghdas, H. Akhavizadegan

    Plan Plan
  • ·MP-18.04 : Pubovaginal sling using autologous dermis for stress incontinence

    Page :170-171

    H. Jeong, S.O. Park, S.J. Oh, I.Y. Seo, J.S. Rim, D.D. Kwon, S. Kim, S.H. Baek, S.C. Park

    Plan Plan
  • ·MP-18.05 : Efficacy and complications of posterior IVS for patients with uterine and vaginal vault prolapse

    Page :171

    S. Choi, H. Kim

    Plan Plan
  • ·MP-18.06 : Surgical interventions following Interstim® sacral nerve modulation implant: 11 years’ experience

    Page :171

    J. Gajewski

    Plan Plan
  • ·MP-18.07 : Hui-Yin: the pelvic floor as center of mental energy

    Page :171-172

    K. Stifter

    Plan Plan
  • ·MP-18.08 : A prospective comparative study of tension-free vaginal tape and tension-free vaginal tape obturator inside-out for the treatment of female stress urinary incontinence

    Page :172

    D.H. Lim, C. Moon, H.Y. Moon, C.S. Kim, J. Rho

    Plan Plan
  • ·MP-18.09 : Efficacy and complications of the TVT operation: 6 year clinical experience

    Page :172

    M. Roslan, M. Lubocki, M. Wasyl, J. Gabiga, K. Wêgrzyn

    Plan Plan
  • ·MP-18.10 : Safety and efficacy of tension-free vaginal slings in older women comparing to younger patients

    Page :172-173

    C. Konstantinidis, A. Siatelis, D. Volanis, P. Kartsaklis, I. Karyotis, S. Andreadakis, S. Vlachos, P. Melidis, A. Gekas, D. Delakas

    Plan Plan
  • ·MP-18.11 : Tension-free vaginal slings in obese patients

    Page :173

    C. Konstantinidis, A. Siatelis, D. Volanis, P. Kartsaklis, I. Paleodimos, S. Andreadakis, P. Melidis, I. Karyotis, A. Gekas, D. Delakas

    Plan Plan
  • ·MP-18.12 : Our experience of ablation of Ho:YAG laser in the complex treatment of patients with recurrent and interstitial cystitis

    Page :173

    A.V. Zaitcev, D.U. Pushkar, V.V. Djakov, I.V. Galchikov

    Plan Plan
  • ·MP-18.13 : Should every wet woman get tension-free vaginal tape for stress urinary incontinence? Five years’ experience from a single institution

    Page :173-174

    M. Scholz, W. Lüftenegger, M. Wallis, W. Höltl

    Plan Plan
  • ·MP-18.14 : The “Manchester” procedure, a simple and durable no-prosthesis technique for the treatment of vaginal prolapse

    Page :174

    R. Fourcade, A. Qarro, R. Hajj Hassan, B. Makhoul

    Plan Plan
  • ·MP-18.15 : Treatment of stress urinary incontinence: pubovaginal sling or transobturator?

    Page :174

    M. Arslan, T. Degirmenci, B. Gunlusoy, K. Ilhan, N. Nergiz, S. Minareci, A. Ayder

    Plan Plan
  • ·MP-18.16 : Endometriosis with severe functional impairment of the urological tract at first diagnosis successfully treated with surgery

    Page :174-175

    P. Rehder, N. Leonhartsberger, K. Tosun, G. Pinggera, G. Bartsch, C. Gozzi

    Plan Plan
  • ·MP-18.17 : Comparison of retropubic and transobturator approach for surgical treatment of female stress incontinence

    Page :175

    T. Realfonso, U. Di Mauro, G. Napodano, O. Intilla, R. Sanseverino

    Plan Plan
  • ·MP-18.18 : TVT placed via the obturator route is safer than the retropubic approach

    Page :175

    G. Boustead, J. Constantinou

    Plan Plan
  • ·MP-18.19 : Comparison of the short-term result of tension-free vaginal tape (TVT) and trans-obturator vaginal tape (TOT) for the treatment of female stress urinary incontinence: multicenter study

    Page :175-176

    Y.J. Seo, D.G. Kim, W.H. Cha, J.W. Lee, T.G. Kwon, D.Y. Kim

    Plan Plan
  • ·MP-18.20 : Comparison of the results of tension-free vaginal tape and intra-vaginal sling in bladder neck suspension for patients with stress urinary incontinence

    Page :176

    K. Radkhah, M. Nowroozi

    Plan Plan
  • ·MP-19.01 : The effect of a nephroureterectomy upon glomerular filtration rate

    Page :176

    J. Meyer, G. Delves, M. Sullivan, S. Keoghane

    Plan Plan
  • ·MP-19.02 : How safe it is to combine radical nephrectomy with other major abdominal surgical procedures? Sixteen year single centre experience

    Page :176

    B. Somani, G. Nabi, J. N’Dow, S. Swami

    Plan Plan
  • ·MP-19.03 : Retroperitoneoscopy for treatment of ureteral stones

    Page :177

    S. Hossain, A. Hossain, S. Khan, M. Islam, S. Rahman, A. Wahab

    Plan Plan
  • ·MP-19.04 : Flexible retrograde ureteroscopy in pyelocalyceal diverticulum treatment

    Page :177

    R. Multescu, P. Geavlete, D. Georgescu, C. Persu

    Plan Plan
  • ·MP-19.05 : Percutaneous nephrolithotomy (PCNL) in horseshoe kidneys

    Page :177

    M. Darabi Mahboob, R. Taghavi, R. Mahdavi, H. Ahmadnia

    Plan Plan
  • ·MP-19.06 : Familial pheochromocytoma: Comparison with sporadic form

    Page :177-178

    A. Safwat, M. Bissada, R. Jackson, N. Sakati, A. El-Zawahry, N. Bissada

    Plan Plan
  • ·MP-19.07 : Long-term results of endoureterotomy employing a holmium laser

    Page :178

    H. Hibi, T. Ohori, Y. Yamada, N. Honda

    Plan Plan
  • ·MP-19.08 : Evaluation of prolonged warm and cold ischemia on the solitary kidney during partial nephrectomy in a rabbit model

    Page :178

    S. Tyritzis, A. Kyroudi, C. Evangelou, M. Peroulis, G. Mantziaras, N. Kostomitsopoulos, P. Karayannacos, C. Constantinides

    Plan Plan
  • ·MP-19.09 : Interventional management of renal angiomyolipoma associated with tuberous sclerosis complex: our experience

    Page :178-179

    S. Misra, J. Cox, C. Kingswood

    Plan Plan
  • ·MP-19.10 : Does intermittent low weekly doses of docetaxel-estramustine have an impact on treatment outcome in hormone refractory prostate cancer?

    Page :179

    H. El-Shawaf, K.M. Galal, A.-M.M. Mourad

    Plan Plan
  • ·MP-19.11 : The effect of ring-NF-kB decoy oligonucleotide on the kidney for the experimental unilateral ureteral obstruction of mouse

    Page :179-180

    J. Park, K. Park, K. Lee, H. Jung, G. Moon

    Plan Plan
  • ·MP-19.12 : Cytoreductive nephrectomy for metastatic renal cell carcinoma In the presence of nonconventional histology

    Page :180

    W. Kassouf, R. Sanchez-Ortiz, P. Tamboli, S. Matin, D. Swanson, C. Wood

    Plan Plan
  • ·MP-19.13 : A multicenter, randomized, phase III trial of a novel autologous therapeutic vaccine (vitespen) vs. observation as adjuvant therapy in patients at high risk of recurrence after nephrectomy for renal cell carcinoma

    Page :180

    C. Wood, B. Escudier, L. Lacombe, A. Hoos, R. Gupta, R. Flanigan, R. Figlin, P. Srivastava

    Plan Plan
  • ·MP-19.14 : Comparison of laparoscopic and open adrenalectomy: a Czech experience

    Page :180-181

    V. Student, M. Hrabec, I. Hartmann, A. Vidlar

    Plan Plan
  • ·MP-19.15 : Balloon assisted nephrectomy for the huge hydronephrotic kidney; Minilaparotomy using naturally obtained giant kidney balloon and artificial PTB balloon

    Page :181

    S. Yoon, J. Lee, H. Jung, M. Lee, J. Yun, E. Lee, J. Paick

    Plan Plan
  • ·MP-19.16 : Abstract Withdrawn

    Page :181

    
  • ·MP-19.17 : Recipient outcome in laparoscopic vs open live donor nephrectomy

    Page :181

    A. Kumar, R. Pamposh, S. Anees, D. Deepak, V. Pamposh

    Plan Plan
  • ·MP-19.18 : Retroperitoneoscopic live donor nephrectomy for allotransplantation: An initial experience

    Page :182

    A. Kumar, D. Dubey, A. Srivastava, R. Goyal

    Plan Plan
  • ·MP-19.19 : The suppressive effect of selenium on renal inflammation in a rat model of pyelonephritis with delayed treatment

    Page :182

    J.S. Park, K.S. Lee, H.C. Jung, G.H. Moon

    Plan Plan
  • ·MP-20.01 : The clinical importance of very small renal tumors

    Page :182

    H. Wunderlich, A. Berndt, K. Junker, J. Schubert

    Plan Plan
  • ·MP-20.02 : Nephron sparing surgery in cases of multifocal renal cell carcinoma: sense and senselessness

    Page :183

    H. Wunderlich, K. Junker, O. Reichelt, A. Schlichter, A. Berndt, J. Schubert

    Plan Plan
  • ·MP-20.03 : Molecular mechanisms of nonsteroidal anti-inflammatory drugs induced apoptosis

    Page :183

    Y. Ou, C. Chen, C. Yang, C. Chen

    Plan Plan
  • ·MP-20.04 : Analysis of the cooling effect in the urinary system during renal radiofrequency thermoablation in pigs

    Page :183

    A. Santos, G. D’Ippolito, L. Castilho, M. Amilcar, M. Srougi

    Plan Plan
  • ·MP-20.05 : Local recurrence of renal cell carcinoma after radical nephrectomy: analysis of 10 clinical cases

    Page :183-184

    A. Pertia, L. Mangadze, G. Bochorishvili

    Plan Plan
  • ·MP-20.06 : Prognostic significance of common preoperative laboratory parameters in renal cell carcinoma

    Page :184

    S. Lee, S. Hong, Y. Kim, I. Chang, J. Han, B. Han, J. Yu, S. Byun

    Plan Plan
  • ·MP-20.07 : Adipocyte modulates cell proliferation in the renal cell carcinoma

    Page :184

    Y. Satoh, A. Kaneko, Y. Tokuda, C. Fujiyama, J. Uozumi

    Plan Plan
  • ·MP-20.08 : When is a renal tumour palpable?

    Page :184-185

    S. Ramsey, M. Aitchison

    Plan Plan
  • ·MP-20.09 : Natural T cell responses to tumour antigen CA9 in a cohort of renal cell carcinoma patients

    Page :185

    T. Chong, D. Cranston, V. Cerundolo

    Plan Plan
  • ·MP-20.10 : The development of tumor specific immunity induced by cryosurgery in murine renal cell carcinoma animal model

    Page :185

    S. Kang, H. Park, J. Bae, K. Shim, D. Moon, J. Lee, D. Yoon, J. Kim, J. Cheon

    Plan Plan
  • ·MP-20.11 : Comparison of proteomic profiles of renal cell carcinoma between conventional type and papillary type

    Page :185

    J. Hwa, J. Jung, J. Hyun, K. Chung

    Plan Plan
  • ·MP-20.12 : Vascular endothelial growth factor (VEGF), fibroblast growth factor basic (FGFb) and endothelial growth factor receptor (EGFR) expression in kidney tumors

    Page :185-186

    O. Blanco, A. Tejido, F. Cabrera, I. Vegh, O. Leiva

    Plan Plan
  • ·MP-20.13 : Is current staging defined by TNM appropriate in renal cell carcinoma?

    Page :186

    J. Dominguez, J. Salvadó, A. Velasco, A. Bustamante, P. Troncoso, R. Pinochet

    Plan Plan
  • ·MP-20.14 : Two serum biomarkers of renal cell carcinoma by surface enhanced laser desorption / ionization mass spectrometry

    Page :186

    T. Hara, K. Honda, T. Umaki, M. Ono, Y. Hayashida, K. Naito, S. Hirohashi, T. Yamada

    Plan Plan
  • ·MP-20.15 : Late onset of metastasis after surgery for renal cell cancer prefers unusual locations

    Page :186-187

    K. Lipsky, R. Zigeuner, L. Schips, P. Rehak, C. Langner

    Plan Plan
  • ·MP-20.16 : Trends in laparoscopic radical urological procedures in England

    Page :187

    V. Hanchanale, A. Al-Sarira, J. McCabe, P. Javle

    Plan Plan
  • ·MP-20.17 : Antitumor and antiangiogenic effect of arginine deiminase on renal cell carcinoma

    Page :187-188

    C.Y. Yoon, D.H. Yoon, Y.J. Shim, E.H. Kim, K.Y. Chae, J.H. Lee, C.G. Kim, N.H. Won, B.H. Min, D.K. Yoon

    Plan Plan
  • ·MP-20.18 : Correlation of caveolin-1 expression on tissue microarray with prognosis in renal cell carcinoma

    Page :188

    S. Kim, Y. Won, H. Joo, S. Kim, H. Ahn, Y. Kim

    Plan Plan
  • ·MP-20.19 : Is frozen biopsy from the tumor bed a must in nephron sparing surgery?

    Page :188

    S. Onol, F. Onol, H. Inal, S. Onur, H. Hayýt, A. Akbas

    Plan Plan
  • ·MP-21.01 : Holmium laser ablation of large prostate glands (HoLAP): an endourological alternative to open prostatectomy

    Page :188-189

    S. Kumar

    Plan Plan
  • ·MP-21.02 : Redo surgery after transurethral vaporization-resection of the prostate

    Page :189

    R. Talic, A. El Tiraifi

    Plan Plan
  • ·MP-21.03 : Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate

    Page :189

    J. Paick, S. Song, J. Ku, S. Oh, S. Kim

    Plan Plan
  • ·MP-21.04 : Gadolinium MRI defects correlated to TUNA treatments; understanding the heating capabilities, patterns, and amount of necrosis

    Page :189-190

    T. Larson, L. Mynderse, C. Huidobro, J. Meyers

    Plan Plan
  • ·MP-21.05 : Efficacy and safety of intravesical Botulinum A toxin for primary bladder neck obstruction in males

    Page :190

    L. Sey Kiat, Q. Leng Choo

    Plan Plan
  • ·MP-21.06 : Safety and efficacy of Gyrus PlasmaKinetic bipolar energy in transurethral resection of the prostate

    Page :190

    T. Brancato, F. Corvese, G. Baffigo, P. Aloisi, R. Alvaro, P. Valenti

    Plan Plan
  • ·MP-21.07 : Correlation between extent of resection during TURP and outcome

    Page :190

    H. Ibrahim, N. Lynn, N. Hon, H. Brace, S. Ghiblawi, S. Coppinger

    Plan Plan
  • ·MP-21.08 : Erectile function after photoselective vaporisation for symptomatic hyperplasia of the prostate

    Page :190-191

    L. Daehlin, J. Frugård, T. Torkelsen

    Plan Plan
  • ·MP-21.09 : Effects of photoselective vaporisation of the prostate (PVP) on symptom score, uroflowmetry and prostate volume

    Page :191

    L. Daehlin, J. Frugård, T. Torkelsen

    Plan Plan
  • ·MP-21.10 : Postoperative prostate specific antigen (PSA) decline can predict the adequacy of adenoma removal with BPH surgical techniques

    Page :191

    P. Gilling, E. Fong, A. Westenberg, L. Wilson, M. Fraundorfer

    Plan Plan
  • ·MP-21.11 : The impact of nandrolone on post-prostatectomy bothersome symptoms

    Page :191-192

    G. Pourmand, K. Moradi, S. Moosavi, A. Abedi, R. Fateh, H. Salehinejad, A. Emamzadeh

    Plan Plan
  • ·MP-21.12 : A prospective randomised study between transurethral vaporisation using plasmakinetic energy and transurethral resection of prostate: five-year results

    Page :192

    P. Chandrasekar, F. Kapasi, J. Virdi

    Plan Plan
  • ·MP-21.13 : Plasmakinetic Superpulse™ TUR compared Plasmakinetic™ enucleation of the prostate

    Page :192

    P. Gilling, A. Westenberg, L. Wilson, M. Fraundorfer

    Plan Plan
  • ·MP-21.14 : Tempro, a new transurethral bipolar radio frequency device for BPH thermal treatment: one-year follow-up

    Page :192-193

    C. Beck

    Plan Plan
  • ·MP-21.15 : Holmium laser enucleation of prostate with mechanical morcellation. The platinum standard

    Page :193

    A. Varshney, A. Agarwal, B. Bansal, M. Bansal

    Plan Plan
  • ·MP-21.16 : Bilobar enucleation of prostate by holmium laser. Is it time saving?

    Page :193

    A. Varshney, A. Agarwal, B. Bansal, M. Bansal

    Plan Plan
  • ·MP-21.17 : Improved endoscope for laser induced resection

    Page :193-194

    M. Reuter, W. Epple, G. Ungemach, A. Verger-Kuhnke

    Plan Plan
  • ·MP-21.18 : Transurethral resection of prostate for large benign prostatic hyperplasia: a comparative study with open prostatectomy

    Page :194

    T. Kwon, H. Kim, K. Kim, E. Yoo, S. Chung, B. Kim, Y. Park

    Plan Plan
  • ·MP-21.19 : The effects of URO-Dr^® treatment and finasteride on the apoptosis of prostate in beagle dogs

    Page :194

    T. Yoo, H. Cho, Y. Youm, J. Park, T. Kim, H. Kim

    Plan Plan
  • ·MP-21.20 : Transurethral microwave thermotherapy (TUMT) using the TherMatrx TMX-2000™ for treatment of benign prostatic hyperplasia: five-year follow-up of multicenter randomized pivotal trial

    Page :194-195

    D. Albala, G. Andriole, B. Davis, G. Eure, J. Kabalian, J. Lingeman, J. Nuzzarello

    Plan Plan
  • ·MP-21.21 : The 2 micron CW laser, a new era for the ablation of prostate obstruction

    Page :195

    M.R. Mahran

    Plan Plan
  • ·MP-22.01 : Molecular changes during intermittent androgen suppression and their prognostic impact in advanced prostate cancer

    Page :195

    H. Augustin, C. Freibauer, L. Bayer, G. Lunglmayr, F. Tschurlovich, W. Kuber, K. Pummer

    Plan Plan
  • ·MP-22.02 : PSA recurrence rates and positive margins after radical retropubic prostatectomy

    Page :195-196

    A. Rempelakos, A. Georgalis, A. Pappas, A. Palantzas, A. Thanos

    Plan Plan
  • ·MP-22.03 : Estimate of rectal complications prior to external radiotherapy for prostate cancer

    Page :196

    A. Rempelakos, A. Koligliatis, V. Kouridou, A. Palantzas, A. Thanos, I. Katsilieris

    Plan Plan
  • ·MP-22.04 : Pilot study of PC-Spes2 in the treatment of hormone refractory prostate cancer (HRPC). Is hope renewed?

    Page :196

    M. Shabbir, R. Cetti, J. Love, B.S.I. Montgomery

    Plan Plan
  • ·MP-22.05 : Nutrition therapy in hormone refractory prostate cancer patients with a polyamine reduced diet. The sooner the better?

    Page :196

    B. Cipolla, R. Havouis, J.P. Moulinoux

    Plan Plan
  • ·MP-22.06 : Phase I study of a novel polyamine free formula as nutrition therapy of metastatic hormone-refractory prostate cancer (HRPC) patients

    Page :196-197

    B. Cipolla, J.Y. Bansard, J.P. Moulinoux

    Plan Plan
  • ·MP-22.07 : Long-term androgen deprivation and cognitive function in men with prostate cancer

    Page :197

    G. Lunglmayr, B. Weidlich, C. Kratzik

    Plan Plan
  • ·MP-22.08 : Phase II study of two doses of ketoconazole (keto) in hormone refractory prostate cancer (HRPC)

    Page :197

    O. Blanco, D. Castellano, A. Rodrı́guez-Antolı́n, L. Paz-Ares, O. Leiva

    Plan Plan
  • ·MP-22.09 : Complete remission in metastatic prostate cancer after combined local and systemic therapy

    Page :197-198

    C. Chaussy, S. Thueroff

    Plan Plan
  • ·MP-22.10 : The efficacy of PC-SPES in hormone refractory prostate cancer

    Page :198

    K.W. Kwak, J. Hong, C. Kim, H. Lee, H. Choi

    Plan Plan
  • ·MP-22.11 : Phase II clinical trial of dutasteride in castration-recurrent prostate cancer

    Page :198

    J. Mohler, J. Yu, O. Sartor, D. Trump

    Plan Plan
  • ·MP-22.12 : The effect of risedronate for prostate cancer patients with lower bone mineral density under androgen-deprivation therapy

    Page :198-199

    K. Ishizaka, T. Machida, N. Kanbe, M. Miyao, Y. Mizuno, S. Masuda, T. Kamai, K. Arai, M. Honda, K. Yoshida

    Plan Plan
  • ·MP-22.13 : A comparative head on efficacy study of three monthly leuprolide depot vs goserelin depot preparations for treatment in patients with prostate cancer

    Page :199

    R. Sood, V. Jain

    Plan Plan
  • ·MP-22.14 : Prospective assessment of hot flashes during treatment with maximum androgen blockade using steroidal or non-steroidal antiandrogens for prostate cancer

    Page :200

    H. Sakai, T. Igawa, H. Kanetake, M. Hayashi, S. Iwasaki, Y. Kusaba, H. Hakariya, T. Hara

    Plan Plan
  • ·MP-22.15 : Effect of thalidomide on plasma vascular endothelial growth factor and serum prostate specific antigen in patients with hormone resistant prostate cancer

    Page :200

    S. Singh, A. Kishore, A. Mandal, M. Agarwal, V. Jha

    Plan Plan
  • ·MP-22.16 : Characteristic in long term survival patient with prostate cancer managed by androgen suppression therapy

    Page :200

    Y.J. Seo, K.S. Sim, J.M. Heo, U. Kim

    Plan Plan

• Video Sessions

  • ·V-01.01 : Laparoscopic ureteroureterostomy for retrocaval ureter

    Page :201

    C. Mallikarjuna, A. Suri Babu

    Plan Plan
  • ·V-01.02 : Novel technique for radical nephroureteretomy and resection of bladder cuff through a single incision with the video-assisted minilaparotomy surgery (VAMS)

    Page :201

    S.C. Yang, W.K. Han, S.J. Hong, M.S. Lee

    Plan Plan
  • ·V-01.03 : Laparoscopic resolution of severe complications during renal surgery

    Page :201

    R. Sanseverino, O. Intilla, U. Di Mauro, G. Napodano, A. Baio, G. Miracolo

    Plan Plan
  • ·V-01.04 : Transmesocolic laparoscopic pyeloplasty in pediatric age group

    Page :201-202

    R. Kapoor, N. Gupta, A. Mandhani

    Plan Plan
  • ·V-01.05 : Laparoscopic adrenalectomy: retroperitoneal access

    Page :202

    C. Ramos, J.M. Campero, N. Zambrano

    Plan Plan
  • ·V-01.06 : Alternative method for renal vein closure in laparoscopic radical nephrectomy

    Page :202

    A. Kheifets, A. Tsivian, S. Benjamin, A. Sidi

    Plan Plan
  • ·V-01.07 : Laparoscopic radical cystectomy: our experience

    Page :202

    I. Coman, A. Cota, C. Rusu, I. Sarb, B. Petrut, B. Feciche, F. Nechita

    Plan Plan
  • ·V-01.08 : Laparoscopic retroperitoneal adrenalectomy and laparoscopic treatment of vena cava injury

    Page :202-203

    M. Arslan, T. Degirmenci, B. Gunlusoy, S. Minareci, A. Ayder

    Plan Plan
  • ·V-01.09 : Hand-assisted laparoscopic approach for T3b radical nephrectomy

    Page :203

    D. Murphy, A. Henderson, A. Rane

    Plan Plan
  • ·V-01.10 : Transperitoneal laparoscopic nephrectomy for giant kidney

    Page :203

    R. Sanseverino, O. Intilla, U. Di Mauro, G. Napodano, A. Barela, T. Realfonso

    Plan Plan
  • ·V-02.01 : Double double J indwelling in neoplastic extrinsic ureteral obstruction

    Page :203

    G. Nita, P. Geavlete, V. Mirciulescu, D. Georgescu

    Plan Plan
  • ·V-02.02 : Urethral-vesical angle for treatment of female stress urinary incontinence: A novel technique

    Page :203-204

    M. Kilinc

    Plan Plan
  • ·V-02.03 : Cystocele repair by vaginal approach with a modified T-shaped tension-free polypropylene mesh. Technique and results

    Page :204

    R. Kapoor, N. Gupta, A. Mandhani

    Plan Plan
  • ·V-02.04 : Endourological stone treatment in pregnant woman

    Page :204

    D. Georgescu, P. Geavlete, D. Soroiu, E. Alexandrescu, C. Persu

    Plan Plan
  • ·V-02.05 : Second-look flexible nephroscopy for restant caliceal stones

    Page :205

    V. Mirciulescu, P. Geavlete, R. Multescu, V. Cauni

    Plan Plan
  • ·V-02.06 : Retrograde intrarenal surgery (RIRS), study of 31 cases

    Page :205

    S. Bapat, K. Pai, S. Purnapatre, P. Yadav, A. Padhye

    Plan Plan
  • ·V-02.07 : Use of Kuntz laser carrier (Karl Storz) and Sachse urethrotome sheath (Karl Storz) in PCNL, a point of technique

    Page :205

    S. Bapat, S. Purnapatre, K. Pai, P. Yadav, A. Padhye

    Plan Plan
  • ·V-02.08 : The role of laparoscopy in the treatment of difficult ureteral stones

    Page :205-206

    M. Yazdani Kachuii, M. Gharaati

    Plan Plan
  • ·V-02.09 : Potency- and continence preserving radical cystectomy with hemiprostatectomy

    Page :206

    M. Wolf, H. Wunderlich, J. Schubert

    Plan Plan
  • ·V-02.10 : Laparoscopic radical cystoprostatectomy (LRC)

    Page :206

    J. Peña, A. Prera, J. Gonzalez, N. Hannaoui, E. Vicente, D. Garcia, C. Abad, J. Prats

    Plan Plan
  • ·V-02.11 : Photodynamic assisted detection and treatment of superficial bladder cancer using the photosensitizer Hexvix®

    Page :206

    K. Thomas, E. Ray, D. Murphy, K. Chatterton, S. Khan, T. O’Brien

    Plan Plan
  • ·V-03.01 : Laparoscopic partial nephrectomy: retroperitoneal access

    Page :207

    C. Ramos, J.M. Campero, N. Zambrano

    Plan Plan
  • ·V-03.02 : Endo-laparoscopic nephrouretherectomy with uretheral blocking by Chevassu catheter: a personal experience

    Page :207

    G. Morgia, M. Deriu, S. Canessa, D. Brotza, M. Madonia

    Plan Plan
  • ·V-03.03 : Laser vaporization in inflammatory ureteral stenosis

    Page :207

    C. Nita, P. Geavlete, V. Mirciulescu, S. Aghamiri

    Plan Plan
  • ·V-03.04 : Ureteroscopy in ureter fissus pathology

    Page :207-208

    V. Mirciulescu, P. Geavlete, D. Georgescu, G. Nita

    Plan Plan
  • ·V-03.05 : Endoscopic treatment in calcified ureteral stents

    Page :208

    V. Cauni, P. Geavlete, D. Georgescu, V. Mirciulescu, C. Persu

    Plan Plan
  • ·V-03.06 : Cooling the urinary system during renal radiofrequency thermoablation in pigs

    Page :208

    A. Santos, G. D’Ippolito, L. Castilho, M. Amilcar, M. Srougi, A. Valim

    Plan Plan
  • ·V-03.07 : Transvesical endoscopic excision of vesical diverticulum

    Page :208-209

    C. Mallikarjuna, A. Suri Babu, K. Vijaya Kumar

    Plan Plan
  • ·V-03.08 : Intrahepatic IVC dissection: An alternative approach for venous thrombectomy in renal cell carcinoma with level III IVC thrombus

    Page :209

    A. Seth, N. Gupta, A. Hemal, P. Dogra, R. Kumar, P. Wadhwa

    Plan Plan
  • ·V-03.09 : Partial circulatory arrest and cardio-pulmonary bypass for removing IVC thrombus extending up to right atrium

    Page :209

    A. Seth, U. Chowdhary, A. Bhan, N. Gupta, A. Dhar

    Plan Plan
  • ·V-03.10 : ReMeEx device (External Mechanical Regulator) for incontinence: implantation and regulation procedure, complications and results at 5 years follow-up

    Page :209-210

    F. Mantovani, S. Paparella, V. Inneo

    Plan Plan
  • ·V-03.11 : Simultaneous repair of the anteroposterior defects and infracoccygeal sacropexy during intravaginal suburethral sling procedure for stress urinary incontinence

    Page :210

    S. Onol, F. Onol, H. Inal, H. Hayýt, S. Onur, O. Kose

    Plan Plan
  • ·V-03.12 : Antegrade miniinvasive nephroureterectomy (AMNUE - laparoscopic nephrectomy, transurethral excision of ureterovesical junction and pararectal incision)

    Page :210

    M. Hora, J. Kleèka, V. Eret, T. Ürge, J. Ferda, O. Hes

    Plan Plan
  • ·V-04.01 : Laparoscopic treatment of retrocaval ureter: our experience and literature review

    Page :210-211

    F. Bagheri, Á. Szántó, C. Pusztai, E. Holman, L. Farkas

    Plan Plan
  • ·V-04.02 : Transperitoneal laparoscopic partial nephrectomy in a horseshoe kidney

    Page :211

    A. Kheifets, A. Tsivian, S. Benjamin, L. Agulansky, A. Sidi

    Plan Plan
  • ·V-04.03 : Y-V pyeloplasty revisited

    Page :211

    A. Kheifets

    Plan Plan
  • ·V-04.04 : Laparoscopic pyeloplasty: retroperitoneal approach

    Page :211-212

    J. Campero, C. Ramos, N. Zambrano

    Plan Plan
  • ·V-04.05 : Laparoscopic treatment for bilateral varicocele

    Page :212

    R. Rabii, B. Querfani, H. Essaki, E. Salim, A. Joual, F. Meziane

    Plan Plan
  • ·V-04.06 : Laparoscopic ureteral reimplantation for an ectopic ureter: a case report

    Page :212

    A. Basiri, F. Mohammad Ali Beigi, H. Abdi, N. Mahmoudnejad

    Plan Plan
  • ·V-04.07 : Left vena cava discovered during laparoscopic donor nephrectomy report of two cases

    Page :212

    N. Simforoosh, F.-M.A. Beygi

    Plan Plan
  • ·V-04.08 : Laparoscopic ureteral reimplantation in ureterovesical junction obstruction, transperitoneal and extra peritoneal method: Initial report

    Page :212-213

    N. Simforoosh, F.-M.A. Beygi

    Plan Plan
  • ·V-04.09 : Laparoscopic partial nephrectomy in a transplanted kidney

    Page :213

    N. De Graeve, A. Rosales, J. Salvador, J. Caffaratti, J. Ponce de Leon, J. Huguet, H. Villavicencio

    Plan Plan
  • ·V-04.10 : Laparoscopic repair of iatrogenic long ureteral injury

    Page :213

    A. Basiri, S. Shahrokhi, H. Shayani-Nasab, H. Karami, F. Mohammad Ali Beigi

    Plan Plan
  • ·V-05.01 : Laser vaporization in recurrent inflammatory urethral strictures

    Page :213-214

    G. Nita, P. Geavlete, S. Bancu

    Plan Plan
  • ·V-05.02 : Transurethral approach in multilocular large prostatic abscesses

    Page :214

    G. Nita, P. Geavlete, V. Mirciulescu, D. Georgescu

    Plan Plan
  • ·V-05.03 : Bipolar endoscopic procedures in complicated urethral strictures

    Page :214

    D. Georgescu, P. Geavlete, V. Cauni, V. Mirciulescu

    Plan Plan
  • ·V-05.04 : Treatment of urethral condyloma by IL-2

    Page :214

    W. Ko, J. Lee

    Plan Plan
  • ·V-05.05 : Sexual rehabilitation after penile plastic surgery

    Page :215

    K. Krajka, W. Lauer, D. Perkowski, M. Markuszewski, M. Matuszewski

    Plan Plan
  • ·V-05.06 : Surgical treatment of Peyronie’s disease

    Page :215

    K. Krajka, M. Markuszewski, M. Matuszewski, W. Moszczyñski

    Plan Plan
  • ·V-05.07 : Darewicts operation for Peyronie’s disease: A preliminary report

    Page :215

    F. Mantovani, S. Paparella, V. Inneo

    Plan Plan
  • ·V-05.08 : The use of buccal mucosal grafts in reconstructive urethral surgery

    Page :215

    G. Barbagli, S. Balò, M. Raber, S. De Stefani, G. Guazzoni, P. Rigatti

    
  • ·V-05.09 : Retroperitoneal lymph node dissection with caval thrombectomy for advanced nonsemonimatous germ cell tumor of the left testicle

    Page :215

    F. Martins, J. Alves, J. Freeman, J. Lencastre, J. Varela

    Plan Plan
  • ·V-05.10 : Urethral hemangioma-laser treatment: point of technique

    Page :216

    E. Abara, J. Doucet

    Plan Plan
  • ·V-05.11 : Penile carcinoma: organ sparing surgery

    Page :216

    M. Djordjevic, S. Perovic, G. Korac

    Plan Plan
  • ·V-06.01 : Extraperitoneal Laparoscopic Radical Prostatectomy (ELRP)

    Page :216

    J. Penña, J. Gonzalez, N. Hannaoui, E. Vicente, D. Garcia, C. Abad, A. Prera, J. Prats

    Plan Plan
  • ·V-06.02 : Laparoscopic radical cystoprostatic adenectomy

    Page :216

    A. Basiri, F. Mohammad Ali Beigi

    Plan Plan
  • ·V-06.03 : Nerve sparing robotic da Vinci radical prostatectomy

    Page :216-217

    N. De Graeve, H. Villavicencio, J. Salvador, J. Palou, J. Gomez

    Plan Plan
  • ·V-06.04 : Retrograde extraperitoneal laparoscopic prostatectomy (RELP): Ascending dissection of the erectile neurovascular bundles

    Page :217

    P. Dubernard, P. Chaffange, P. Chalabreysse, B. Cuzin, P. Pacheco

    Plan Plan
  • ·V-06.05 : HIFU treatment of prostate cancer with Ablatherm® integrated imaging

    Page :217

    C. Chaussy, S. Thueroff

    
  • ·V-06.06 : Interstitial prostatic brachyteraphy: new technique with intraoperative dosimetric evaluation and real time modification of treatment plan

    Page :217

    M. Madonia, G. Barabino, L. Cau, M. Catania, F. Pirozzi Farina, A. Pischedda, M. Dedola, G. Ghisu, G. Canalis, G. Morgia

    Plan Plan
  • ·V-06.07 : Laparoscopic preperitoneal radical prostatectomy: preliminary experience

    Page :217-218

    R. Sanseverino, O. Intilla, U. Di Mauro, G. Napodano, A. Campitelli, R. Angrisani

    Plan Plan
  • ·V-06.08 : Technique for transverse colon continent cutaneous diversion

    Page :218

    N. Bissada, M. Abdallah

    Plan Plan
  • ·V-06.09 : Continent reservoir with hydraulic valve mechanism

    Page :218

    K. Krajka, W. Lauer, M. Markuszewski, M. Matuszewski

    Plan Plan
  • ·V-06.10 : Photoselective vaporization of the prostate: the technique

    Page :218

    C. Ramos, J.M. Campero, N. Zambrano

    Plan Plan
  • ·V-06.11 : Millin operation using new surgical technologies

    Page :218-219

    K. Krajka, M. Markuszewski, M. Matuszewski, D. Perkowski, W. Piaskowski

    Plan Plan
  • ·V-07.01 : Double layer dartos flap coverage of the neourethra in tubularized incised plate urethroplasty (TIPU) repair

    Page :219

    S. Onol, F. Onol, H. Inal, H. Hayýt, S. Onur, A. Akbas

    Plan Plan
  • ·V-07.02 : Reconstructive urethroplasty using porcine acellular matrix: Evolution of the grafting procedure

    Page :219

    F. Mantovani, V. Inneo, S. Paparella

    Plan Plan
  • ·V-07.03 : Evaluation and reconstruction of an extremely rare genitourinary abnormality

    Page :219-220

    U. Altug, M. Cakan, F. Yalçýnkaya, F. Demirel, M. Topçuoðlu

    Plan Plan
  • ·V-07.04 : Membranous urethral rupture endoscopic realignment

    Page :220

    J. Ponce-De-León, L. Gausa, J. Arce, H. Villavicencio

    Plan Plan
  • ·V-07.05 : Buccal mucosa: Versatile graft in anterior urethroplasty

    Page :220

    F. Martins, J. Badona, R. Rodrigues, J. Marcelino, J. Varela, T. Lopes

    
  • ·V-07.06 : Simplified repair of post-pelvic fracture anterior-posterior urethral distraction defect

    Page :220-221

    F. Martins, T. Lopes, S. Boyd

    Plan Plan
  • ·V-07.07 : York Mason trans-sphincteric trans-rectal repair of iatrogenic recto-urinary fistula: case report

    Page :221

    R. Sanseverino, O. Intilla, G. Napodano, A. Barela, U. Di Mauro, T. Realfonso

    Plan Plan
  • ·V-07.08 : Dorsal buccal mucosa onlay graft bulbar urethroplasty by means of fibrin glue

    Page :221

    G. Barbagli, S. De Stefani, M. Sighinolfi, S. Micali, F. Annino, G. Bianchi

    Plan Plan
  • ·V-07.09 : Single stage approach for the reconstruction of exstrophy epispadias cases admitted in aduthood

    Page :221-222

    S. Onol, F. Onol, H. Inal, S. Onur, H. Hayit, H. Cam

    Plan Plan
  • ·V-07.10 : Laparoscopic treatment of benign urachus cyst

    Page :222

    J. Peña, J. Gonzalez, N. Hannaoui, E. Vicente, D. Garcia, C. Abad, A. Prera, J. Prats

    Plan Plan

• Unmoderated Poster Sessions

  • ·UP-01.01 : Antegrade flexible ureteroscopy in lower ureteral stenosis

    Page :223

    R. Multescu, P. Geavlete, D. Soroiu, G. Nita

    Plan Plan
  • ·UP-01.02 : Management of tuberculous strictures of ureter by endourology

    Page :223

    P.C.H. Nguyen, L.C. Vu, V.H. Nguyen, Q.T. Duong, T.M. Ngo

    Plan Plan
  • ·UP-01.03 : Reliability of teleradiology using mobile phone-camera digitally photographed radiographs in making prompt treatment decisions on urological conditions

    Page :223-224

    E. Arada, T. Trinidad

    Plan Plan
  • ·UP-01.04 : Mini-incision muscle-sparing lumbar approach to the kidney, the renal pelvis and the upper ureter

    Page :224

    A. Hinev, S. Paunov

    Plan Plan
  • ·UP-01.05 : Portless endoscopic radical nephrectomy via a single minimum skin incision: experience with initial 11 cases

    Page :224

    T. Yamane, K. Nishiyama, Y. Uchida, H. Kubo, M. Kawahara, M. Nakagawa

    Plan Plan
  • ·UP-01.06 : Permanent metallic stents in ureteric strictures

    Page :224-225

    C. Mallikarjuna, A. Suri Babu, K. Vijaya Kumar

    Plan Plan
  • ·UP-01.07 : A case of 18-OH-DOC and corticosterone producing adrenal adenoma combined with pre-clinical Cushing’s syndrome

    Page :225

    R. Machino, H. Kijima, T. Mizushima, H. Sasano

    Plan Plan
  • ·UP-01.08 : The effect of main symptoms on outcome of blood pressure after nephrectomy

    Page :225

    A. Basiri, N. Simforoosh, S. Shahrokhi, A. Danesh, H. Abdi

    Plan Plan
  • ·UP-01.09 : The glucose metabolism in clear cell and papillary renal cell carcinomas - A structural analysis of components

    Page :225-226

    T. Herrmann, A. Gross, L. Binder, M. Burchardt, U. Jonas, B. Hemmerlein

    Plan Plan
  • ·UP-01.10 : Renal hypertension in patients 10 years after ESWL treatment for renal calculosis

    Page :226

    L. Lekovski, S. Stavridis, M. Kuzmanovski, A. Stavridis

    Plan Plan
  • ·UP-01.11 : The use of Tachosil® surgical patch in partial nephrectomy

    Page :226

    A. Siatelis, C. Konstantinidis, D. Volanis, P. Melidis, I. Karyotis, D. Delakas

    Plan Plan
  • ·UP-01.12 : Double-blind, placebo-controlled, multi-center study for the therapeutic effects of mountain panax ginseng C.A. Meyer extract in males with erectile dysfunction: a preliminary report

    Page :226

    H. Kim, S. Woo, S. Jo, E. Hahn, N. Youn, H. Lee, C. Sul

    Plan Plan
  • ·UP-01.13 : Photoselective vaporization of the prostate: short term results of a new technique for benign prostatic hyperplasia

    Page :226-227

    N. Zambrano, C. Ramos, J. Campero, S. Dietsch, A. Hinrichs, R. Rosenfeld

    Plan Plan
  • ·UP-01.14 : Percutaneous nephropexy with U-tube nephrostomy: long-term follow-up of an alternative technique for treatment of symptomatic nephroptosis

    Page :227

    J. Székely, F. Bagheri, K. Villányi, C. Pusztai, Á. Szántó, T. Beöthe, L. Farkas

    Plan Plan
  • ·UP-01.15 : Pathology of 68 renal epithelial - stromal tumors

    Page :227

    C. Davis, I. Sesterhenn

    Plan Plan
  • ·UP-01.16 : Retroperitoneal versus transperitoneal laparoscopic live donor nephrectomy: results from a prospective randomized trial

    Page :227-228

    A. Kumar, R. Goyal, A. Srivastava, D. Dubey

    Plan Plan
  • ·UP-01.17 : Use of diagnostic percutaneous needle biopsy for indeterminate renal masses: current practice in the UK

    Page :228

    A. Khan, I. Shergill, S. Quereshi, M. Vandal, S. Gujral

    Plan Plan
  • ·UP-01.18 : Effect of the herbal medicine bu-zhong-yi-ki-tang on semen parameters and seminal plasma cytokine levels in idiopathic male infertility

    Page :228

    T. Akashi, A. Watanabe, A. Morii, I. Mizuno, H. Fuse

    Plan Plan
  • ·UP-01.19 : Oligospermic men treated by carnitine and acetylcarnitine

    Page :228

    S. Micic, D. Djordjevic, N. Bojanic, N. Lalic, D. Nale, A. Vuksanovic

    Plan Plan
  • ·UP-01.20 : The use of water jet dissection for nephron sparing surgery in patients with renal cell cancer

    Page :228-229

    J. Djozic, J. Bogdanovic, G. Marusic, V. Sekulic, M. Dukic, Z. Dimitric, R. Herin, M. Djozic, S. Djozic

    Plan Plan
  • ·UP-01.21 : A retrospective study of implications on survival of histopathological subtyping and nuclear grading of renal cell carcinoma

    Page :229

    Y. Kim, J. Huh, J. Lee, S. Chang, S. Jeon

    Plan Plan
  • ·UP-01.22 : Clinical characteristics of xanthogranulomatous pyelonephritis

    Page :229

    Y. Kim, J. Huh, J. Lee

    Plan Plan
  • ·UP-01.23 : Tumour in end-stage kidney

    Page :229-230

    M. Hora, T. Ürge, J. Klečka, T. Reischig, O. Hes, J. Ferda, M. Michal

    Plan Plan
  • ·UP-01.24 : Spontaneous rupture of renal cell carcinoma: a rare acute emergency

    Page :230

    N. Vasdev, S. Kothandaraman, N. Sezhian, A. Thwaini, G. Suresh

    Plan Plan
  • ·UP-01.25 : Stagewise survival in renal cell carcinoma - a single centre experience

    Page :230

    P. Deka, R. Puthenveetil, S. Barua, S. Baruah

    Plan Plan
  • ·UP-01.26 : The impact of tumor associated symptoms on the prognosis of the patients with renal cell carcinoma

    Page :230-231

    K. Lee, T. Kwon, B. Kim, D. Kim, J. Park, C. Kim, H. Jung, D. Kim, I. Cho, H. Lee

    Plan Plan
  • ·UP-01.27 : Renal tumor with tumor thrombosis of inferior vena cava or right atrium: clinicopathological features, surgical techniques and outcomes

    Page :231

    M. Ayati

    Plan Plan
  • ·UP-01.28 : Changing practice patterns in the treatment of small renal tumors

    Page :231

    T. Moon, S. Nakada, S. Hedican, D. Jarrard, J. Gee, R. Bruskewitz

    Plan Plan
  • ·UP-01.29 : Laparoscopic radical nephrectomy compared with open radical nephrectomy. Initial experience of Tata memorial hospital, India

    Page :231-232

    Y. Thyavihally, H. Tongaonkar, A. Kakade

    Plan Plan
  • ·UP-01.30 : Does the microvascular invasion of perirenal fat have a role in the outcome of patients with renal cell carcinoma?

    Page :232

    V. Bucuras, A. Dema, M. Botoca, A. Cumpanas, R. Bardan

    Plan Plan
  • ·UP-01.31 : Therapeutic procedure in pyeloureteric obstruction and associated segmental ureteric hypoplasia in childhood

    Page :232

    U. Friedrich, R. Vetter

    Plan Plan
  • ·UP-01.32 : Postoperative renal function of ureteropelvic junction obstruction

    Page :232-233

    Y. Koikawa, T. Yamaguchi, T. Konomoto, Y. Akita

    Plan Plan
  • ·UP-01.33 : HLA antigens system and congenital ureteropelvic junction obstruction

    Page :233

    S. Falahatkar, S. Tavasoli Yousefabad, A. Shamsa, S. Nikpoor

    Plan Plan
  • ·UP-01.34 : Giant ureterocele causing outflow obstruction

    Page :233

    P. Deka, R. Puthenveetil, S. Barua, S. Baruah

    Plan Plan
  • ·UP-01.35 : Hypospadias surgery at Red Cross Children’s Hospital: 10 years, 600 cases

    Page :233

    J. Lazarus, L. Jee

    Plan Plan
  • ·UP-01.36 : Hypospadias repair: a surgeon’s 25-year experience

    Page :233-234

    H. Chang, K. Kim

    Plan Plan
  • ·UP-01.37 : Differential diagnostic of priapism in childhood

    Page :234

    A. Schlichter, U. Löffler, M. Beintker, J. Schubert

    Plan Plan
  • ·UP-01.38 : Results of primary bladder exstrophy closure, at Mulago Hospital (Uganda)

    Page :234

    S. Watya, S. Muwazi, I. Kajja

    Plan Plan
  • ·UP-01.39 : Ventral penile curvature without hypospadias: points to consider in diagnosis and surgical treatment

    Page :234

    H. Inal

    Plan Plan
  • ·UP-01.40 : The comparison of the therapeutic effect of oral diclofenac sodium, imipiramin and their combination in the treatment of primary nocturnal enuresis

    Page :235

    M. Hosseini, L. Ghahramani, M. Amini, D. Irani, F. Emamghorayshi

    Plan Plan
  • ·UP-01.41 : Paediatric balanitis xerotica obliterans: an 8-year experience

    Page :235

    A. Khan, B. Madhok, I. Shergill, M. Arya, J. Barua

    Plan Plan
  • ·UP-01.42 : Detrusor injections with botulinum toxin A (BTX-A) for detrusor overactivity (DO): is there a difference in congenital spinal cord defects (CCD) and traumatic spinal cord injuries (SCI)?

    Page :235

    J. Grosse, G. Kramer, D. Rohrmann, G. Jakse

    Plan Plan
  • ·UP-01.43 : Optimizing the results of tubular incised plate urethroplasty using double breasted deepithelialized skin flap in hypospadias repair

    Page :236

    A. Elkassaby, A. Al-Kandari, T. Elzayat

    Plan Plan
  • ·UP-01.44 : Snodgrass technique of urethroplasty modified with the adjunct of techniques of substitution urethroplasty: experience in 125 cases in prospective study

    Page :236

    Z. Bhuiyan, M.F. Islam, S.A. Khan, K.M.H. Tawhid

    Plan Plan
  • ·UP-01.45 : Squamous cell carcinoma of the penis: prognostic factors

    Page :236-237

    P. Nunes, N. Maia, B. Parada, V. Dias, F. Rolo, A. Mota

    Plan Plan
  • ·UP-01.46 : Combined chemotherapy in metastatic penile cancer

    Page :237

    A. Rempelakos, T. Arvanitakis, A. Palantzas, A. Georgalis, A. Thanos

    Plan Plan
  • ·UP-01.47 : Testicular cancer: two years’ experience of multidisciplinary approach in KwaZulu Natal, Durban, South Africa

    Page :237

    E. Abdel Goad, S. Jhugroo, A. Jodan, R. Venter, Z. Bereczky

    Plan Plan
  • ·UP-01.48 : The diagnostic value of C-reactive protein and erythrocyte sedimentation rate for patients with an acute scrotum

    Page :237-238

    S. Asgari, M. Mansourghanai, A. Roshani, G. Mokhtari

    Plan Plan
  • ·UP-01.49 : Prostatic abscess - Indian scenario

    Page :238

    C. Mallikarjuna, A. Suri Babu

    Plan Plan
  • ·UP-01.50 : Primary cancer of the penis among Xhosa population in Transkei, South Africa

    Page :238

    N. Bustamante Salazar, N. Bustamante Sigarroa, Y. Ordaz Fuentes, M. Garcia Jardon

    Plan Plan
  • ·UP-01.51 : Abstract Unavailable

    Page :238

    
  • ·UP-01.52 : Penile cancer: Do GUM clinic referrals delay the diagnosis?

    Page :238

    S. Ravichandran, A. Arulanandarajah, N. Parr

    Plan Plan
  • ·UP-01.53 : Surgical management of penile fracture: our experience

    Page :239

    F. Cabrera Meirás, O. Blanco Carballo, A. Sanchı́s Bonet, G. Duque Ruiz, J. Duarte Ojeda, A. Tejido Sánchez, E. Alvarez González, A. Martin Parada, O. Leiva Galvis

    Plan Plan
  • ·UP-01.54 : ‘Desperation’ retroperitoneal lymph node dissection for post chemotherapy residual nodal masses in NSGCT of testis

    Page :239

    A. Seth, P. Wadhwa, N. Gupta, A. Hemal, P. Dogra, R. Kumar

    Plan Plan
  • ·UP-01.55 : Radiological surveillance for simple intratesticular cysts: an 11-year experience

    Page :239

    A. Khan, F. Kapasi, I. Shergill, B. Potluri, C. Barber

    Plan Plan
  • ·UP-01.56 : The correlation of parooxonase/arylesterase activities with lipoproteins and apolipoprotein Al and B in renal transplant patients

    Page :239-240

    A. Afshari Taghizadeh, M. Ansari Khadem, S. Samadzadeh

    Plan Plan
  • ·UP-01.57 : Malignancy in renal transplanted patients

    Page :240

    A. Afshari Taghizadeh, M. Fallah Mohmmadi, A. Tehranchi, M. Sadehdel

    Plan Plan
  • ·UP-01.58 : Transplantation of enbloc cadaveric pediatric kidney to adult

    Page :240

    R. Mahdavi Zafarghandi, D. Arab, R. Taghavi, H. Gholmrezaee, M. Yazdani, N. Simforosh, A. Tabibi

    Plan Plan
  • ·UP-01.59 : Effects of papaverin hydrochloride in diuresis and function of graft after kidney transplantation, comparison with lidocaine and furozemide

    Page :240

    R. Zafarghandi Mahdavi, R. Taghavi, M. Mahdavi, M. Darabi, D. Arab, A. Delijani, H. Mejramian, F. Fathi

    Plan Plan
  • ·UP-01.60 : Microchimerism and renal transplantation: doubt still persists

    Page :240-241

    G. Pourmand, M. Nikoobakht, A. Mehrsai, M. Taherimahmoudi, A. Saraji, A. Emamzadeh

    Plan Plan
  • ·UP-01.61 : Results of the first 40 laparoscopic donor nephrectomies

    Page :241

    H. Gholamrezaie, A. Shahrazad, A. Shadab, A. Khalili

    Plan Plan
  • ·UP-01.62 : Live open donor nephrectomy: a multidisciplinary approach facilitates post operative recovery

    Page :241

    J. Beatty, K. Junejo, J. McNeill, M. Chawdhery

    Plan Plan
  • ·UP-01.63 : Postoperative lymphoceles in renal transplantation

    Page :241-242

    D. Basic, D. Milutinovic, M. Djokic, J. Hadzi Djokic, Z. Dzamic, D. Radivojevic, R. Blagojevic-Lazic

    Plan Plan
  • ·UP-01.64 : Vascular graft interposition in renal allograft implantation

    Page :242

    D. Milutinovic, D. Basic, M. Djokic, Djokic J. Hadzi

    Plan Plan
  • ·UP-01.65 : New technique for allograft ureteral ureteroneocystostomy to make possible endoscopic handling of allograft urologic complications

    Page :242

    A. Zomorrodi, A. Buhluli

    Plan Plan
  • ·UP-01.66 : Renal transplantation in patients with hepatitis B or C

    Page :242

    B. Parada, A. Figueiredo, P. Nunes, F. Macário, R. Alves, A. Carvalho, A. Mota

    Plan Plan
  • ·UP-01.67 : Evolution of renal transplantation over time. Comparative study of two different periods: 1980-1995 vs. 1996-2005

    Page :242-243

    B. Parada, A. Figueiredo, P. Nunes, C. Bastos, F. Rolo, A. Mota

    Plan Plan
  • ·UP-01.68 : Influence of the immunological factors in renal transplantation: one-single center experience

    Page :243

    B. Parada, A. Figueiredo, P. Nunes, F. Macário, A. Mota

    Plan Plan
  • ·UP-01.69 : A comparative study of urological complications between fine prolene with catgut chromic suture material in ureteral anastomosis in renal transplantation

    Page :243-244

    A. Pasha Akbarzadeh, H. Gholamrezaie

    Plan Plan
  • ·UP-01.70 : Comparative study of two techniques of ureteroneocystostomy (Taguchi and Lich-Gregoir)

    Page :244

    P. Moreira, B. Parada, A. Figueiredo, N. Maia, P. Nunes, C. Bastos, A. Mota

    Plan Plan
  • ·UP-01.71 : Patients submitted to a second or third renal transplant: evaluation of results

    Page :244-245

    P. Moreira, P. Nunes, A. Figueiredo, N. Maia, B. Parada, A. Roseiro, A. Mota

    Plan Plan
  • ·UP-01.72 : Risk factors for delayed graft function and their influence in renal graft outcome

    Page :245

    A. Figueiredo, P. Moreira, B. Parada, P. Nunes, F. Macario, C. Bastos, A. Mota

    Plan Plan
  • ·UP-01.73 : Our experience with early postoperative vascular complications in living vs cadaveric renal transplantation

    Page :245

    D. Milutinovic, D. Basic, Z. Boric, M. Djokic, R. Blagojevic-Lazic, D. Radivojevic, Z. Dzamic, J. Djokic Hadzi

    Plan Plan
  • ·UP-01.74 : Efficacy of foreskin grafts for bulbopendulous urethral strictures

    Page :245-246

    A. Lecki

    Plan Plan
  • ·UP-01.75 : Adult urethral stricture disease after childhood hypospadias repair: an unexpected source of severe urethral stricture

    Page :246

    R.S. Santucci, C. Hammer

    Plan Plan
  • ·UP-01.76 : Changing patterns of adult and paediatric genito-urinary reconstruction in southern Nigeria

    Page :246

    L. Akporiaye

    Plan Plan
  • ·UP-01.77 : Long-term results of endoscopic primary realignment of posterior urethral injury accompanied with pelvic bone fracture

    Page :246-247

    J. Lee, H. Chung, W. Na, M. Choi

    Plan Plan
  • ·UP-01.78 : Dorsal onlay graft urethroplasty using buccal mucosa in extensive anterior urethral strictures

    Page :247

    Zafarghandi R. Mahdavi, Kachooe M. Yazdani, D. Arab, A. Ahanian, M. Mahdavi

    Plan Plan
  • ·UP-01.79 : The good and bad of urethral stents

    Page :247

    M. Eisenberg, S. Elliott, J. McAninch

    Plan Plan
  • ·UP-01.80 : Closure and continence in obstetric VVF involving the continence mechanism

    Page :247

    J. Naude, I. Vaz

    Plan Plan
  • ·UP-01.81 : Maintaining long term patency of the Mitrofanoff stoma

    Page :248

    J. Naude

    Plan Plan
  • ·UP-01.82 : Testis injury: efficacy of American Association for the Surgery of Trauma organ injury scale

    Page :248

    K. Yoo, J. Kim, S. Lee, S. Chang, K. Ahn

    Plan Plan
  • ·UP-01.83 : Comparison of the curative potencial of direct vision internal urethrotomy versus open uretroplasty

    Page :248

    R. Gomez, P. Marchetti, C. Ramos

    Plan Plan
  • ·UP-01.84 : Initial experience and challenges of urethroplasty in a new urology unit in Nigeria

    Page :248-249

    I. Mungadi, I. Ntia

    Plan Plan
  • ·UP-01.85 : Injuries to the pelvis in andrology

    Page :249

    R. Grill, V. Džupa, V. Báca

    Plan Plan
  • ·UP-01.86 : The influence of visitorship program on the development of urethroplasty service for complicated urethral cases in a general hospital in Kuwait

    Page :249

    A. Al-Kandari, Y. Elshebiny, H. Ibrahim, H. Shaaban, H. Al-Enezi, A. Elkassaby

    Plan Plan
  • ·UP-01.87 : The use of buccal mucosa in urethroplasty

    Page :249-250

    K.E.K. Aboah

    Plan Plan
  • ·UP-01.88 : Darifenacin is also effective in neurogenic bladder dysfunction (multiple sclerosis)

    Page :250

    S. Carl, S. Laschke

    Plan Plan
  • ·UP-01.89 : A comparison of the results of intravaginal suburethral sling and transobturator tape procedures in the surgical treatment of stress urinary incontinence

    Page :250

    S. Onol, F. Onol, H. Inal, S. Onur, O. Köse

    Plan Plan
  • ·UP-01.90 : Effect of lumbar-epidural administration of tramadol on neurophysiology of bladder

    Page :250

    S. Singh, M. Agarwal, Y. Batra, A. Mandal

    Plan Plan
  • ·UP-01.91 : Effects of estrogen on postmenopausal urinary incontinence rat model

    Page :251

    Hayashi N. Narihiko, Y. Kubota Yoshinobu, T.X. Minor, T.F. Lue

    Plan Plan
  • ·UP-01.92 : Tumor necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract

    Page :251

    R. Zigeuner, G. Hutterer, T. Chromecki, S. Leibl, P. Rehak, C. Langner

    Plan Plan
  • ·UP-02.01 : Erectile dysfunction: a dilemma and man’s solutions through the ages

    Page :252

    M. Omar, O. Karim, H. Motiwala

    Plan Plan
  • ·UP-02.02 : History of brachytherapy in prostate cancer

    Page :252

    A. Rempelakos, E. Koutsiaris, A. Thanos, E. Poulakou-Rebelakou

    Plan Plan
  • ·UP-02.03 : History of vasectomy

    Page :252

    P. Kumar, A. Chowdhury, J. Pati

    Plan Plan
  • ·UP-02.04 : The renal colic of the Byzantine emperor John VI Cantacuzenus (1347-1354)

    Page :252-253

    E. Poulakou-Rebelakou, E. Koutsiaris, C. Tsiamis, A. Rempelakos

    Plan Plan
  • ·UP-02.05 : Venereal diseases in early 20th century Greece

    Page :253

    E. Poulakou-Rebelakou, C. Tsiamis, E. Koutsiaris

    Plan Plan
  • ·UP-02.06 : Urology in Islamic medicine

    Page :253

    A. Al Dayel

    
  • ·UP-02.07 : Single drug therapy in the treatment of male sexual/erectile dysfunction in Islamic medicine

    Page :253-254

    A. Al Dayel, N. Al Zuhair

    Plan Plan
  • ·UP-02.08 : The history of the first urology department in the world

    Page :254

    R. Sosnowski, T. Demkow, W. Rogowski, A. Borowka

    Plan Plan
  • ·UP-02.09 : Penile adorning through ages, from “way of life” to “life style”

    Page :254

    M. Omar, A. Hussain, H. Motiwala, O. Karim

    Plan Plan
  • ·UP-02.10 : On social responsibility of genito-urology in Agenda 21

    Page :254

    E. Neu, M. Michailov, J. Stiglmayr, J. Hess, C. Reiser, B. Zoepfl, H. Zoepfl

    Plan Plan
  • ·UP-02.11 : Psychosomatics in genito-urology

    Page :255

    M. Michailov, L. Steib, E. Neu, H. Schumitz, U. Welscher, G. Weber

    Plan Plan
  • ·UP-02.12 : Long-term experience with Memotherm urethral stents in the management of BPH and urethral strictures

    Page :255

    R. Shimpi

    Plan Plan
  • ·UP-02.13 : Urology in Iraqi Kurdistan

    Page :255

    C. Evans

    
  • ·UP-02.14 : Scrotoscopy: a new diagnostic and therapeutic tool

    Page :255-256

    R. Shimpi

    Plan Plan
  • ·UP-02.15 : A prospective study on therapeutic advice provided by an expert computer system designed to assess lower urinary tract symptoms

    Page :256

    R. John, P. Sanders, C. Chilton, M. Henley

    Plan Plan
  • ·UP-02.16 : Global better sex survey: South Africa

    Page :256

    E. Baraldi

    Plan Plan
  • ·UP-02.17 : Development of a Farsi questionnaire to assess the knowledge of primary school teachers about voiding dysfunction of students in West Azerbaijan Province, Iran

    Page :256

    D. Mehraban, S. Samadzadeh, M. Moosavi, M. Salehi

    Plan Plan
  • ·UP-02.18 : Laparoscopic training protocol using small animal model in urology

    Page :257

    W. Cho, T. Kim, G. Kong, J. Yoon, K. Sung

    Plan Plan
  • ·UP-02.19 : Prostate cancer detection in men with an initial diagnosis of atypical small acinar proliferations

    Page :257

    C. Chabert, S. Napaki, P. Mancuso

    Plan Plan
  • ·UP-02.20 : Predicting the risk factors of inguinal hernia following radical retropubic prostatectomy

    Page :257

    Y. Ou, C. Twu, C. Cheng, H. Ho, C. Yang

    Plan Plan
  • ·UP-02.21 : The evolution of radioimmunoscintigraphy: sharper images and outcomes data

    Page :257-258

    M. Manyak

    Plan Plan
  • ·UP-02.22 : Superior anti-tumor immune response of dendritic cells fused with prostate cancer cells compared with tumor lysate-pulsed dendritic cells

    Page :258

    C.S. Kim, J.M. Lee, B.H. Chung, H.Y. Choi

    Plan Plan
  • ·UP-02.23 : Biochemoimmunotherapy (BCITx) consisting of autologous tumour derived freeze-dried exosomes with resuspended encapsulated vinorelbine termed as exosomal-vinorelbine-tartrate (EVT) (under patent) induces apoptosis in metastatic hormone refractory prostate Ca (MHRPC)

    Page :258-259

    J. Giannios, P. Lambrinos, N. Alexandropoulos

    
  • ·UP-02.24 : Clinical value of PSA parameters for detection of prostate cancer in Chinese people: 325 cases

    Page :259

    X.R. Zhang, Y.M. Xu, J. Zhang

    Plan Plan
  • ·UP-02.25 : Fatigue, prostate cancer and exercise

    Page :259

    B. Serdà

    Plan Plan
  • ·UP-02.26 : Use of intravesical temperature as core body temperature following kidney transplantation and comparision with rectal, axillary and oral measurement

    Page :259

    H. Ahmadnia, M. Khaje Daluee, M. Mojahedi, D. Soroush

    Plan Plan
  • ·UP-02.27 : The association between genetic variant of luteinizing hormone and the incidence and prognosis of prostate cancer in groups of multi-ethnic origin

    Page :259-260

    A. Thwaini, M. Naase, F. Chinegwundoh, S. Baithun, R. Ahmed, D. Morgan, L. Richard, R. Iles

    Plan Plan
  • ·UP-02.28 : Effect of finasteride flutamide, cyproterone acetate and castration on rat’s prostate vascularity

    Page :260

    A. Yarmohamadi, H. Ahmadnia, M. Darabi, B. Feizzadeh, A. Gaviandam Titkanlo

    Plan Plan
  • ·UP-02.29 : Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7

    Page :260

    C. Mian, M. Lodde, E. Comploj, F. Marziani, A. Chicchetti, A. Spada, M. Mian, A. Pycha, L. Lusuardi

    Plan Plan
  • ·UP-02.30 : Analysis of gene expression in prostate cancer circulating tumour cells (CTCs) allows rational targeting of therapy for androgen independent prostate cancer

    Page :260-261

    G. Shaw, T. Purkiss, D. Prowse, T. Oliver

    Plan Plan
  • ·UP-02.31 : The role of body-coil MR imaging in the preoperative staging of prostate cancer patients before radical protstatectomy

    Page :261

    M. Abdel-Khalek, A.F. El-Sherbeny, E. Ibrahiem

    Plan Plan
  • ·UP-02.32 : Does transrectal ultrasound add value in the staging of clinical T3a prostate cancer?

    Page :261

    C. Hsu, S. Joniau, R. Oyen, T. Roskams, H. Van Poppel

    Plan Plan
  • ·UP-02.33 : Anatomical basis for pelvic lymph node dissection during radical perineal prostatectomy: results of an autopsy study and implications for the clinic

    Page :261-262

    E. Veliev, I. Li, V. Motalov

    Plan Plan
  • ·UP-02.34 : Early use of the vacuum constriction device following radical retropubic prostatectomy: a randomized clinical trial

    Page :262

    M. Monga, T. Kohler, K. Hendlin, I. Ryndin, B. Canales, D. Weiland, N. Nakib, A. Ramani, K. Anderson, P. Reddy, R. Ugarte

    Plan Plan
  • ·UP-02.35 : Clinicopathological evaluation of radical retropubic prostatectomy: positive outcome even at institutes with very few experiences

    Page :262

    T. Okamura, H. Akita, Y. Hashimoto, K. Tozawa, K. Kohri

    Plan Plan
  • ·UP-02.36 : Immune response and anti-tumor activity of preoperative peptide vaccination for patients with localized prostate cancer

    Page :262-263

    M. Noguchi, Y. Akihisa, M. Harada, J. Mizoguchi, O. Nakashima, K. Itoh, K. Matsuoka

    Plan Plan
  • ·UP-02.37 : The role of testosterone in regulation of the expression of genes of several proliferation factors

    Page :263

    A. Pechersky, O. Loran, V. Pechersky, M. Vonsky, A. Mittenberg, V. Semiglazov

    Plan Plan
  • ·UP-02.38 : The role of testosterone in regulation of the pulse mode of incretion of some hormones and mytotic activity

    Page :263

    A. Pechersky, V. Semiglazov, O. Loran, A. Karpischenko, V. Pechersky, V. Mazurov

    Plan Plan
  • ·UP-02.39 : Important role of the adipocyte-cancer cell interaction in the prostate cancer

    Page :263-264

    Y. Satoh, A. Kaneko, Y. Tokuda, C. Fujiyama, J. Uozumi

    Plan Plan
  • ·UP-02.40 : Transrectal color Doppler ultrasonography monitoring neurovascular bundle blockade relieves pain during prostate biopsy

    Page :264

    Y. Nasu, N. Ono, E. Ando

    Plan Plan
  • ·UP-02.41 : A comparative study of fascin expression in adenocarcinomas of the prostate gland and urothelial carcinomas

    Page :264

    F. Karasavvidou, T. Anagnostou, E. Tziastoudi, V. Tzortzis, G. Moutzouris, M. Melekos, G. Koukoulis

    Plan Plan
  • ·UP-02.42 : Quantitative proteomic approaches for the determination of carcinogenesis biomarkers in prostate tissue

    Page :264-265

    S. Tyritzis, G. Spiros, P. Zerefos, A. Papadopoulou, A. Vlahou, C. Tamvakopoulos, S. Kossida, J. Diaz, K. Pavlakis, C. Constantinides

    Plan Plan
  • ·UP-02.43 : A single surgeons’ experience in the efficacy of three modalities for the management of prostate cancer

    Page :265

    J. Bennett, P. Alphonse, N. Smith, S. Hill

    Plan Plan
  • ·UP-02.44 : Review of 220 radical prostatecomies done by one surgeon

    Page :265

    P. De Bruin, P. Nicolle

    Plan Plan
  • ·UP-02.45 : Should radical prostatectomy become standard procedure at low-volume hospitals? Findings of a patient survey

    Page :265-266

    X. Krah, G. Atanassov, E. Klose, G. Eschholz

    Plan Plan
  • ·UP-02.46 : Dynamic contrast enhanced magnetic resonance (DCE-MR) imaging: a useful modality for the early diagnosis of prostate cancer

    Page :266

    T. Watanabe, K. Wada, M. Inoue, S. Uehara, K. Monden, T. Saika, Y. Nasu, H. Kumon, N. Akazawa, I. Togami

    Plan Plan
  • ·UP-02.47 : Laparoscopy assisted radical retropubic prostatectomy (LARRP): initial experience

    Page :266

    W. Ko

    Plan Plan
  • ·UP-02.48 : The sensitivity of prostate octant biopsy in detection of clinical T1c prostate cancer

    Page :266-267

    B. Elias, R. Tomaskin, K. Kajo, J. Luptak, J. Svihra, J. Kliment

    Plan Plan
  • ·UP-02.49 : Prophylactic per-operative narrowing of the internal inguinal annulus at radical retropubic prostatectomy decreases the risk of post-operative inguinal hernia

    Page :267

    J. Stranne, G. Aus, S. Bergdahl, J. Damber, J. Hugosson, A. Khatami, L. Roxvall, P. Lodding

    Plan Plan
  • ·UP-02.50 : A study of the role of insulin like growth factor 1 (IGF1) and rapamycin sensitive signaling in an androgen independent prostate cancer cell line

    Page :267

    R. John, M. Larvin, S. Thomas, M. Henley

    Plan Plan
  • ·UP-02.51 : Initial experience with PET-CT imaging for staging and follow-up of patients with prostate cancer

    Page :268

    P. Malmström, V. Iyer, J. Sörensen, G. Sandblom, M. Häggman, B. Långström

    Plan Plan
  • ·UP-02.52 : Prostate cancer treatment with high intensity focused ultrasound (HIFU) by Ablatherm® with real time integrated imaging

    Page :268

    C. Chaussy, S. Thueroff

    Plan Plan
  • ·UP-02.53 : High-dose rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer

    Page :268

    Y. Jo, R. Hara, T. Fujii, M. Yokoyama, S. Miyaji, A. Nagai

    Plan Plan
  • ·UP-02.54 : Ten years local high intensity focused ultrasound (HIFU) by Ablatherm® for prostate cancer: profile of side effects

    Page :268-269

    C. Chaussy, S. Thueroff

    Plan Plan
  • ·UP-02.55 : Transrectal non-invasive prostate cancer treatment by high intensity focused ultrasound (HIFU). Is available technology identical?

    Page :269

    C. Chaussy, S. Thueroff

    Plan Plan
  • ·UP-02.56 : C-reactive protein and white blood cell count after prostate biopsy in patients under antibiotic coverage

    Page :269

    M. Basar, D. Kýlýc, H. Unal, O. Ozluk, H. Basar, E. Batislam

    Plan Plan
  • ·UP-02.57 : The effects of garlic on serum prostatic specific antigen

    Page :269

    D. Mehraban, G. Naderi, R. Akbari Gilani, F. Esfahani

    Plan Plan
  • ·UP-02.58 : High intensity focused ultrasound therapy for localized prostate cancer

    Page :270

    K.W. Kwak, J. Hong, C. Kim, W. Park, H. Lee, H. Choi

    Plan Plan
  • ·UP-02.59 : Laparoscopic radical prostatectomy by a single surgeon in South Korea

    Page :270

    T. Hwang, S. Hong, S. Seo, J. Kim

    Plan Plan
  • ·UP-02.60 : Strategy of the treatment for localized prostatic cancer

    Page :270-271

    A. Yasukawa, S. Kouda, T. Oguchi

    Plan Plan
  • ·UP-02.61 : Value of the percentage of positive cores in prostatic biopsy to detect extracapsular extension

    Page :271

    A. Barbagelata, F. Gómez Veiga, J. Ponce Dı́az Reixa, L. Alvarez Castelo, E. Romero Selas, S. Pertega, J. Janeiro, P. Casas, M. Gonzalez-Martin

    Plan Plan  
  • ·UP-02.62 : Latent carcinoma of the prostate in Turkey: an autopsy study

    Page :271

    C. Güler, F. Aktepe, E. Tüzel, H. Dilek, H. Küçüker, B. Akdoðan, I. Uzun, K. Polat

    Plan Plan
  • ·UP-02.63 : Extended 12 systematic prostate biopsy protocol can improve prostate cancer detection

    Page :271-272

    B. Trajcevska-Boskovska, V. Georgiev, Z. Popov, B. Bogoeva, S. Banev

    Plan Plan
  • ·UP-02.64 : The results of the study KAPROS in the region of Olomouc

    Page :272

    V. Student, R. Fiala, A. Vidlář, M. Hrabec, M. Grepl

    Plan Plan
  • ·UP-02.65 : The relationship of preoperative PSA levels to prostatic weight and tumor size

    Page :272

    B. Furusato, I. Sesterhenn, I. Rosner, D. Osborn, J. Cullen, Y. Chen, C. Davis, D. McLeod

    Plan Plan
  • ·UP-02.66 : Can urinary PSA determination improve T-staging of prostate cancer?

    Page :272

    T. Pejcic, J. Hadzi-Djokic, R. Radosavljevic, L. Hajdukovic, B. Milkovic

    Plan Plan
  • ·UP-02.67 : Is it possible to predict exact PSA behavior during long-term interval of tumor growth using the mathematical model?

    Page :273

    T. Pejcic, A. Marjanovic, J. Hadzi-Djokic

    Plan Plan
  • ·UP-02.68 : Urinary prostate specific antigen: the novel tool for prostate cancer response assessment?

    Page :273

    T. Pejcic, J. Hadzi-Djokic, M. Acimovic, L. Hajdukovic, A. Janjic

    Plan Plan
  • ·UP-02.69 : Open radical retropubic prostatectomy: results on 83 patients

    Page :273

    J. Hadzi-Djokic, T. Pejcic, V. Colovic, Z. Filipovic, D. Basic, A. Janjic

    Plan Plan
  • ·UP-02.70 : Analysis of complexed prostatic specific antigen and their ratios to detect prostate cancer undergoing a first biopsy with total PSA 4-10ng/ml: a series of 1055 patients

    Page :273-274

    F. Gómez Veiga, A. Barbagelata López, J. Ponce Dı́az-Reixa, S. Pertega, L. Alvarez Castelo, E. Romero Selas, P. Casas Agudo, J. Janeiro Pais, M. Gonzalez Martin

    Plan Plan
  • ·UP-02.71 : Application of fractal analysis in the study of prostatic biopsies

    Page :274

    P. Pavlopoulos, N. Kavantzas, P. Kakouri, S. Touloupides, S. Bouzoukas

    Plan Plan
  • ·UP-02.72 : Immunohistochemical study of chromogranin A and HER-2 expression in bone metastatic prostate cancer

    Page :274

    T. Taki, Y. Yamada, S. Aoki, K. Nakamura, K. Naruse, M. Tobiume, K. Zennami, R. Katsuda, N. Honda

    Plan Plan
  • ·UP-02.73 : High intensity focused ultrasound in the treatment of prostate cancer: preliminary experience

    Page :274-275

    R. Sanseverino, O. Intilla, A. Campitelli, R. Angrisani, U. Di Mauro, G. Napodano

    Plan Plan
  • ·UP-02.74 : The relationship between serum PSA level and tumor volume persists in current ERA

    Page :275

    A. Ochiai, P. Troncoso, R.J. Babaian

    Plan Plan
  • ·UP-02.75 : The value of PSA in diagnosis of prostate cancer in non-screened population

    Page :275

    V. Vukotic Maletic, S. Cerovic, M. Lazic, S. Savic, M. Kozomara

    Plan Plan
  • ·UP-02.76 : The bone loss in patients with prostate cancer treated by different approaches: radical prostatectomy, orchiectomy or hormonal therapy

    Page :275-276

    V. Bucuras, D. Bucuras, R. Bardan

    Plan Plan
  • ·UP-02.77 : Challenges to research and management of prostate cancer in a developing economy: A call for international cooperation and support

    Page :276

    A. Popoola, S. Kuranga

    Plan Plan
  • ·UP-02.78 : Should we anesthetize for transrectal ultrasound guided biopsy of prostate? A randomized trial comparing local anesthesia versus no anesthesia

    Page :276

    S. Sambandam, N. Sezhian, S. Kothandaraman, G. Suresh, N. Vasdev

    Plan Plan
  • ·UP-02.79 : Does methylprednisolone acetate increase the success rate of medical therapy for passing distal ureteral stone?

    Page :276

    S. Falahatkar, S. Tavasoli Yousefabad, M. Salehi, H. Shiri, S. Nikpoor

    Plan Plan
  • ·UP-02.80 : Asymptomatic microscopic hematuria and urinary lithiasis

    Page :276-277

    S. Falahatkar, S. Tavasoli Yousefabad, S. Nikpour

    Plan Plan
  • ·UP-02.81 : Reliability of dipstick test in urine analysis

    Page :277

    S.A. Asgari, S. Falahatkar, S. Tavasoli Yousefabad, M.B. Mogaddam, S.K. Agamir, M.M. Ghanaei

    Plan Plan
  • ·UP-02.82 : Complications of treatment dendritic nephrolithiasis at advanced stages

    Page :277

    E.K. Yanenko, N.A. Lopatkin, A.G. Martov, N.K. Dzeranov

    
  • ·UP-02.83 : Open surgical treatment of patients with dendritic nephrolithiasis

    Page :277-278

    E. Yanenko, N. Lopatkin, A. Martov, N. Dzeranov

    Plan Plan
  • ·UP-02.84 : Analysis of the subjective pain and need of analgesics during shockwave lithotripsy

    Page :278

    S. Paick, B. Lee, H. Kim, Y. Lho

    Plan Plan
  • ·UP-02.85 : Comparison color Doppler ultrasonography with IVP in ureteral obstruction due to ureteral stone

    Page :278

    H. Ahmadnia, S. Nekoee, A. Yarmohamadi

    Plan Plan
  • ·UP-02.86 : The safety of bilateral ureteroscopy for ureteral obstructing calculi

    Page :278

    W. Abu Arafeh, R. Salah Eddin, M. Zilberman

    Plan Plan
  • ·UP-02.87 : Comparison of urinary proteins in calcium stone formers and healthy individuals: a case-control study

    Page :278-279

    G. Pourmand, H. Nasseh, A. Sarrafnejad, A. Mojtahedi, A. Mehrsai, D. Hamidi Alamdari, K. Nourijelyani, A. Emamzadeh

    Plan Plan
  • ·UP-02.88 : Results of percutaneous nephrostolithotomy (PCNL) in lower calyceal stones

    Page :279

    M.R. Darabi Mahboob, R. Taghavi, R. Mahdavi, H. Ahmadnia

    Plan Plan
  • ·UP-02.89 : A comparison between percutaneous nephrolithotomy (PCNL) and open renal surgery for treatment of renal stones: outcomes and complications

    Page :279

    M. Darabi Mahboob, H. Ahmadnia

    Plan Plan
  • ·UP-02.90 : Head down, side up: rigid ureteroscopic removal of renal, renal pelvis and upper 1/3 ureteric calculi

    Page :279-280

    D. Sharma

    Plan Plan
  • ·UP-02.91 : Treatment of distal ureteric stones: Comparing Dornier S II lithotriptor versus semi-rigid ureteroscopy

    Page :280

    T. Anagnostou, V. Tzortzis, E. Aravantinos, A. Karatzas, G. Moutzouris, M. Melekos

    Plan Plan
  • ·UP-02.92 : Selective renal embolization: a successful way to control significant bleeding after percutaneous nephrolithotomy (PCNL)

    Page :280

    T. El-Leithy

    Plan Plan
  • ·UP-02.93 : Pitfalls of ESWL referral system in patients with renal stones who had JJ stent insertion

    Page :280

    A. Khan, P. Duncann, B. Maraj, R. Miller

    Plan Plan
  • ·UP-02.94 : Safety, efficacy and outcome of holmium laser ureterolithotripsy in patients with renal impairment

    Page :280-281

    A. Safwat, N. Bissada, U. Kumar, M. Taha, A. Gafaar, A. El-Taher, M. Abdalla

    Plan Plan
  • ·UP-02.95 : Holmium laser ureterolithotripsy: when is a stent indicated?

    Page :281

    A. Safwat, A. Bissada, U. Kumar, M. Taha, A. Gafaar, M. Abdalla, N. Bissada

    Plan Plan
  • ·UP-02.96 : Effects of stone location on outcome of ureteric stones managed by holmium laser lithotripsy

    Page :281

    A. Safwat, N. Bissada, U. Kumar, A. Finkbeiner, M. Taha, A. Gafaar, A. El-Taher, M. Abdalla

    Plan Plan
  • ·UP-02.97 : A silent giant ureteric calculus with giant hydronephrosis

    Page :281-282

    R. Puthenveetil, P. Deka, S. Barua, S. Baruah

    Plan Plan
  • ·UP-02.98 : Complication of the results and complications between standard and tubeless PCNL

    Page :282

    M. Darabi Mahboob, R. Taghavi, R. Mahdavi, M. Keshvari, K. Tavakoli

    Plan Plan
  • ·UP-02.99 : Use of holmium:YAG laser for endoscopic lithotripsy

    Page :282

    A. Hossain, S. Hossain, S. Khan, A. Salam

    Plan Plan
  • ·UP-02.100 : Randomized prospective evaluation of nephrostomy tube configuration on post-operative pain

    Page :282

    M. Monga, D. Weiland, J. Kim, S. Best, C. Lee, K. Hendlin, K. Anderson

    Plan Plan
  • ·UP-02.101 : Laparoscopic pyelolithotomy in a pelvic kidney and use of nephroscope for stone extraction

    Page :282-283

    R. Maghsoudi, A. Zolfaghari, J. Gholivandan, N. Ghorbani

    Plan Plan
  • ·UP-02.102 : Lower tract urinary calculi as an index of urological services in a developing country

    Page :283

    K. Bowa, M. Labib

    Plan Plan
  • ·UP-02.103 : Ureteroscopic extraction of difficult ureteral stone

    Page :283

    K. Kim, S. Cho

    Plan Plan
  • ·UP-02.104 : Validation of the ureteral stent symptom questionnaire in Turkish patients

    Page :283-284

    L. Tunc, B. Kupeli, M. Ilhan, C. Acar, O. Kara, I. Bozkirli

    Plan Plan
  • ·UP-02.105 : Prospective evaluation of interannual variation in 24 hour urine risk factors of CA-Oxalate stone patients and healthy individuals

    Page :284

    S. Yesil, B. Kupeli, L. Tunc, U. Karaoglan, I. Bozkirli

    Plan Plan
  • ·UP-02.106 : Is pneumatic ureteroscopic lithotripsy an alternative to extracorporeal shock wave lithotripsy in the treatment of large upper ureteral stones bigger than 10mm?

    Page :284

    M. Arslan, B. Gunlusoy, T. Degirmenci, N. Nergiz, S. Minareci, A. Ayder

    Plan Plan
  • ·UP-02.107 : The results of ureteroscopic lithotripsy in the treatment of bilateral ureter stones with different localizations

    Page :284

    M. Arslan, B. Gunlusoy, T. Degirmenci, N. Nergiz, S. Minareci, A. Ayder

    Plan Plan
  • ·UP-02.108 : Presentation, outcomes and interventions for renal and ureteric stones presenting in a defined community

    Page :284-285

    P. Davidson, I. Sheerin, C. Frampton

    Plan Plan
  • ·UP-02.109 : Comparison of patient-controlled analgesia using alfentanil with intramuscular pethidine in extracorporeal shock wave lithotripsy (ESWL)

    Page :285

    H. Ibrahim, N. Hon, Z. Hussain, D. Brathwaite, K. Hickmott, S. Coppinger

    Plan Plan
  • ·UP-02.110 : Results of SWL therapy for renal stone by Storz Modulith SLK

    Page :285

    S. Mousavi-Bahar, S. Amirhasani

    Plan Plan
  • ·UP-02.111 : Comparative analysis of age specific values of PSA, free to total PSA ratio, and PSA density in Korean men

    Page :285

    C.Y. Yoon, D.H. Yoon, J.W. Kim, J. Lee, N.S. Kim, D.K. Yoon

    Plan Plan
  • ·UP-03.01 : Feasibility of open simple prostatectomy with early vascular control

    Page :286

    M. Labib

    Plan Plan
  • ·UP-03.02 : Comparison of selective biochemical and hormonal factors in men with BPH

    Page :286

    A. Lecki

    Plan Plan
  • ·UP-03.03 : Disposable bladder (Ellik) evacuators: are they different?

    Page :286

    S. Ravichandran, G. Reddy, D. O’Sullivan

    Plan Plan
  • ·UP-03.04 : Is transition zone index useful in assessing bladder outflow obstruction due to benign prostatic hyperplasia? A prospective study

    Page :286-287

    S.L. Sailo, B. Viswaroop, S. Kumar, G. Gopalakrishnan, N.S. Kekre

    Plan Plan
  • ·UP-03.05 : Predictive factors affecting urethral stricture development after transurethral resection of the prostate in patients with benign prostatic hyperplasia

    Page :287

    Y. Jeong, J. Lim, B. Park, J. Park, H. Kim, Y. Kim, Y. Park, M. Kim

    Plan Plan
  • ·UP-03.06 : A modification in our current TWOC (trial without catheter) methodology and its proposed benefits – A prospective randomized study

    Page :287

    N. Vasdev, A. Thwaini, N. Sezhian, S. Kothandaraman, G. Suresh

    Plan Plan
  • ·UP-03.07 : The management of benign prostatic obstruction (BPO) in the third world

    Page :287

    D. Sharma

    Plan Plan
  • ·UP-03.09 : The relationship between PSA and prostate volume

    Page :288

    J. Rim, H. Rhew, S. Park, H. Jeong, S. Baik, S. Oh

    Plan Plan
  • ·UP-03.10 : The risk factor of delirium after transurethral resection of prostate

    Page :288

    J. Rim, H. Rhew, S. Park, H. Jeong, S. Baik

    Plan Plan
  • ·UP-03.11 : Abstract Withdrawn

    Page :288

    
  • ·UP-03.12 : Evaluation of prostate volume, age, serum prostate specific antigen and testosterone in patients with benign prostate hyperplasia with lower urinary tract symptoms

    Page :288-289

    J. Park, M. Lee, Y. Park

    Plan Plan
  • ·UP-03.13 : The role of PSA in predicting TURP specimen weight

    Page :289

    H. Ibrahim, N. Lynn, A. Elves, S. Ghiblawi, C. Beacock, S. Coppinger

    Plan Plan
  • ·UP-03.14 : Holmium laser enucleation of the prostate combined with mechanical morcellation: The early clinical experience with 44 patients

    Page :289

    Y. Shiraishi, H. Negoro, K. Okubo, T. Okada, S. Moroi, M. Kawakita

    Plan Plan
  • ·UP-03.15 : Does detrusor thickness estimated by ultrasound correlate with obstructed urine flowmetry in men with LUTS? A pilot study

    Page :289

    R. Surange, P. Joshi, C. Ong, N. Jeygopal, N. Sharma, M. Gupta

    Plan Plan
  • ·UP-03.16 : The importance of intravesical prostate protrusion in predicting bladder outlet obstruction in patients with good urinary flow

    Page :289-290

    H. Ho, K. Lim, K. Foo, M. Wong

    Plan Plan
  • ·UP-03.17 : Radiofrequency induced thermotherapy for BPH – 2 year clinical experience

    Page :290

    M. Roslan, M. Wasyl, M. Strzyzewski, J. Gabiga, K. Wegrzyn

    Plan Plan
  • ·UP-03.19 : Clinical correlation of prostatic calculi with lower urinary tract symptoms

    Page :290

    K. Ahn, B. Park, S. Jeon, S. Lee, S. Chang

    Plan Plan
  • ·UP-03.20 : Comparison of clinical effect after alpha-blocker monotherapy and combination therapy with finasteride in respect of transitional zone volume and transitional zone index in prostate volume less than 40g

    Page :290-291

    S. Yoon, D. Seong, Y. Kim

    Plan Plan
  • ·UP-03.21 : Compliance with treatment and surveillance in LUTS/BPH: ensuring evidence based practice

    Page :291

    M. Hehir, J. Graham, K. Riddle, V. Crispin

    Plan Plan
  • ·UP-03.22 : Is acute urinary retention (AUR) really linked to prostate volume?

    Page :291

    R. Fourcade, R. Hajj Hassan, A. Qarro, B. Makhoul

    Plan Plan
  • ·UP-03.23 : The importance of the role of the cytochrome P450 system in potential drug-drug and drug-herb interactions in the treatment of incontinence and lower urinary tract symptoms

    Page :291

    P. Hartman, T. Larson, L. Mynderse

    Plan Plan
  • ·UP-03.24 : The safety and efficacy evaluation of Tamsulosin and Dutasteride and combination therapy in patients with benign prostatic hypertrophy (BPH): a single-blind parallel, randomized, comparative, prospective, phase III trial

    Page :292

    R. Sood, V. Jain

    Plan Plan
  • ·UP-03.25 : The effects of finasteride on the expression of hypoxia inducible factor (HIF-1a) and vascular endothelial growth factor (VEGF) in benign prostatic hyperplasia

    Page :292

    A. Lekas, A. Lazaris, M. Chrisofos, A. Papatsoris, D. Lappas, E. Patsouris, C. Deliveliotis

    Plan Plan
  • ·UP-03.26 : What is effective and safe dose-raising method in patients with concomitant benign prostatic hyperplasia and hypertension after initial doxazosin 4mg: doxazosin 8mg versus combined therapy with doxazosin 4mg and tamsulosin 0.2mg

    Page :292-293

    I. Cho, J. Kim, K. Lee, K.S. Lee, Y. Chang

    Plan Plan
  • ·UP-03.27 : BPO: suprapubic prostatectomy, no cystostomy

    Page :293

    M. Hosseini

    Plan Plan
  • ·UP-03.28 : Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA): preliminary results

    Page :293

    T. Realfonso, A. Barela, G. Napodano, A. Baio, G. Miracolo, R. Sanseverino

    Plan Plan
  • ·UP-03.29 : Preliminary result of a study of converting patients on uroselective alpha-adrenergic blockers to a generic alpha-blocker, Prazosin

    Page :293

    W.J. Chua, G.E. Chiong, R. Kamaraj, E. Kesavan

    Plan Plan
  • ·UP-03.30 : A retrospective cost benefit analysis of photoselective vaporization of the prostate (PVP) versus transurethral resection of the prostate (TURP): The UCLA experience

    Page :293-294

    R. Reiter, B. Shurtleff, J. Lam

    Plan Plan
  • ·UP-03.31 : Clinical evaluation of urine tumor marker in the diagnosis of urothelial cancer

    Page :294

    H. Ikeda, S. Seko, R. Kanaoka, M. Oki, M. Mizutani, S. Matsuki, H. Sonobe

    Plan Plan
  • ·UP-03.32 : A prospective study into the tolerability of side effects of intravesical BCG in the management of superficial bladder cancer

    Page :294-295

    B. Poh, F. Ng

    Plan Plan
  • ·UP-03.33 : Relation of lymph node positivity and the periods elapsed between the initial and last TURBT with radical cystectomy and number of TURBT in invasive bladder tumors

    Page :295

    O. Ugurlu, O. Adsan, U. Gonulalan, M. Kosan, O. Akdemir, M. Cetinkaya

    Plan Plan
  • ·UP-03.34 : Radical cystectomy and creation of new badder using intestine in bladder cancer

    Page :295

    M. Darabi Mahboob, H. Ahmadnia

    Plan Plan
  • ·UP-03.35 : Comparison of the different intravesical chemotherapy agents effects (mitomycin-C, thiotepa, mitomycin-C+thiotepa, BCG) on superficial transitional cell carcinoma of the bladder after TURBT (over 5 years of experience)

    Page :295-296

    A. Yarmohamadi, S. Yarmohamadi

    Plan Plan
  • ·UP-03.36 : Immunohistochemical analysis of fascin in low and high grade urothelial carcinomas

    Page :296

    F. Karasavvidou, T. Anagnostou, D. Pappa, V. Tzortzis, G. Moutzouris, M. Melekos, G. Koukoulis

    Plan Plan
  • ·UP-03.37 : Preoperative selective internal iliac arterial chemotherapy for invasive bladder cancer

    Page :296

    M. Li, N. Li, Y. Na

    Plan Plan
  • ·UP-03.38 : Comparison of urine nuclear matrix protein 22 (NMP22) qualitative tests and urine cytology in the detection of bladder cancer at first presentation and during surveillance

    Page :296-297

    E. Kehinde, K. Kapila, J. Anim, F. Al-Mulla, O. Mojiminiyi, V. Abraham-Varghese

    Plan Plan
  • ·UP-03.39 : The XPC genotype might affect p53 alteration in muscle-invasive bladder cancer

    Page :297

    S. Sakano, H. Matsumoto, Y. Kawai, J. Akao, S. Eguchi, T. Hara, K. Nagao, C. Ohmi, H. Matsuyama, K. Naito

    Plan Plan
  • ·UP-03.40 : Comparative evaluation of diagnostic performance of urinary bladder cancer antigen and urine cytology in transitional cell carcinoma of the bladder

    Page :297

    D. Mehraban, S. Samadzadeh, M. Moosavi, H. Kayhan

    Plan Plan
  • ·UP-03.41 : Atypical urine cytology: wastebasket or valid diagnostic category?

    Page :297-298

    S. Misra, A. Berresford, G. Stockford

    Plan Plan
  • ·UP-03.42 : A comparison of the urine ThinPrep® test and MAGE A1-6 RT-nested PCR for the diagnosis of bladder cancer with voided, drainage, and irrigated urine samples

    Page :298

    D. Kim, T. Oh, T. Kwon, Y. Seo

    Plan Plan
  • ·UP-03.43 : CT scan and MRI scan findings in metastatic mucin secreting adenocarcinoma of urachal remnant

    Page :298

    M. Omar, M. Sharma, V. Mishra, O. Karim, H. Motiwala

    Plan Plan
  • ·UP-03.44 : False-positive lesions detected by fluorescence cystoscopy: A clue to early malignancy?

    Page :298

    K. Hendricksen, P. Moonen, A. van der Heijden, J. Witjes

    Plan Plan
  • ·UP-03.45 : Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy

    Page :298-299

    F. Cabrera Meirás, O. Blanco Carballo, A. Sanchı́s Bonet, G. Duque Ruiz, A. Martin Parada, A. Tejido Sánchez, O. Leiva Galvis

    Plan Plan
  • ·UP-03.46 : Assessment of levels of amino acids, polyamines, metanephrines and catheholamines in serum and urine samples in patients with carcinoma of the bladder, adenocarcinoma of the prostate and BPH

    Page :299

    C. Slavov, V. Mitev, L. Mateva, B. Benkova, V. Lozanov, E. Popov

    Plan Plan
  • ·UP-03.47 : Efficacy and toxicity of gemcitabine plus cisplatin chemotherapy in advanced or metastatic urothelial carcinoma: The largest single center study from Turkey

    Page :299

    M. Arslan, B. Gunlusoy, T. Degirmenci, N. Nergiz, K. Ýlhan, S. Minareci, A. Ayder

    Plan Plan
  • ·UP-03.48 : Apical injection of periprostatic block gives better pain control than traditional basilar injection

    Page :299-300

    J. Jones, C. Nguyen

    Plan Plan
  • ·UP-03.49 : Gemcitabine plus cisplatine versus methotrexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic transitional cell carcinoma of bladder

    Page :300

    M. Arslan, B. Gunlusoy, T. Degirmenci, N. Nergiz, S. Minareci, A. Ayder

    Plan Plan
  • ·UP-03.50 : Laparoscopic radical cystoprostatectomy with ileal conduit and laparoscopic simple cystectomy with orthotopic bladder reconstruction: Initial 2 cases

    Page :300

    M. Conradie, R. Mierzwinski, F. Nel, G. Dawber

    Plan Plan
  • ·UP-03.51 : “Le Bag” ileocaecal neobladder after radical cystectomy for bladder cancer: results from a contemporary experience

    Page :300

    A. Khan, I. Shergill, M. Arya, K. Mammen

    Plan Plan
  • ·UP-03.52 : Imaging of renal cell carcinoma and prostate cancer using refractive index radiology

    Page :300-301

    C. Yoon, D. Yoon, D. Sung, J. Lee, A. Kim, C. Oh, J. Je, D. Yoon

    Plan Plan
  • ·UP-03.53 : Superficial perineal pouch in males: multidetector-row ct (MDCT) cadaveric study

    Page :301

    C.Y. Yoon, D.J. Sung, D.H. Yoon, S.W. Park, Y.W. Kim, J.J. Kim, D.K. Yoon

    Plan Plan
  • ·UP-03.55 : 11C-acetate PET imaging for renal tumor

    Page :301

    N. Oyama, T. Kaneda, M. Nakai, N. Shioyama, Y. Matsuta, Y. Miwa, O. Yokoyama, H. Okazawa, Y. Fujibayashi, Y. Yonekura

    Plan Plan
  • ·UP-03.56 : Outcome analysis following surgery for female urethral diverticula using validated instruments

    Page :301-302

    R. Rivera, H. Tunuguntla, P. Barboglio, J. Lone, S. Kim, A. Gousse

    Plan Plan
  • ·UP-03.57 : The role of nephrostomy and antegrade stenting in malignant ureteric obstruction

    Page :302

    A. Chowdhury, P. Kumar, C. Lee, V. Nargund, J. Pati

    Plan Plan
  • ·UP-03.58 : Clinical implications of image guided biopsy of the indeterminate renal masses

    Page :302

    B. Somani, G. Nabi, J. Hussey, P. Thorpe, J. N’Dow, S. McClinton

    Plan Plan
  • ·UP-03.59 : Initial clinical experience and design of a custom trans-urethral ultrasound probe for prostate imaging and guidance during minimally invasive prostate procedures

    Page :302-303

    B. Davis, T. Wilson, L. Mynderse, M. Kadri, D. Dull, S. Barnes, N. Hangiandreaou, J. Greenleaf, R. Robb, D. Holmes

    Plan Plan
  • ·UP-03.60 : Does image orientation make a difference in percutaneous renal access?

    Page :303

    R. Kapoor, G. Nitin, M. Anil

    Plan Plan
  • ·UP-03.61 : Estimated GFR: modifying the standards for IVU administration in adult patients

    Page :303

    N. Hersey, J. Beatty

    Plan Plan
  • ·UP-03.62 : Indole-3-carbinol and 3,3’ diindolylmethane induce apoptosis in human prostate cancer cells

    Page :303-304

    A. Stein, B. Appel, M. Nachshon, A. Haj, F. Fares

    Plan Plan
  • ·UP-03.63 : Condylomata acuminata of the lower urinary tract: a case report

    Page :304

    D. Cicin-Sain, N. Kalauz, M. Dominis

    Plan Plan
  • ·UP-03.64 : Pelvic lipomatosis (PL) presenting as obstructive uropathy: a case report

    Page :304

    S. Bapat, P. Ketan, P. Satyajeet, Y. Pushkaraj, P. Abhijit

    Plan Plan
  • ·UP-03.65 : Laparoscopic treatment for renal hydatid cyst

    Page :304-305

    R. Rabii, H. Essaki, A. Joual, F. Meziane

    Plan Plan
  • ·UP-03.66 : Urogenital tuberculosis, a rare disease in Germany. Experiences of a department of urology from 1994 until 2006

    Page :305

    X. Krah, E. Klose, G. Atanassov, G. Eschholz

    Plan Plan
  • ·UP-03.67 : da Vinci^® prostatectomy: athermal nerve sparing technique and its effect on erectile recovery, negative margin rates and time efficiency

    Page :305

    R. Fagin

    Plan Plan
  • ·UP-03.68 : Ureteroscopic management of ureteral injury during gynecological surgery

    Page :305-306

    M. Nikoobakht, G. Pourmand, A. Mehrsai, A. Emamzadeh

    Plan Plan
  • ·UP-03.69 : Preoperative corporal biopsy can predict postoperative results in veno-occlusive erectile dysfunction

    Page :306

    M. Nikoobakht, A. Mehrsai, A. Saraji, A. Meysami, A. Emamzadeh

    Plan Plan
  • ·UP-03.70 : The relationship between lipid profile and erectile dysfunction

    Page :306

    M. Nikoobakht, A. Emamzadeh, H. Nasseh, G. Pourmand, A. Mehrsai

    Plan Plan
  • ·UP-03.71 : Assessment of sexual function (libido, potency, fertility) in patients before and after renal transplantation

    Page :306

    M. Mahboob Darabi, H. Ahmadnia, R. Taghavi

    Plan Plan
  • ·UP-03.72 : Incidence of prostate diseases and analysis of sexual function after prostatic biopsy

    Page :306-307

    S. Dutkiewicz

    Plan Plan
  • ·UP-03.73 : Slow releasing antibiotics membrane coated penile prosthesis in preventing prosthetic infections: an experimental rabbit model

    Page :307

    D. Tuglu, M. Basar, G. Bayramoglu, Y. Arica, D. Kilic, O. Bozdogan, E. Batislam

    Plan Plan
  • ·UP-03.74 : Sulcus nervi dorsalis penis/clitoridis: a previously unreported pubic structure and its clinical use

    Page :307

    L. Jarolim, J. Sedy, O. Nanka, J. Walro

    Plan Plan
  • ·UP-03.75 : Comparing sexual function between suprapubic prostatectomy and TURP in patient with BPH

    Page :307-308

    M. Razaghi, S. Hoseini, H. Kaeami, M. Barghi, S. Niknam

    Plan Plan
  • ·UP-03.76 : Evaluation of treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors

    Page :308

    P. Chandrasekar, G. Krishnamoorthy, V. Sundarajan, B. Potluri

    Plan Plan
  • ·UP-03.77 : Farsi International Index of Erectile Function questionnaire as a screening tool before the performance of Doppler sonography in Iranian impotent men

    Page :308

    D. Mehraban, S. Shabani-Nia, G. Naderi, S. Kazemeyni, P. Araghi, M. Sedighi, A. Razi

    Plan Plan
  • ·UP-03.78 : A novel technique for insertion of semi rigid penile prosthesis in completely fibrosed corpora

    Page :308-309

    M. Omar, V. Mishra, O. Karim, H. Motiwala

    Plan Plan
  • ·UP-03.79 : Comparison of sexual activity in smokers and non-smoker men

    Page :309

    M. Hosseini, H. Yarmohammadi

    Plan Plan
  • ·UP-03.80 : Chronic pelvic pain in a male patient: joint view of a urologist and an anatomist

    Page :309

    M. Urban, V. Báca, R. Grill, V. Džupa, J. Herácek

    Plan Plan
  • ·UP-03.81 : Urodynamic analysis of men with normal prostate less than 20g combined with lower urinary tract symptoms

    Page :309

    Y. Kim, J. Huh, J. Lee

    Plan Plan
  • ·UP-03.82 : IVS: A successful technique in treatment of patients with stress urinary incontinence

    Page :309-310

    M. Darabi Mahboob, M. Keshvari, H. Ahmadnia

    Plan Plan
  • ·UP-03.83 : Abstract Withdrawn

    Page :310

    
  • ·UP-03.84 : Urinary urgency: using urodynamic parameters to differentiate detrusor overactivity with and without incontinence

    Page :310

    B. Stahl, N. Dwyer, K. Kreder

    Plan Plan
  • ·UP-03.85 : Comparative effects of duloxetine, besipirdine, and clomipramine on striated sphincter activity and bladder function in a rabbit model

    Page :310-311

    R. Vela Navarrete, F. Pérez Martı́nez, C. Castilla Reparaz, J. Ferté, H. Bienaymé, P. Attali

    Plan Plan
  • ·UP-03.86 : Credibility of abdominal leak point pressure in evaluation of stress urinary incontinence

    Page :311

    S. Yande

    Plan Plan
  • ·UP-03.87 : Systematic approach to diagnosis of genitourinary fistula in women

    Page :311

    M. Abdallah, N. Bissada, A. Feinkbeinar

    Plan Plan  
  • ·UP-03.88 : Bladder and urethral duplication: a case report

    Page :312

    S. Bapat, K. Pai, S. Purnapatre, P. Yadav, A. Padhye

    Plan Plan
  • ·UP-03.89 : Transobturator vaginal tape technique with the use of renal pedicle clamp in female stress urinary incontinence treatment

    Page :312

    S. Onol, F. Onol, H. Inal, S. Onur, O. Kose

    Plan Plan
  • ·UP-03.90 : Study of pelvic organ prolapse with dynamic MR imaging

    Page :312

    T. Realfonso, A. Manto, A. Cozzolino, U. Di Mauro, G. Napodano, R. Sanseverino

    Plan Plan
  • ·UP-03.91 : A new air-based technique in measurement of urethra pressure profile—T-doc system

    Page :312

    S. Laschke, S. Carl

    Plan Plan
  • ·UP-03.92 : Cyclooxigenase-2 expression in pTa/pT1 urothelial bladder carcinoma: the association between immunoreactivity location and tumour recurrence

    Page :312-313

    I. Mokos, J. Pasini, J. Jakic-Razumovic

    Plan Plan
  • ·UP-03.93 : 20q13 gain is associated with chromosomal instability in transitional cell carcinomas of the upper urinary tract

    Page :313

    J. Akao, H. Mastuyama, Y. Yamamoto, S. Sakano, K. Naito

    Plan Plan
  • ·UP-03.94 : Subdivision of Stage pT3 in urothelial carcinoma of the renal pelvis facilitates detection of patients at high risk for failure

    Page :313-314

    R. Zigeuner, G. Hutterer, T. Chromecki, P. Rehak, C. Langner

    Plan Plan
  • ·UP-03.95 : EGFR expression in urothelial carcinoma of the upper urinary tract correlates with disease progression and metaplastic morphology

    Page :314

    R. Zigeuner, G. Hutterer, T. Chromecki, S. Leibl, P. Rehak, C. Langner

    Plan Plan
  • ·UP-03.96 : Impact of tumor stage, tumor grade, and vascular invasion on metastasis-free survival of patients with urothelial carcinoma of the upper urinary tract

    Page :314

    G. Hutterer, R. Zigeuner, T. Chromecki, S. Leibl, P. Rehak, C. Langner

    Plan Plan
  • ·UP-03.97 : Biological significance of squamous and glandular differentiation in urothelial cell carcinoma of the upper urinary tract

    Page :314-315

    G. Hutterer, R. Zigeuner, T. Chromecki, P. Rehak, C. Langner

    Plan Plan
  • ·UP-03.98 : Radical cystectomy for invasive bladder cancer in patients eighty years or older: clinical parameters affecting morbidity

    Page :315

    M. Brausi, M. Gavioli, G. Verrini, G. Peracchia, G. de Luca, G. Simonini, M. Viola

    Plan Plan
  • ·UP-03.99 : Bladder tumor development after transitional cell carcinoma of the upper urinary tract is related to tumor location

    Page :315

    T. Chromecki, R. Zigeuner, G. Hutterer, P. Rehak, C. Langner

    Plan Plan
  • ·UP-03.100 : COX-2 expression in urothelial carcinomas of the upper urinary tract correlates with tumor progression

    Page :315-316

    T. Chromecki, R. Zigeuner, G. Hutterer, P. Rehak, C. Langner

    Plan Plan
  • ·UP-03.101 : Refining of the NMP22 in the diagnosis of bladder cancer

    Page :316

    C. Noh, J. Kim, S. Kim, R. Sung

    Plan Plan